Du benytter en nettleser vi ikke støtter. Se informasjon om nettlesere

12. Referanser

Abeler, V. M., & Kjørstad, K. E. (1991). Endometrial adenocarcinoma in Norway. A study of a total population. Cancer, 67(12), 3093-3103.

Abu-Rustum, N. R., & Aghajanian, C. (1998). Management of malignant germ cell tumors of the ovary. Seminars in Oncology, 25(2), 235-242.

Albrektsen, G., Heuch, I., Wik, E., & Salvesen, H. B. (2009). Parity and time interval since childbirth influence survival in endometrial cancer patients. International Journal of Gynecological Cancer, 19(4), 665-669. https://doi.org/10.1111/IGC.0b013e3181a3e1bf

Ali, A. T. (2014). Reproductive factors and the risk of endometrial cancer. International Journal of Gynecological Cancer, 24(3), 384-393. https://doi.org/10.1097/igc.0000000000000075

Amant, F., Halaska, M. J., Fumagalli, M., Dahl Steffensen, K., Lok, C., Van Calsteren, K., . . . Nulman, I. (2014). Gynecologic cancers in pregnancy: guidelines of a second international consensus meeting. International Journal of Gynecological Cancer, 24(3), 394-403. https://doi.org/10.1097/igc.0000000000000062

Amant, F., Moerman, P., Neven, P., Timmerman, D., Van Limbergen, E., & Vergote, I. (2005). Endometrial cancer. Lancet, 366(9484), 491-505. https://doi.org/10.1016/s0140-6736(05)67063-8

Anastasiadis, P. G., Koutlaki, N. G., Skaphida, P. G., Galazios, G. C., Tsikouras, P. N., & Liberis, V. A. (2000). Endometrial polyps: prevalence, detection, and malignant potential in women with abnormal uterine bleeding. European Journal of Gynaecological Oncology, 21(2), 180-183.

Andreyev, H. J., Benton, B. E., Lalji, A., Norton, C., Mohammed, K., Gage, H., . . . Lindsay, J. O. (2013). Algorithm-based management of patients with gastrointestinal symptoms in patients after pelvic radiation treatment (ORBIT): a randomised controlled trial. Lancet, 382(9910), 2084-2092. https://doi.org/10.1016/s0140-6736(13)61648-7

Andreyev, H. J., Davidson, S. E., Gillespie, C., Allum, W. H., & Swarbrick, E. (2012). Practice guidance on the management of acute and chronic gastrointestinal problems arising as a result of treatment for cancer. Gut, 61(2), 179-192. https://doi.org/10.1136/gutjnl-2011-300563

Andreyev, H. J., Muls, A. C., Norton, C., Ralph, C., Watson, L., Shaw, C., & Lindsay, J. O. (2015). Guidance: The practical management of the gastrointestinal symptoms of pelvic radiation disease. Frontline Gastroenterol, 6(1), 53-72. https://doi.org/10.1136/flgastro-2014-100468

Andreyev, H. J., Wotherspoon, A., Denham, J. W., & Hauer-Jensen, M. (2010). Defining pelvic-radiation disease for the survivorship era. Lancet Oncology, 11(4), 310-312. https://doi.org/10.1016/s1470-2045(10)70026-7

Anraku, M., Yokoi, K., Nakagawa, K., Fujisawa, T., Nakajima, J., Akiyama, H., . . . Kobayashi, K. (2004). Pulmonary metastases from uterine malignancies: results of surgical resection in 133 patients. Journal of Thoracic and Cardiovascular Surgery, 127(4), 1107-1112. https://doi.org/10.1016/j.jtcvs.2003.10.011

Ansink, A., & van der Velden, J. (2000). Surgical interventions for early squamous cell carcinoma of the vulva. Cochrane Database of Systematic Reviews, (2), CD002036. https://doi.org/10.1002/14651858.cd002036

Antoniou, A., Pharoah, P. D., Narod, S., Risch, H. A., Eyfjord, J. E., Hopper, J. L., . . . Easton, D. F. (2003). Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. American Journal of Human Genetics, 72(5), 1117-1130. https://doi.org/10.1086/375033

Arbyn, M., Redman, C. W. E., Verdoodt, F., Kyrgiou, M., Tzafetas, M., Ghaem-Maghami, S., . . . Moss, E. L. (2017). Incomplete excision of cervical precancer as a predictor of treatment failure: a systematic review and meta-analysis. Lancet Oncology, 18(12), 1665-1679. https://doi.org/10.1016/s1470-2045(17)30700-3

Arbyn, M., Tommasino, M., Depuydt, C., & Dillner, J. (2014). Are 20 human papillomavirus types causing cervical cancer? Journal of Pathology, 234(4), 431-435. https://doi.org/10.1002/path.4424

ASTEC study group, Kitchener, H., Swart, A. M., Qian, Q., Amos, C., & Parmar, M. K. (2009). Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet, 373(9658), 125-136. https://doi.org/10.1016/s0140-6736(08)61766-3

Aviki, E. M., Esselen, K. M., Barcia, S. M., Nucci, M. R., Horowitz, N. S., Feltmate, C. M., . . . Muto, M. G. (2015). Does plastic surgical consultation improve the outcome of patients undergoing radical vulvectomy for squamous cell carcinoma of the vulva? Gynecologic Oncology, 137(1), 60-65. https://doi.org/10.1016/j.ygyno.2015.02.001

Bachmann, C., Bachmann, R., Brucker, S. Y., Staebler, A., Fend, F., Grischke, E. M., & Wallwiener, D. (2015). Role of Pelvic and Para-aortic Lymph Node Metastases in Optimally Cytoreduced Advanced Ovarian Cancer. Anticancer Research, 35(6), 3479-3484.

Bachmann, L. M., ter Riet, G., Clark, T. J., Gupta, J. K., & Khan, K. S. (2003). Probability analysis for diagnosis of endometrial hyperplasia and cancer in postmenopausal bleeding: an approach for a rational diagnostic workup. Acta Obstetricia et Gynecologica Scandinavica, 82(6), 564-569. https://doi.org/10.1034/j.1600-0412.2003.00176.x

Baergen, R. N., Rutgers, J. L., Young, R. H., Osann, K., & Scully, R. E. (2006). Placental site trophoblastic tumor: A study of 55 cases and review of the literature emphasizing factors of prognostic significance. Gynecologic Oncology, 100(3), 511-520. https://doi.org/10.1016/j.ygyno.2005.08.058

Baker, W. D., Pierce, S. R., Mills, A. M., Gehrig, P. A., & Duska, L. R. (2017). Nonoperative management of atypical endometrial hyperplasia and grade 1 endometrial cancer with the levonorgestrel intrauterine device in medically ill post-menopausal women. Gynecologic Oncology, 146(1), 34-38. https://doi.org/10.1016/j.ygyno.2017.04.006

Ballester, M., Dubernard, G., Lécuru, F., Heitz, D., Mathevet, P., Marret, H., . . . Daraï, E. (2011). Detection rate and diagnostic accuracy of sentinel-node biopsy in early stage endometrial cancer: a prospective multicentre study (SENTI-ENDO). Lancet Oncology, 12(5), 469-476. https://doi.org/10.1016/s1470-2045(11)70070-5

Balleyguier, C., Sala, E., Da Cunha, T., Bergman, A., Brkljacic, B., Danza, F., . . . Kinkel, K. (2011). Staging of uterine cervical cancer with MRI: guidelines of the European Society of Urogenital Radiology. European Radiology, 21(5), 1102-1110. https://doi.org/10.1007/s00330-010-1998-x

Banno, K., Yanokura, M., Kobayashi, Y., Kawaguchi, M., Nomura, H., Hirasawa, A., . . . Aoki, D. (2009). Endometrial cancer as a familial tumor: pathology and molecular carcinogenesis (review). Curr Genomics, 10(2), 127-132. https://doi.org/10.2174/138920209787847069

Barakat, R., Hensley, M. L., Bhaskaran, D., Rastogi, P., Korytowsky, B., Boyd, J., . . . Offit, K. (2002). Prophylactic Oophorectomy in Patients at Risk for Hereditary Ovarian Carcinoma. Gynecologic Oncology, 84(3), 482.

Barakat, R. R., Bundy, B. N., Spirtos, N. M., Bell, J., & Mannel, R. S. (2006). Randomized double-blind trial of estrogen replacement therapy versus placebo in stage I or II endometrial cancer: a Gynecologic Oncology Group Study. Journal of Clinical Oncology, 24(4), 587-592. https://doi.org/10.1200/jco.2005.02.8464

Barlin, J. N., Khoury-Collado, F., Kim, C. H., Leitao, M. M., Jr., Chi, D. S., Sonoda, Y., . . . Abu-Rustum, N. R. (2012). The importance of applying a sentinel lymph node mapping algorithm in endometrial cancer staging: beyond removal of blue nodes. Gynecologic Oncology, 125(3), 531-535. https://doi.org/10.1016/j.ygyno.2012.02.021

Barrow, E., Robinson, L., Alduaij, W., Shenton, A., Clancy, T., Lalloo, F., . . . Evans, D. G. (2009). Cumulative lifetime incidence of extracolonic cancers in Lynch syndrome: a report of 121 families with proven mutations. Clinical Genetics, 75(2), 141-149. https://doi.org/10.1111/j.1399-0004.2008.01125.x

Baxter, N. N., Habermann, E. B., Tepper, J. E., Durham, S. B., & Virnig, B. A. (2005). Risk of pelvic fractures in older women following pelvic irradiation. JAMA, 294(20), 2587-2593. https://doi.org/10.1001/jama.294.20.2587

Beller, U., Quinn, M. A., Benedet, J. L., Creasman, W. T., Ngan, H. Y., Maisonneuve, P., . . . Heintz, A. P. (2006). Carcinoma of the vulva. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. International Journal of Gynaecology and Obstetrics, 95 Suppl 1, S7-27. https://doi.org/10.1016/s0020-7292(06)60028-3

Benedetti Panici, P., Basile, S., Maneschi, F., Alberto Lissoni, A., Signorelli, M., Scambia, G., . . . Mangioni, C. (2008). Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. Journal of the National Cancer Institute, 100(23), 1707-1716. https://doi.org/10.1093/jnci/djn397

Bennett, M. H., Feldmeier, J., Hampson, N. B., Smee, R., & Milross, C. (2016). Hyperbaric oxygen therapy for late radiation tissue injury. Cochrane Database of Systematic Reviews, 4(4), CD005005. https://doi.org/10.1002/14651858.CD005005.pub4

Bentivegna, E., Morice, P., Uzan, C., & Gouy, S. (2016). Fertility-sparing surgery in epithelial ovarian cancer. Future Oncology (London, England), 12(3), 389-398. https://doi.org/10.2217/fon.15.319

Berek, J. S., & Hacker, N. F. (2010). Nonepitelial ovarian and fallopian tube cancers. I: J. S. Berek & N. F. Hacker (red.), Practical Gynecologic Oncology (s. 509-536). Philadelphia: Lippincott Williams & Wilkins.

Bergeron, C., Nogales, F. F., Masseroli, M., Abeler, V., Duvillard, P., Müller-Holzner, E., . . . Wells, M. (1999). A multicentric European study testing the reproducibility of the WHO classification of endometrial hyperplasia with a proposal of a simplified working classification for biopsy and curettage specimens. American Journal of Surgical Pathology, 23(9), 1102-1108. https://doi.org/10.1097/00000478-199909000-00014

Berkowitz, R. S., & Goldstein, D. P. (1994). Gestational Trophoblastic Neoplasia. I: J. S. Berek & N. F. Hacker (red.), Practical gynecologic oncology (2. utg., s. 457–478). Baltimore: Williams & Wilkins.

Bese, N. S., Hendry, J., & Jeremic, B. (2007). Effects of prolongation of overall treatment time due to unplanned interruptions during radiotherapy of different tumor sites and practical methods for compensation. International Journal of Radiation Oncology, Biology, Physics, 68(3), 654-661. https://doi.org/10.1016/j.ijrobp.2007.03.010

Bhatla, N., Aoki, D., Sharma, D. N., & Sankaranarayanan, R. (2018). Cancer of the cervix uteri. International Journal of Gynecology and Obstetrics, 143(Supplement 2), 22-36. https://doi.org/http://dx.doi.org/10.1002/ijgo.12611

Biglia, N., Zanfagnin, V., Daniele, A., Robba, E., & Bounous, V. E. (2017). Lower Body Lymphedema in Patients with Gynecologic Cancer. Anticancer Research, 37(8), 4005-4015. https://doi.org/10.21873/anticanres.11785

Billmire, D., Vinocur, C., Rescorla, F., Cushing, B., London, W., Schlatter, M., . . . Olson, T. (2004). Outcome and staging evaluation in malignant germ cell tumors of the ovary in children and adolescents: an intergroup study. Journal of Pediatric Surgery, 39(3), 424-429; discussion 424-429.

Bisharah, M., & Tulandi, T. (2003). Laparoscopic preservation of ovarian function: an underused procedure. American Journal of Obstetrics and Gynecology, 188(2), 367-370. https://doi.org/10.1067/mob.2003.38

Bjarnason, K., Cerin, A., Lindgren, R., & Weber, T. (1999). Adverse endometrial effects during long cycle hormone replacement therapy. Scandinavian Long Cycle Study Group. Maturitas, 32(3), 161-170. https://doi.org/10.1016/s0378-5122(99)00033-x

Bjørge, T., Engeland, A., Hansen, S., & Tropé, C. G. (1998). Prognosis of patients with ovarian cancer and borderline tumours diagnosed in Norway between 1954 and 1993. International Journal of Cancer, 75(5), 663-670.

Björkholm, E. (2000). Vulvacancer (Rapport / Svensk förenings för obstetrik och gynekologi arbets- och referensgrupp nr. 44). Stockholm: Svenska läkaresällskapet.

Blackledge, G., Lawton, F., Redman, C., & Kelly, K. (1989). Response of patients in phase II studies of chemotherapy in ovarian cancer: implications for patient treatment and the design of phase II trials. British Journal of Cancer, 59(4), 650-653. https://doi.org/10.1038/bjc.1989.132

Board of Faculty of Clinical Oncology. (2008). The timely delivery of radical radiotherapy: standards and guidelines for the management of unscheduled treatment interruptions (3. utg.). London: The Royal College of Radiologists.

Bodurka-Bevers, D., Morris, M., Eifel, P. J., Levenback, C., Bevers, M. W., Lucas, K. R., & Wharton, J. T. (2000). Posttherapy surveillance of women with cervical cancer: an outcomes analysis. Gynecologic Oncology, 78(2), 187-193. https://doi.org/10.1006/gyno.2000.5860

Bogani, G., Mariani, A., Paolini, B., Ditto, A., & Raspagliesi, F. (2019). Low-volume disease in endometrial cancer: The role of micrometastasis and isolated tumor cells. Gynecologic Oncology, 153(3), 670-675. https://doi.org/10.1016/j.ygyno.2019.02.027

Bollineni, V. R., Ytre-Hauge, S., Bollineni-Balabay, O., Salvesen, H. B., & Haldorsen, I. S. (2016). High Diagnostic Value of 18F-FDG PET/CT in Endometrial Cancer: Systematic Review and Meta-Analysis of the Literature. Journal of Nuclear Medicine, 57(6), 879-885. https://doi.org/10.2967/jnumed.115.170597

Bonadona, V., Bonaïti, B., Olschwang, S., Grandjouan, S., Huiart, L., Longy, M., . . . Bonaiti-Pellie, C. (2011). Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome. JAMA, 305(22), 2304-2310. https://doi.org/10.1001/jama.2011.743

Bosch, F. X., Broker, T. R., Forman, D., Moscicki, A. B., Gillison, M. L., Doorbar, J., . . . de Sanjose, S. (2013). Comprehensive control of human papillomavirus infections and related diseases. Vaccine, 31 Suppl 7, H1-31. https://doi.org/10.1016/j.vaccine.2013.10.003

Bouchard-Fortier, G., Reade, C. J., & Covens, A. (2014). Non-radical surgery for small early-stage cervical cancer. Is it time? Gynecologic Oncology, 132(3), 624-627. https://doi.org/10.1016/j.ygyno.2014.01.037

Boulware, R. J., Caderao, J. B., Delclos, L., Wharton, J. T., & Peters, L. J. (1979). Whole pelvis megavoltage irradiation with single doses of 1000 rad to palliate advanced gynecologic cancers. International Journal of Radiation Oncology, Biology, Physics, 5(3), 333-338. https://doi.org/10.1016/0360-3016(79)91212-4

Bourgioti, C., Chatoupis, K., & Moulopoulos, L. A. (2016). Current imaging strategies for the evaluation of uterine cervical cancer. World J Radiol, 8(4), 342-354. https://doi.org/10.4329/wjr.v8.i4.342

Bowring, J., Strander, B., Young, M., Evans, H., & Walker, P. (2010). The Swede score: evaluation of a scoring system designed to improve the predictive value of colposcopy. Journal of Lower Genital Tract Disease, 14(4), 301-305. https://doi.org/10.1097/LGT.0b013e3181d77756

Brewer, M., Gershenson, D. M., Herzog, C. E., Mitchell, M. F., Silva, E. G., & Wharton, J. T. (1999). Outcome and reproductive function after chemotherapy for ovarian dysgerminoma. Journal of Clinical Oncology, 17(9), 2670-2675.

Brinton, L. A., James, V. L., & Sherman, M. E. (2009). Epidemiology of Gynecologic Cancers. I: R. R. Barakat, M. Markman, & M. E. Randall (red.), Principles and Practice of Gynecologic Oncology (5. utg., s. 1-30). Baltimore: Lippincott Williams & Wilkins.

Bristow, R. E., & Chi, D. S. (2006). Platinum-based neoadjuvant chemotherapy and interval surgical cytoreduction for advanced ovarian cancer: a meta-analysis. Gynecologic Oncology, 103(3), 1070-1076. https://doi.org/10.1016/j.ygyno.2006.06.025

Bristow, R. E., Puri, I., & Chi, D. S. (2009). Cytoreductive surgery for recurrent ovarian cancer: a meta-analysis. Gynecologic Oncology, 112(1), 265-274. https://doi.org/10.1016/j.ygyno.2008.08.033

Bristow, R. E., Santillan, A., Diaz-Montes, T. P., Gardner, G. J., Giuntoli, R. L., 2nd, Meisner, B. C., . . . Armstrong, D. K. (2007). Centralization of care for patients with advanced-stage ovarian cancer: a cost-effectiveness analysis. Cancer, 109(8), 1513-1522. https://doi.org/10.1002/cncr.22561

Brohet, R. M., Goldgar, D. E., Easton, D. F., Antoniou, A. C., Andrieu, N., Chang-Claude, J., . . . Rookus, M. A. (2007). Oral contraceptives and breast cancer risk in the international BRCA1/2 carrier cohort study: a report from EMBRACE, GENEPSO, GEO-HEBON, and the IBCCS Collaborating Group. Journal of Clinical Oncology, 25(25), 3831-3836. https://doi.org/10.1200/JCO.2007.11.1179

Brooks, R. A., Rader, J. S., Dehdashti, F., Mutch, D. G., Powell, M. A., Thaker, P. H., . . . Grigsby, P. W. (2009). Surveillance FDG-PET detection of asymptomatic recurrences in patients with cervical cancer. Gynecologic Oncology, 112(1), 104-109. https://doi.org/10.1016/j.ygyno.2008.08.028

Buamah, P. K., Rake, M. O., Drake, S. R., & Skillen, A. W. (1990). Serum CA 12-5 concentrations and CA 12-5/CEA ratios in patients with epithelial ovarian cancer. Journal of Surgical Oncology, 44(2), 97-99. https://doi.org/10.1002/jso.2930440207

Buchali, A., Koswig, S., Dinges, S., Rosenthal, P., Salk, J., Lackner, G., . . . Budach, V. (1999). Impact of the filling status of the bladder and rectum on their integral dose distribution and the movement of the uterus in the treatment planning of gynaecological cancer. Radiotherapy and Oncology, 52(1), 29-34. https://doi.org/10.1016/s0167-8140(99)00068-7

Buchanan, D. D., Rosty, C., Clendenning, M., Spurdle, A. B., & Win, A. K. (2014). Clinical problems of colorectal cancer and endometrial cancer cases with unknown cause of tumor mismatch repair deficiency (suspected Lynch syndrome). Appl Clin Genet, 7, 183-193. https://doi.org/10.2147/tacg.S48625

Burger, C. W., Van De Swaluw, A., Mooij, T. M., & Van Leeuwen, F. E. (2009). Risk of borderline and invasive ovarian tumors after ovarian stimulation for in vitro fertilization in a large Dutch cohort after 15 years of follow-up. Gynecologic Oncology, 1, S4-S5. https://doi.org/http://dx.doi.org/10.1016/j.ygyno.2008.10.020

Baak, J. P., Mutter, G. L., Robboy, S., van Diest, P. J., Uyterlinde, A. M., Orbo, A., . . . Verheijen, R. H. (2005). The molecular genetics and morphometry-based endometrial intraepithelial neoplasia classification system predicts disease progression in endometrial hyperplasia more accurately than the 1994 World Health Organization classification system. Cancer, 103(11), 2304-2312. https://doi.org/10.1002/cncr.21058

Baak, J. P., Nauta, J. J., Wisse-Brekelmans, E. C., & Bezemer, P. D. (1988). Architectural and nuclear morphometrical features together are more important prognosticators in endometrial hyperplasias than nuclear morphometrical features alone. Journal of Pathology, 154(4), 335-341. https://doi.org/10.1002/path.1711540409

Baak, J. P., Wisse-Brekelmans, E. C., Fleege, J. C., van der Putten, H. W., & Bezemer, P. D. (1992). Assessment of the risk on endometrial cancer in hyperplasia, by means of morphological and morphometrical features. Pathology, Research and Practice, 188(7), 856-859. https://doi.org/10.1016/s0344-0338(11)80244-x

Baak, J. P., Ørbo, A., van Diest, P. J., Jiwa, M., de Bruin, P., Broeckaert, M., . . . Kenemans, P. (2001). Prospective multicenter evaluation of the morphometric D-score for prediction of the outcome of endometrial hyperplasias. American Journal of Surgical Pathology, 25(7), 930-935. https://doi.org/10.1097/00000478-200107000-00012

Baasland, I., Hagen, B., Vogt, C., Valla, M., & Romundstad, P. R. (2016). Colposcopy and additive diagnostic value of biopsies from colposcopy-negative areas to detect cervical dysplasia. Acta Obstetricia et Gynecologica Scandinavica, 95(11), 1258-1263. https://doi.org/10.1111/aogs.13009

Cadron, I., Leunen, K., Van Gorp, T., Amant, F., Neven, P., & Vergote, I. (2007). Management of borderline ovarian neoplasms. Journal of Clinical Oncology, 25(20), 2928-2937. https://doi.org/10.1200/jco.2007.10.8076

Camara, O., & Sehouli, J. (2009). Controversies in the management of ovarian cancer--pros and cons for lymph node dissection in ovarian cancer. Anticancer Research, 29(7), 2837-2843.

Camatte, S., Morice, P., Thoury, A., Fourchotte, V., Pautier, P., Lhomme, C., . . . Castaigne, D. (2004). Impact of surgical staging in patients with macroscopic "stage I" ovarian borderline tumours: analysis of a continuous series of 101 cases. European Journal of Cancer, 40(12), 1842-1849. https://doi.org/10.1016/j.ejca.2004.04.017

Cancer Facts & Figures 2013. (2013). Atlanta: American Cancer Society. Hentet fra http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/document/acspc-036845.pdf

Casey, S., Harley, I., Jamison, J., Molijn, A., van den Munckhof, H., & McCluggage, W. G. (2015). A rare case of HPV-negative cervical squamous cell carcinoma. International Journal of Gynecological Pathology, 34(2), 208-212. https://doi.org/10.1097/pgp.0000000000000132

Castle, P. E., Schiffman, M., Herrero, R., Hildesheim, A., Rodriguez, A. C., Bratti, M. C., . . . Burk, R. D. (2005). A prospective study of age trends in cervical human papillomavirus acquisition and persistence in Guanacaste, Costa Rica. Journal of Infectious Diseases, 191(11), 1808-1816. https://doi.org/10.1086/428779

Castle, P. E., Schiffman, M., Wheeler, C. M., & Solomon, D. (2009). Evidence for frequent regression of cervical intraepithelial neoplasia-grade 2. Obstetrics and Gynecology, 113(1), 18-25. https://doi.org/10.1097/AOG.0b013e31818f5008

Cervixcancerprevention: riktlinjer för utredning, behandling och uppföljning av cervikal intraepitelial neoplasi (CIN). (2010). (Arbets- och Referensgruppen för Cervixcancerprevention Nr 63 2010). Umå: Svensk Förening för Obstetrik och Gynekologi. Hentet fra https://www.sfog.se/media/18454/intro_arg63_.pdf

Cetina, L., Garcia-Arias, A., Uribe Mde, J., Candelaria, M., Rivera, L., Oñate-Ocaña, L., . . . Dueñas-Gonzalez, A. (2008). Concurrent chemoradiation with carboplatin for elderly, diabetic and hypertensive patients with locally advanced cervical cancer. European Journal of Gynaecological Oncology, 29(6), 608-612.

Chai, Y., Wang, T., Wang, J., Yang, Y., Gao, Y., Gao, J., . . . Liu, Z. (2014). Radical hysterectomy with adjuvant radiotherapy versus radical radiotherapy for FIGO stage IIB cervical cancer. BMC Cancer, 14, 63. https://doi.org/10.1186/1471-2407-14-63

Champer, M., Huang, Y., Hou, J. Y., Tergas, A. I., Burke, W. M., Hillyer, G. C., . . . Wright, J. D. (2018). Adherence to treatment recommendations and outcomes for women with ovarian cancer at first recurrence. Gynecologic Oncology, 148(1), 19-27. https://doi.org/10.1016/j.ygyno.2017.11.008

Chan, J. K., Cheung, M. K., Huh, W. K., Osann, K., Husain, A., Teng, N. N., & Kapp, D. S. (2006). Therapeutic role of lymph node resection in endometrioid corpus cancer: a study of 12,333 patients. Cancer, 107(8), 1823-1830. https://doi.org/10.1002/cncr.22185

Chan, J. K., Lin, Y. G., Loizzi, V., Ghobriel, M., DiSaia, P. J., & Berman, M. L. (2003). Borderline ovarian tumors in reproductive-age women. Fertility-sparing surgery and outcome. Journal of Reproductive Medicine, 48(10), 756-760.

Chan, J. K., Sugiyama, V., Pham, H., Gu, M., Rutgers, J., Osann, K., . . . Disaia, P. J. (2007). Margin distance and other clinico-pathologic prognostic factors in vulvar carcinoma: a multivariate analysis. Gynecologic Oncology, 104(3), 636-641. https://doi.org/10.1016/j.ygyno.2006.10.004

Chan, J. K., Tian, C., Teoh, D., Monk, B. J., Herzog, T., Kapp, D. S., & Bell, J. (2010). Survival after recurrence in early-stage high-risk epithelial ovarian cancer: a Gynecologic Oncology Group study. Gynecologic Oncology, 116(3), 307-311. https://doi.org/10.1016/j.ygyno.2009.10.074

Charra-Brunaud, C., Harter, V., Delannes, M., Haie-Meder, C., Quetin, P., Kerr, C., . . . Peiffert, D. (2012). Impact of 3D image-based PDR brachytherapy on outcome of patients treated for cervix carcinoma in France: results of the French STIC prospective study. Radiotherapy and Oncology, 103(3), 305-313. https://doi.org/10.1016/j.radonc.2012.04.007

Chemoradiotherapy for Cervical Cancer Meta-analysis Collaboration (CCCMAC). (2010). Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: individual patient data meta-analysis. Cochrane Database of Systematic Reviews, 2010(1), CD008285. https://doi.org/10.1002/14651858.Cd008285

Chemotherapy Followed By Surgery Vs Radiotherapy Plus Chemotherapy in Patients With Stage IB or II Cervical Cancer [pågående studie]. (2002-2019). (NCT00039338). Hentet fra https://clinicaltrials.gov/ct2/show/NCT00039338

Chi, D. S., Eisenhauer, E. L., Lang, J., Huh, J., Haddad, L., Abu-Rustum, N. R., . . . Barakat, R. R. (2006). What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)? Gynecologic Oncology, 103(2), 559-564. https://doi.org/10.1016/j.ygyno.2006.03.051

Chittenden, B. G., Fullerton, G., Maheshwari, A., & Bhattacharya, S. (2009). Polycystic ovary syndrome and the risk of gynaecological cancer: a systematic review. Reprod Biomed Online, 19(3), 398-405. https://doi.org/10.1016/s1472-6483(10)60175-7

Chiva, L., Zanagnolo, V., Querleu, D., Martin-Calvo, N., Arévalo-Serrano, J., Căpîlna, M. E., . . . Alcazar, J. L. (2020). SUCCOR study: an international European cohort observational study comparing minimally invasive surgery versus open abdominal radical hysterectomy in patients with stage IB1 cervical cancer. International Journal of Gynecological Cancer, 30(9), 1269-1277. https://doi.org/10.1136/ijgc-2020-001506

Choi, C. W., Cho, C. K., Yoo, S. Y., Kim, M. S., Yang, K. M., Yoo, H. J., . . . Kim, B. J. (2009). Image-guided stereotactic body radiation therapy in patients with isolated para-aortic lymph node metastases from uterine cervical and corpus cancer. International Journal of Radiation Oncology, Biology, Physics, 74(1), 147-153. https://doi.org/10.1016/j.ijrobp.2008.07.020

Chou, H. H., Wang, C. C., Lai, C. H., Hong, J. H., Ng, K. K., Chang, T. C., . . . Chang, J. T. (2001). Isolated paraaortic lymph node recurrence after definitive irradiation for cervical carcinoma. International Journal of Radiation Oncology, Biology, Physics, 51(2), 442-448. https://doi.org/10.1016/s0360-3016(01)01628-5

Chung, H. C., Ros, W., Delord, J. P., Perets, R., Italiano, A., Shapira-Frommer, R., . . . Leary, A. (2019). Efficacy and Safety of Pembrolizumab in Previously Treated Advanced Cervical Cancer: Results From the Phase II KEYNOTE-158 Study. Journal of Clinical Oncology, 37(17), 1470-1478. https://doi.org/10.1200/jco.18.01265

Chung, H. H., Kim, S. K., Kim, T. H., Lee, S., Kang, K. W., Kim, J. Y., & Park, S. Y. (2006). Clinical impact of FDG-PET imaging in post-therapy surveillance of uterine cervical cancer: from diagnosis to prognosis. Gynecologic Oncology, 103(1), 165-170. https://doi.org/10.1016/j.ygyno.2006.02.016

Cibula, D., Pötter, R., Planchamp, F., Avall-Lundqvist, E., Fischerova, D., Haie-Meder, C., . . . Raspollini, M. R. (2018). The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology Guidelines for the Management of Patients with Cervical Cancer. Virchows Archiv, 472(6), 919-936. https://doi.org/10.1007/s00428-018-2362-9

Cibula, D., Pötter, R., Planchamp, F., Avall-Lundqvist, E., Fischerova, D., Haie Meder, C., . . . Raspollini, M. R. (2018). The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology guidelines for the management of patients with cervical cancer. Radiotherapy and Oncology, 127(3), 404-416. https://doi.org/10.1016/j.radonc.2018.03.003

Cisplatin and Radiation Therapy With or Without Carboplatin and Paclitaxel in Patients With Locally Advanced Cervical Cancer [pågående studie]. (2012-2018). (NCT01414608). Hentet fra https://clinicaltrials.gov/ct2/show/NCT01414608

Clarke, R. E., Tenorio, L. M., Hussey, J. R., Toklu, A. S., Cone, D. L., Hinojosa, J. G., . . . Walker, M. B. (2008). Hyperbaric oxygen treatment of chronic refractory radiation proctitis: a randomized and controlled double-blind crossover trial with long-term follow-up. International Journal of Radiation Oncology, Biology, Physics, 72(1), 134-143. https://doi.org/10.1016/j.ijrobp.2007.12.048

Clinical Effectiveness Group, & British Association for Sexual Health and HIV. (2014). 2014 UK national guideline on the management of vulval conditions. London: British Association for Sexual Health and HIV. Hentet fra http://www.bashh.org/documents/UK%20national%20guideline%20for%20the%20management%20of%20vulval%20conditions%202014.pdf

Cohen, I. (2004). Endometrial pathologies associated with postmenopausal tamoxifen treatment. Gynecologic Oncology, 94(2), 256-266. https://doi.org/10.1016/j.ygyno.2004.03.048

Coleman, R. L., Ali, S., Levenback, C. F., Gold, M. A., Fowler, J. M., Judson, P. L., . . . Trimble, C. L. (2013). Is bilateral lymphadenectomy for midline squamous carcinoma of the vulva always necessary? An analysis from Gynecologic Oncology Group (GOG) 173. Gynecologic Oncology, 128(2), 155-159. https://doi.org/10.1016/j.ygyno.2012.11.034

Collaborative Group on Epidemiological Studies of Ovarian Cancer. (2012). Ovarian cancer and body size: individual participant meta-analysis including 25,157 women with ovarian cancer from 47 epidemiological studies. PLoS Medicine, 9(4), e1001200. https://doi.org/10.1371/journal.pmed.1001200

Collaborative Group on Epidemiological Studies of Ovarian Cancer, Beral, V., Doll, R., Hermon, C., Peto, R., & Reeves, G. (2008). Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23,257 women with ovarian cancer and 87,303 controls. Lancet, 371(9609), 303-314. https://doi.org/10.1016/S0140-6736(08)60167-1

Colombo, N., Creutzberg, C., Amant, F., Bosse, T., González-Martin, A., Ledermann, J., . . . Sessa, C. (2016). ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: Diagnosis, Treatment and Follow-up. International Journal of Gynecological Cancer, 26(1), 2-30. https://doi.org/10.1097/igc.0000000000000609

Colombo, N., Parma, G., Zanagnolo, V., & Insinga, A. (2007). Management of ovarian stromal cell tumors. Journal of Clinical Oncology, 25(20), 2944-2951. https://doi.org/10.1200/jco.2007.11.1005

Colombo, N., Preti, E., Landoni, F., Carinelli, S., Colombo, A., Marini, C., & Sessa, C. (2013). Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology, 24 Suppl 6, vi33-38. https://doi.org/10.1093/annonc/mdt353

Colombo, N., Sessa, C., Bois, A. d., Ledermann, J., McCluggage, W. G., McNeish, I., . . . Querleu, D. (2019). ESMO–ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease. International Journal of Gynecological Cancer, 29(4), 728-760. https://doi.org/10.1136/ijgc-2019-000308

Colombo, N., Sessa, C., du Bois, A., Ledermann, J., McCluggage, W. G., McNeish, I., . . . Group, E. E. O. C. C. C. W. (2019). ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease†. Annals of Oncology, 30(5), 672-705. https://doi.org/10.1093/annonc/mdz062

Colombo, N., Van Gorp, T., Parma, G., Amant, F., Gatta, G., Sessa, C., & Vergote, I. (2006). Ovarian cancer. Critical Reviews in Oncology/Hematology, 60(2), 159-179. https://doi.org/10.1016/j.critrevonc.2006.03.004

Combination oral contraceptive use and the risk of endometrial cancer. The Cancer and Steroid Hormone Study of the Centers for Disease Control and the National Institute of Child Health and Human Development. (1987). JAMA, 257(6), 796-800.

Committee on Gynecologic Practice. (2014). Tamoxifen and uterine cancer (Committee Opinion no 601). Washington, DC: American College of Obstetricians and Gynecologists. Hentet fra http://www.acog.org/-/media/Committee-Opinions/Committee-on-Gynecologic-Practice/co601.pdf?dmc=1&ts=20150203T1931301384

Committee on Gynecologic Practice, Society of Gynecologic Oncology,. (2015). The American College of Obstetricians and Gynecologists Committee Opinion no. 631. Endometrial intraepithelial neoplasia. Obstetrics and Gynecology, 125(5), 1272-1278. https://doi.org/10.1097/01.Aog.0000465189.50026.20

Common Terminology Criteria for Adverse Events (CTCAE) Version 5.0. (2017). Washington, D.C.: U.S. Department of Health and Human Services. Hentet fra https://ctep.cancer.gov/protocoldevelopment/electronic_applications/docs/ctcae_v5_quick_reference_5x7.pdf

Coumbos, A., Sehouli, J., Chekerov, R., Schaedel, D., Oskay-Oezcelik, G., Lichtenegger, W., . . . North-Eastern German Society of Gynecological, O. (2009). Clinical management of borderline tumours of the ovary: results of a multicentre survey of 323 clinics in Germany. British Journal of Cancer, 100(11), 1731-1738. https://doi.org/10.1038/sj.bjc.6605065

Crean-Tate, K. K., Faubion, S. S., Pederson, H. J., Vencill, J. A., & Batur, P. (2020). Management of genitourinary syndrome of menopause in female cancer patients: a focus on vaginal hormonal therapy. American Journal of Obstetrics and Gynecology, 222(2), 103-113. https://doi.org/10.1016/j.ajog.2019.08.043

Creasman, W. T., Morrow, C. P., Bundy, B. N., Homesley, H. D., Graham, J. E., & Heller, P. B. (1987). Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study. Cancer, 60(8 Suppl), 2035-2041.

Creutzberg, C. L., van Putten, W. L., Koper, P. C., Lybeert, M. L., Jobsen, J. J., Warlam-Rodenhuis, C. C., . . . van Lent, M. (2000). Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma. Lancet, 355(9213), 1404-1411.

Crijnen, T. E. M., Janssen-Heijnen, M. L. G., Gelderblom, H., Morreau, J., Nooij, M. A., Kenter, G. G., & Vasen, H. F. A. (2005). Survival of patients with ovarian cancer due to a mismatch repair defect. Familial Cancer, 4(4), 301-305. https://doi.org/10.1007/s10689-005-6573-2

Crissman, J. D., Azoury, R. S., Barnes, A. E., & Schellhas, H. F. (1981). Endometrial carcinoma in women 40 years of age or younger. Obstetrics and Gynecology, 57(6), 699-704.

Crosbie, E. J., Ryan, N. A. J., Arends, M. J., Bosse, T., Burn, J., Cornes, J. M., . . . Evans, D. G. (2019). The Manchester International Consensus Group recommendations for the management of gynecological cancers in Lynch syndrome. Genetics in Medicine, 21(10), 2390-2400. https://doi.org/10.1038/s41436-019-0489-y

Cusimano, M. C., Vicus, D., Pulman, K., Maganti, M., Bernardini, M. Q., Bouchard-Fortier, G., . . . Ferguson, S. E. (2021). Assessment of Sentinel Lymph Node Biopsy vs Lymphadenectomy for Intermediate- and High-Grade Endometrial Cancer Staging. JAMA Surg, 156(2), 157-164. https://doi.org/10.1001/jamasurg.2020.5060

D'Souza, D. P., Rumble, R. B., Fyles, A., Yaremko, B., & Warde, P. (2012). Intensity-modulated radiotherapy in the treatment of gynaecological cancers. Clinical Oncology (Royal College of Radiologists), 24(7), 499-507. https://doi.org/10.1016/j.clon.2012.05.005

Das, P., Delclos, M. E., Skibber, J. M., Rodriguez-Bigas, M. A., Feig, B. W., Chang, G. J., . . . Crane, C. H. (2010). Hyperfractionated accelerated radiotherapy for rectal cancer in patients with prior pelvic irradiation. International Journal of Radiation Oncology, Biology, Physics, 77(1), 60-65. https://doi.org/10.1016/j.ijrobp.2009.04.056

Davis, S. R., Moreau, M., Kroll, R., Bouchard, C., Panay, N., Gass, M., . . . Studd, J. (2008). Testosterone for low libido in postmenopausal women not taking estrogen. New England Journal of Medicine, 359(19), 2005-2017. https://doi.org/10.1056/NEJMoa0707302

Dawson, L. A., Kavanagh, B. D., Paulino, A. C., Das, S. K., Miften, M., Li, X. A., . . . Schultheiss, T. E. (2010). Radiation-Associated Kidney Injury. International Journal of Radiation Oncology Biology Physics, 76(3 SUPPL.), S108-S115. https://doi.org/http://dx.doi.org/10.1016/j.ijrobp.2009.02.089

de Araujo Souza, P. S., Sichero, L., & Maciag, P. C. (2009). HPV variants and HLA polymorphisms: the role of variability on the risk of cervical cancer. Future Oncology (London, England), 5(3), 359-370. https://doi.org/10.2217/fon.09.8

De Giorgi, U., Richard, S., Badoglio, M., Kanfer, E., Bourrhis, J. H., Nicolas-Virelizier, E., . . . Bregni, M. (2017). Salvage high-dose chemotherapy in female patients with relapsed/refractory germ-cell tumors: a retrospective analysis of the European Group for Blood and Marrow Transplantation (EBMT). Annals of Oncology, 28(8), 1910-1916. https://doi.org/10.1093/annonc/mdx259

De Hullu, J. A., Hollema, H., Lolkema, S., Boezen, M., Boonstra, H., Burger, M. P., . . . Van Der Zee, A. G. (2002). Vulvar carcinoma. The price of less radical surgery. Cancer, 95(11), 2331-2338. https://doi.org/10.1002/cncr.10969

de Hullu, J. A., van der Avoort, I. A., Oonk, M. H., & van der Zee, A. G. (2006). Management of vulvar cancers. European Journal of Surgical Oncology, 32(8), 825-831. https://doi.org/10.1016/j.ejso.2006.03.035

de Hullu, J. A., & van der Zee, A. G. (2006). Surgery and radiotherapy in vulvar cancer. Critical Reviews in Oncology/Hematology, 60(1), 38-58. https://doi.org/10.1016/j.critrevonc.2006.02.008

Decloedt, J., & Vergote, I. (1999). Laparoscopy in gynaecologic oncology: a review. Critical Reviews in Oncology/Hematology, 31(1), 15-26.

Dhakal, H. P., Nesland, J. M., Førsund, M., Trope, C. G., & Holm, R. (2013). Primary tumor vascularity, HIF-1alpha and VEGF expression in vulvar squamous cell carcinomas: their relationships with clinicopathological characteristics and prognostic impact. BMC Cancer, 13, 506. https://doi.org/10.1186/1471-2407-13-506

Di Donato, V., Palaia, I., D'Aniello, D., Musacchio, L., Santangelo, G., Di Mauro, F., . . . Benedetti Panici, P. (2020). Does Hormone Replacement Therapy Impact the Prognosis in Endometrial Cancer Survivors? A Systematic Review. Oncology, 98(4), 195-201. https://doi.org/10.1159/000505427

Dijkhuizen, F. P., Mol, B. W., Brolmann, H. A., & Heintz, A. P. (2000). The accuracy of endometrial sampling in the diagnosis of patients with endometrial carcinoma and hyperplasia: a meta-analysis. Cancer, 89(8), 1765-1772.

Dillner, J., Kallings, I., Brihmer, C., Sikström, B., Koskela, P., Lehtinen, M., . . . Mardh, P. A. (1996). Seropositivities to human papillomavirus types 16, 18, or 33 capsids and to Chlamydia trachomatis are markers of sexual behavior. Journal of Infectious Diseases, 173(6), 1394-1398.

Dillner, J., Nygård, M., Munk, C., Hortlund, M., Hansen, B. T., Lagheden, C., . . . Kjaer, S. K. (2018). Decline of HPV infections in Scandinavian cervical screening populations after introduction of HPV vaccination programs. Vaccine, 36(26), 3820-3829. https://doi.org/10.1016/j.vaccine.2018.05.019

Dimopoulos, J. C., Kirisits, C., Petric, P., Georg, P., Lang, S., Berger, D., & Pötter, R. (2006). The Vienna applicator for combined intracavitary and interstitial brachytherapy of cervical cancer: clinical feasibility and preliminary results. International Journal of Radiation Oncology, Biology, Physics, 66(1), 83-90. https://doi.org/10.1016/j.ijrobp.2006.04.041

Doherty, J. A., Cushing-Haugen, K. L., Saltzman, B. S., Voigt, L. F., Hill, D. A., Beresford, S. A., . . . Weiss, N. S. (2007). Long-term use of postmenopausal estrogen and progestin hormone therapies and the risk of endometrial cancer. American Journal of Obstetrics and Gynecology, 197(2), 139.e131-137. https://doi.org/10.1016/j.ajog.2007.01.019

Domchek, S., & Kaunitz, A. M. (2016). Use of systemic hormone therapy in BRCA mutation carriers. Menopause, 23(9), 1026-1027. https://doi.org/10.1097/GME.0000000000000724

Domchek, S. M., Friebel, T. M., Singer, C. F., Evans, D. G., Lynch, H. T., Isaacs, C., . . . Rebbeck, T. R. (2010). Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality. JAMA, 304(9), 967-975. https://doi.org/10.1001/jama.2010.1237

Dossus, L., Allen, N., Kaaks, R., Bakken, K., Lund, E., Tjonneland, A., . . . Riboli, E. (2010). Reproductive risk factors and endometrial cancer: the European Prospective Investigation into Cancer and Nutrition. International Journal of Cancer, 127(2), 442-451. https://doi.org/10.1002/ijc.25050

Dowty, J. G., Win, A. K., Buchanan, D. D., Lindor, N. M., Macrae, F. A., Clendenning, M., . . . Jenkins, M. A. (2013). Cancer risks for MLH1 and MSH2 mutation carriers. Human Mutation, 34(3), 490-497. https://doi.org/10.1002/humu.22262

du Bois, A., Ewald-Riegler, N., Bois, O. D., & Harter, P. (2009). Borderline-tumoren des ovars - Eine systematische ubersicht. Geburtshilfe und Frauenheilkunde, 69(9), 807-833. https://doi.org/http://dx.doi.org/10.1055/s-0029-1186007

du Bois, A., Ewald-Riegler, N., de Gregorio, N., Reuss, A., Mahner, S., Fotopoulou, C., . . . Arbeitsgmeinschaft Gynäkologische Onkologie Study, G. (2013). Borderline tumours of the ovary: A cohort study of the Arbeitsgmeinschaft Gynäkologische Onkologie (AGO) Study Group. European Journal of Cancer, 49(8), 1905-1914. https://doi.org/10.1016/j.ejca.2013.01.035

Dubay, R. A., Rose, P. G., O'Malley, D. M., Shalodi, A. D., Ludin, A., & Selim, M. A. (2004). Evaluation of concurrent and adjuvant carboplatin with radiation therapy for locally advanced cervical cancer. Gynecologic Oncology, 94(1), 121-124. https://doi.org/10.1016/j.ygyno.2004.03.034

Dudley, S., & Viswanathan, A. (2019). Margins in vulvar cancer: challenges to classical clinicopathologic vulvar recurrence risk factors. Gynecologic Oncology, 154(2), 253-254. https://doi.org/10.1016/j.ygyno.2019.07.007

Dunton, C. J., Baak, J. P., Palazzo, J. P., van Diest, P. J., McHugh, M., & Widra, E. A. (1996). Use of computerized morphometric analyses of endometrial hyperplasias in the prediction of coexistent cancer. American Journal of Obstetrics and Gynecology, 174(5), 1518-1521. https://doi.org/10.1016/s0002-9378(96)70599-9

Duska, L. R., Garrett, A., Rueda, B. R., Haas, J., Chang, Y., & Fuller, A. F. (2001). Endometrial cancer in women 40 years old or younger. Gynecologic Oncology, 83(2), 388-393. https://doi.org/10.1006/gyno.2001.6434

Dørum, A., Heimdal, K., Løvslett, K., Kristensen, G., Hansen, L. J., Sandvei, R., . . . Møller, P. (1999). Prospectively detected cancer in familial breast/ovarian cancer screening. Acta Obstetricia et Gynecologica Scandinavica, 78(10), 906-911.

Dørum, A., Tonstad, S., Liavaag, A. H., Michelsen, T. M., Hildrum, B., & Dahl, A. A. (2008). Bilateral oophorectomy before 50 years of age is significantly associated with the metabolic syndrome and Framingham risk score: a controlled, population-based study (HUNT-2). Gynecologic Oncology, 109(3), 377-383. https://doi.org/10.1016/j.ygyno.2008.02.025

Edey, K. A., Allan, E., Murdoch, J. B., Cooper, S., & Bryant, A. (2013). Interventions for the treatment of Paget's disease of the vulva. Cochrane Database of Systematic Reviews, (10), CD009245. https://doi.org/10.1002/14651858.CD009245.pub2

Eifel, P. J., Jhingran, A., Bodurka, D. C., Levenback, C., & Thames, H. (2002). Correlation of smoking history and other patient characteristics with major complications of pelvic radiation therapy for cervical cancer. Journal of Clinical Oncology, 20(17), 3651-3657. https://doi.org/10.1200/jco.2002.10.128

Einhorn, L. H., Rapoport, B., Navari, R. M., Herrstedt, J., & Brames, M. J. (2017). 2016 updated MASCC/ESMO consensus recommendations: prevention of nausea and vomiting following multiple-day chemotherapy, high-dose chemotherapy, and breakthrough nausea and vomiting. Supportive Care in Cancer, 25(1), 303-308. https://doi.org/10.1007/s00520-016-3449-y

Elit, L., Chambers, A., Fyles, A., Covens, A., Carey, M., & Fung, M. F. (2004). Systematic review of adjuvant care for women with Stage I ovarian carcinoma. Cancer, 101(9), 1926-1935. https://doi.org/10.1002/cncr.20595

Elit, L., Fyles, A. W., Devries, M. C., Oliver, T. K., & Fung-Kee-Fung, M. (2009). Follow-up for women after treatment for cervical cancer: a systematic review. Gynecologic Oncology, 114(3), 528-535. https://doi.org/10.1016/j.ygyno.2009.06.001

Erickson, B. K., Conner, M. G., & Landen, C. N., Jr. (2013). The role of the fallopian tube in the origin of ovarian cancer. American Journal of Obstetrics and Gynecology, 209(5), 409-414. https://doi.org/10.1016/j.ajog.2013.04.019

Erridge, S. C., Kerr, G. R., Downing, D., Duncan, W., & Price, A. (2002). The effect of overall treatment time on the survival and toxicity of radical radiotherapy for cervical carcinoma. Radiotherapy and Oncology, 63(1), 59-66. https://doi.org/10.1016/s0167-8140(02)00012-9

Essel, K. G., & Moore, K. N. (2018). Niraparib for the treatment of ovarian cancer. Expert Review of Anticancer Therapy, 18(8), 727-733. https://doi.org/10.1080/14737140.2018.1490180

Estape, R. E., Angioli, R., Madrigal, M., Janicek, M., Gomez, C., Penalver, M., & Averette, H. (1998). Close vaginal margins as a prognostic factor after radical hysterectomy. Gynecologic Oncology, 68(3), 229-232. https://doi.org/10.1006/gyno.1998.4960

Evans-Metcalf, E. R., Brooks, S. E., Reale, F. R., & Baker, S. P. (1998). Profile of women 45 years of age and younger with endometrial cancer. Obstetrics and Gynecology, 91(3), 349-354. https://doi.org/10.1016/s0029-7844(97)00668-6

Evans, D. G. R., Clayton, R., Donnai, P., Shenton, A., & Lalloo, F. (2009). Risk-reducing surgery for ovarian cancer: outcomes in 300 surgeries suggest a low peritoneal primary risk. European Journal of Human Genetics, 17(11), 1381-1385. https://doi.org/10.1038/ejhg.2009.60

Fadare, O. (2009). Recent developments on the significance and pathogenesis of lymph node involvement in ovarian serous tumors of low malignant potential (borderline tumors). International Journal of Gynecological Cancer, 19(1), 103-108. https://doi.org/10.1111/IGC.0b013e3181991a49

Fader, A. N., Arriba, L. N., Frasure, H. E., & von Gruenigen, V. E. (2009). Endometrial cancer and obesity: epidemiology, biomarkers, prevention and survivorship. Gynecologic Oncology, 114(1), 121-127. https://doi.org/10.1016/j.ygyno.2009.03.039

Fader, A. N., Roque, D. M., Siegel, E., Buza, N., Hui, P., Abdelghany, O., . . . Santin, A. D. (2020). Randomized Phase II Trial of Carboplatin-Paclitaxel Compared with Carboplatin-Paclitaxel-Trastuzumab in Advanced (Stage III-IV) or Recurrent Uterine Serous Carcinomas that Overexpress Her2/Neu (NCT01367002): Updated Overall Survival Analysis. Clinical Cancer Research, 26(15), 3928-3935. https://doi.org/10.1158/1078-0432.Ccr-20-0953

Fasmer, K. E., Hodneland, E., Dybvik, J. A., Wagner-Larsen, K., Trovik, J., Salvesen, Ø., . . . Haldorsen, I. H. S. (2021). Whole-Volume Tumor MRI Radiomics for Prognostic Modeling in Endometrial Cancer. Journal of Magnetic Resonance Imaging, 53(3), 928-937. https://doi.org/10.1002/jmri.27444

Fathalla, M. F. (1971). Incessant ovulation--a factor in ovarian neoplasia? Lancet, 2(7716), 163-163. https://doi.org/10.1016/s0140-6736(71)92335-x

Fauvet, R., Boccara, J., Dufournet, C., Poncelet, C., & Darai, E. (2005). Laparoscopic management of borderline ovarian tumors: results of a French multicenter study. Annals of Oncology, 16(3), 403-410. https://doi.org/10.1093/annonc/mdi083

Favero, G., Chiantera, V., Oleszczuk, A., Gallotta, V., Hertel, H., Herrmann, J., . . . Schneider, A. (2010). Invasive cervical cancer during pregnancy: laparoscopic nodal evaluation before oncologic treatment delay. Gynecologic Oncology, 118(2), 123-127. https://doi.org/10.1016/j.ygyno.2010.04.012

Fearnley, E. J., Marquart, L., Spurdle, A. B., Weinstein, P., Webb, P. M., & Australian Ovarian Cancer Study Group and Australian National Endometrial Cancer Study Group. (2010). Polycystic ovary syndrome increases the risk of endometrial cancer in women aged less than 50 years: an Australian case-control study. Cancer Causes and Control, 21(12), 2303-2308. https://doi.org/10.1007/s10552-010-9658-7

Ferenczy, A., & Gelfand, M. (1989). The biologic significance of cytologic atypia in progestogen-treated endometrial hyperplasia. American Journal of Obstetrics and Gynecology, 160(1), 126-131. https://doi.org/10.1016/0002-9378(89)90103-8

Ferreira, M. R., Muls, A., Dearnaley, D. P., & Andreyev, H. J. (2014). Microbiota and radiation-induced bowel toxicity: lessons from inflammatory bowel disease for the radiation oncologist. Lancet Oncology, 15(3), e139-147. https://doi.org/10.1016/s1470-2045(13)70504-7

Ferris, D. G., Cox, J. T., O'Connor, D. M., Wright, V. C., & Foerster, J. (2004). Modern colposcopy: textbook and atlas (2. utg.). Dubuque, Iowa: Kendall/Hunt.

FIGO (International Federation of Gynecology and Obstetrics) 26th Annual Report on the Results of Treatment in Gynecological Cancer. (2006). International Journal of Gynaecology and Obstetrics, 95 Suppl 1, S1-257. https://doi.org/10.1016/s0020-7292(06)60025-8

FIGO Committee on Gynecologic Oncology. (2014). FIGO staging for carcinoma of the vulva, cervix, and corpus uteri. International Journal of Gynaecology and Obstetrics, 125(2), 97-98. https://doi.org/10.1016/j.ijgo.2014.02.003

Finch, A. P. M., Lubinski, J., Møller, P., Singer, C. F., Karlan, B., Senter, L., . . . Narod, S. A. (2014). Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation. Journal of Clinical Oncology, 32(15), 1547-1553. https://doi.org/10.1200/jco.2013.53.2820

Fisher, B., Costantino, J. P., Redmond, C. K., Fisher, E. R., Wickerham, D. L., & Cronin, W. M. (1994). Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14. Journal of the National Cancer Institute, 86(7), 527-537. https://doi.org/10.1093/jnci/86.7.527

Fokdal, L., Pötter, R., Kirchheiner, K., Lindegaard, J. C., Jensen, N. B. K., Kirisits, C., . . . Tanderup, K. (2018). Physician assessed and patient reported urinary morbidity after radio-chemotherapy and image guided adaptive brachytherapy for locally advanced cervical cancer. Radiotherapy and Oncology, 127(3), 423-430. https://doi.org/10.1016/j.radonc.2018.05.002

Fokdal, L., Sturdza, A., Mazeron, R., Haie-Meder, C., Tan, L. T., Gillham, C., . . . Tanderup, K. (2016). Image guided adaptive brachytherapy with combined intracavitary and interstitial technique improves the therapeutic ratio in locally advanced cervical cancer: Analysis from the retroEMBRACE study. Radiotherapy and Oncology, 120(3), 434-440. https://doi.org/10.1016/j.radonc.2016.03.020

Fokdal, L., Tanderup, K., Hokland, S. B., Røhl, L., Pedersen, E. M., Nielsen, S. K., . . . Lindegaard, J. C. (2013). Clinical feasibility of combined intracavitary/interstitial brachytherapy in locally advanced cervical cancer employing MRI with a tandem/ring applicator in situ and virtual preplanning of the interstitial component. Radiotherapy and Oncology, 107(1), 63-68. https://doi.org/10.1016/j.radonc.2013.01.010

Fokdal, L., Tanderup, K., Pötter, R., Sturdza, A., Kirchheiner, K., Chargari, C., . . . Lindegaard, J. C. (2019). Risk Factors for Ureteral Stricture After Radiochemotherapy Including Image Guided Adaptive Brachytherapy in Cervical Cancer: Results From the EMBRACE Studies. International Journal of Radiation Oncology, Biology, Physics, 103(4), 887-894. https://doi.org/10.1016/j.ijrobp.2018.11.006

Forman, D., de Martel, C., Lacey, C. J., Soerjomataram, I., Lortet-Tieulent, J., Bruni, L., . . . Franceschi, S. (2012). Global burden of human papillomavirus and related diseases. Vaccine, 30 Suppl 5, F12-23. https://doi.org/10.1016/j.vaccine.2012.07.055

Fortin, A., Morice, P., Thoury, A., Camatte, S., Dhainaut, C., & Madelenat, P. (2007). Impact of infertility drugs after treatment of borderline ovarian tumors: results of a retrospective multicenter study. Fertility and Sterility, 87(3), 591-596. https://doi.org/10.1016/j.fertnstert.2006.07.1503

Friebel, T. M., Domchek, S. M., & Rebbeck, T. R. (2014). Modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: systematic review and meta-analysis. Journal of the National Cancer Institute, 106(6), dju091-dju091. https://doi.org/10.1093/jnci/dju091

Frumovitz, M., Munsell, M. F., Burzawa, J. K., Byers, L. A., Ramalingam, P., Brown, J., & Coleman, R. L. (2017). Combination therapy with topotecan, paclitaxel, and bevacizumab improves progression-free survival in recurrent small cell neuroendocrine carcinoma of the cervix. Gynecologic Oncology, 144(1), 46-50. https://doi.org/10.1016/j.ygyno.2016.10.040

Fu, Y., & Zhuang, Z. (2014). Long-term effects of levonorgestrel-releasing intrauterine system on tamoxifen-treated breast cancer patients: a meta-analysis. International Journal of Clinical and Experimental Pathology, 7(10), 6419-6429.

Fung-Kee-Fung, M., Dodge, J., Elit, L., Lukka, H., Chambers, A., Oliver, T., & the Gynecology Cancer Disease Site Group. (2006). Follow-up after primary therapy for endometrial cancer (Evidence-based Series 4-9 IN REVIEW). Toronto (ON): Program in Evidence-based Care og Cancer Care Ontario. Hentet fra https://www.cancercare.on.ca/common/pages/UserFile.aspx?serverId=6&path=/File%20Database/CCO%20Files/PEBC/pebc4-9f.pdf

Furness, S., Roberts, H., Marjoribanks, J., & Lethaby, A. (2012). Hormone therapy in postmenopausal women and risk of endometrial hyperplasia. Cochrane Database of Systematic Reviews, (8), CD000402. https://doi.org/10.1002/14651858.CD000402.pub4

Fyles, A., Keane, T. J., Barton, M., & Simm, J. (1992). The effect of treatment duration in the local control of cervix cancer. Radiotherapy and Oncology, 25(4), 273-279. https://doi.org/10.1016/0167-8140(92)90247-r

Gaba, F., Piek, J., Menon, U., & Manchanda, R. (2019). Risk-reducing early salpingectomy and delayed oophorectomy as a two-staged alternative for primary prevention of ovarian cancer in women at increased risk: a commentary. BJOG: An International Journal of Obstetrics and Gynaecology, 126(7), 831-839. https://doi.org/10.1111/1471-0528.15651

Gadducci, A., Barsotti, C., Cosio, S., Domenici, L., & Riccardo Genazzani, A. (2011). Smoking habit, immune suppression, oral contraceptive use, and hormone replacement therapy use and cervical carcinogenesis: a review of the literature. Gynecological Endocrinology, 27(8), 597-604. https://doi.org/10.3109/09513590.2011.558953

Gaffney, D. K., King, B., Viswanathan, A. N., Barkati, M., Beriwal, S., Eifel, P., . . . Bosch, W. (2016). Consensus Recommendations for Radiation Therapy Contouring and Treatment of Vulvar Carcinoma. International Journal of Radiation Oncology, Biology, Physics, 95(4), 1191-1200. https://doi.org/10.1016/j.ijrobp.2016.02.043

Gage, J. C., Hanson, V. W., Abbey, K., Dippery, S., Gardner, S., Kubota, J., . . . Jeronimo, J. (2006). Number of cervical biopsies and sensitivity of colposcopy. Obstetrics and Gynecology, 108(2), 264-272. https://doi.org/10.1097/01.aog.0000220505.18525.85

Gallos, I. D., Ganesan, R., & Gupta, J. K. (2013). Prediction of regression and relapse of endometrial hyperplasia with conservative therapy. Obstetrics and Gynecology, 121(6), 1165-1171. https://doi.org/10.1097/AOG.0b013e31828cb563

Gallos, I. D., Krishan, P., Shehmar, M., Ganesan, R., & Gupta, J. K. (2013). LNG-IUS versus oral progestogen treatment for endometrial hyperplasia: a long-term comparative cohort study. Human Reproduction, 28(11), 2966-2971. https://doi.org/10.1093/humrep/det320

Gallos, I. D., Shehmar, M., Thangaratinam, S., Papapostolou, T. K., Coomarasamy, A., & Gupta, J. K. (2010). Oral progestogens vs levonorgestrel-releasing intrauterine system for endometrial hyperplasia: a systematic review and metaanalysis. American Journal of Obstetrics and Gynecology, 203(6), 547.e541-510. https://doi.org/10.1016/j.ajog.2010.07.037

Gallos, I. D., Yap, J., Rajkhowa, M., Luesley, D. M., Coomarasamy, A., & Gupta, J. K. (2012). Regression, relapse, and live birth rates with fertility-sparing therapy for endometrial cancer and atypical complex endometrial hyperplasia: a systematic review and metaanalysis. American Journal of Obstetrics and Gynecology, 207(4), 266.e261-212. https://doi.org/10.1016/j.ajog.2012.08.011

Galaal, K., Bryant, A., Fisher, A. D., Al-Khaduri, M., Kew, F., & Lopes, A. D. (2012). Laparoscopy versus laparotomy for the management of early stage endometrial cancer. Cochrane Database of Systematic Reviews, (9), CD006655. https://doi.org/10.1002/14651858.CD006655.pub2

Gamer, E. I., Garrett, A., Goldstein, D. P., & Berkowitz, R. S. (2004). Significance of chest computed tomography findings in the evaluation and treatment of persistent gestational trophoblastic neoplasia. Journal of Reproductive Medicine, 49(6), 411-414.

Gandhi, A. K., Sharma, D. N., Rath, G. K., Julka, P. K., Subramani, V., Sharma, S., . . . Thulkar, S. (2013). Early clinical outcomes and toxicity of intensity modulated versus conventional pelvic radiation therapy for locally advanced cervix carcinoma: a prospective randomized study. International Journal of Radiation Oncology, Biology, Physics, 87(3), 542-548. https://doi.org/10.1016/j.ijrobp.2013.06.2059

Garland, S. M., Kjaer, S. K., Muñoz, N., Block, S. L., Brown, D. R., DiNubile, M. J., . . . Velicer, C. (2016). Impact and Effectiveness of the Quadrivalent Human Papillomavirus Vaccine: A Systematic Review of 10 Years of Real-world Experience. Clinical Infectious Diseases, 63(4), 519-527. https://doi.org/10.1093/cid/ciw354

Garland, S. M., Paavonen, J., Jaisamrarn, U., Naud, P., Salmerón, J., Chow, S. N., . . . Dubin, G. (2016). Prior human papillomavirus-16/18 AS04-adjuvanted vaccination prevents recurrent high grade cervical intraepithelial neoplasia after definitive surgical therapy: Post-hoc analysis from a randomized controlled trial. International Journal of Cancer, 139(12), 2812-2826. https://doi.org/10.1002/ijc.30391

Garuti, G., Mirra, M., & Luerti, M. (2006). Hysteroscopic view in atypical endometrial hyperplasias: A correlation with pathologic findings on hysterectomy specimens. Journal of Minimally Invasive Gynecology, 13(4), 325-330. https://doi.org/10.1016/j.jmig.2006.03.010

Genetic/Familial High-Risk Assessment: Colorectal. [NCCN Guideline]. Version 1. (2020). Plymouth Meeting, PA: National Comprehensive Cancer Network.

Gentry-Maharaj, A., & Karpinskyj, C. (2020). Current and future approaches to screening for endometrial cancer. Best Practice & Research: Clinical Obstetrics & Gynaecology, 65, 79-97. https://doi.org/10.1016/j.bpobgyn.2019.12.006

Gershenson, D. M. (1993). Update on malignant ovarian germ cell tumors. Cancer, 71(4 Suppl), 1581-1590.

Gershenson, D. M. (2007). Management of ovarian germ cell tumors. Journal of Clinical Oncology, 25(20), 2938-2943. https://doi.org/10.1200/jco.2007.10.8738

Gershenson, D. M., Bodurka, D. C., Coleman, R. L., Lu, K. H., Malpica, A., & Sun, C. C. (2017). Hormonal Maintenance Therapy for Women With Low-Grade Serous Cancer of the Ovary or Peritoneum. Journal of Clinical Oncology, 35(10), 1103-1111. https://doi.org/10.1200/JCO.2016.71.0632

Ghaem-Maghami, S., & Soutter, W. P. (2009). Re: Effect of margin status on cervical intraepithelial neoplasia recurrence following LLETZ in women over 50 years. BJOG: An International Journal of Obstetrics and Gynaecology, 116(3), 465. https://doi.org/10.1111/j.1471-0528.2008.02048.x

Giede, K. C., Kieser, K., Dodge, J., & Rosen, B. (2005). Who should operate on patients with ovarian cancer? An evidence-based review. Gynecologic Oncology, 99(2), 447-461. https://doi.org/10.1016/j.ygyno.2005.07.008

Gill, B. S., Lin, J. F., Krivak, T. C., Sukumvanich, P., Laskey, R. A., Ross, M. S., . . . Beriwal, S. (2014). National Cancer Data Base analysis of radiation therapy consolidation modality for cervical cancer: the impact of new technological advancements. International Journal of Radiation Oncology, Biology, Physics, 90(5), 1083-1090. https://doi.org/10.1016/j.ijrobp.2014.07.017

Gill, S. E., McGree, M. E., Weaver, A. L., Cliby, W. A., & Langstraat, C. L. (2017). Optimizing the treatment of ovarian cancer: Neoadjuvant chemotherapy and interval debulking versus primary debulking surgery for epithelial ovarian cancers likely to have suboptimal resection. Gynecologic Oncology, 144(2), 266-273. https://doi.org/10.1016/j.ygyno.2016.11.021

Girinsky, T., Rey, A., Roche, B., Haie, C., Gerbaulet, A., Randrianarivello, H., & Chassagne, D. (1993). Overall treatment time in advanced cervical carcinomas: a critical parameter in treatment outcome. International Journal of Radiation Oncology, Biology, Physics, 27(5), 1051-1056. https://doi.org/10.1016/0360-3016(93)90522-w

Glover, M., Smerdon, G. R., Andreyev, H. J., Benton, B. E., Bothma, P., Firth, O., . . . Yarnold, J. (2016). Hyperbaric oxygen for patients with chronic bowel dysfunction after pelvic radiotherapy (HOT2): a randomised, double-blind, sham-controlled phase 3 trial. Lancet Oncology, 17(2), 224-233. https://doi.org/10.1016/s1470-2045(15)00461-1

Goff, B. A., Mandel, L. S., Drescher, C. W., Urban, N., Gough, S., Schurman, K. M., . . . Andersen, M. R. (2007). Development of an ovarian cancer symptom index: possibilities for earlier detection. Cancer, 109(2), 221-227. https://doi.org/10.1002/cncr.22371

Goldstein, D. P., & Berkowitz, R. S. (2010). Management of molar pregnancy and gestational trophoblastic neoplasms. I: G. C. Peltecu & C. G. Tropé (red.), Gynecologic Oncology (s. 483-494). Bucharest  Publishing House of the Romanian Academy.

Gómez-Hidalgo, N. R., Ramirez, P. T., Ngo, B., Pérez-Hoyos, S., Coreas, N., Sanchez-Iglesias, J. L., . . . Gil-Moreno, A. (2020). Oncologic impact of micrometastases or isolated tumor cells in sentinel lymph nodes of patients with endometrial cancer: a meta-analysis. Clinical & Translational Oncology, 22(8), 1272-1279. https://doi.org/10.1007/s12094-019-02249-x

Goodfellow, P. J., Billingsley, C. C., Lankes, H. A., Ali, S., Cohn, D. E., Broaddus, R. J., . . . Mutch, D. (2015). Combined Microsatellite Instability, MLH1 Methylation Analysis, and Immunohistochemistry for Lynch Syndrome Screening in Endometrial Cancers From GOG210: An NRG Oncology and Gynecologic Oncology Group Study. Journal of Clinical Oncology, 33(36), 4301-4308. https://doi.org/10.1200/jco.2015.63.9518

Gore, M. E., Fryatt, I., Wiltshaw, E., & Dawson, T. (1990). Treatment of relapsed carcinoma of the ovary with cisplatin or carboplatin following initial treatment with these compounds. Gynecologic Oncology, 36(2), 207-211. https://doi.org/10.1016/0090-8258(90)90174-j

Gore, M. E., Hackshaw, A., Brady, W. E., Penson, R. T., Zaino, R. J., McCluggage, W. G., & Ganesan, R. (2015). Multicentre trial of carboplatin/paclitaxel versus oxaliplatin/capecitabine, each with/without bevacizumab, as first line chemotherapy for patients with mucinous epithelial ovarian cancer (mEOC). Journal of Clinical Oncology, 33(SUPPL.), abstract 5528.

Gouy, S., Saidani, M., Maulard, A., Faron, M., Bach-Hamba, S., Bentivegna, E., . . . Morice, P. (2017). Staging surgery in early-stage ovarian mucinous tumors according to expansile and infiltrative types. Gynecologic oncology reports, 22, 21-25. https://doi.org/10.1016/j.gore.2017.08.006

Grady, D., Gebretsadik, T., Kerlikowske, K., Ernster, V., & Petitti, D. (1995). Hormone replacement therapy and endometrial cancer risk: a meta-analysis. Obstetrics and Gynecology, 85(2), 304-313. https://doi.org/10.1016/0029-7844(94)00383-o

Gravitt, P. E. (2011). The known unknowns of HPV natural history. Journal of Clinical Investigation, 121(12), 4593-4599. https://doi.org/10.1172/jci57149

Green, J. A., Kirwan, J. M., Tierney, J. F., Symonds, P., Fresco, L., Collingwood, M., & Williams, C. J. (2001). Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis. Lancet, 358(9284), 781-786. https://doi.org/10.1016/s0140-6736(01)05965-7

Grigsby, P. W. (2007). The role of FDG-PET/CT imaging after radiation therapy. Gynecologic Oncology, 107(1 Suppl 1), S27-29. https://doi.org/10.1016/j.ygyno.2007.07.034

Grindedal, E. M., Renkonen-Sinisalo, L., Vasen, H., Evans, G., Sala, P., Blanco, I., . . . Moller, P. (2010). Survival in women with MMR mutations and ovarian cancer: a multicentre study in Lynch syndrome kindreds. Journal of Medical Genetics, 47(2), 99-102. https://doi.org/10.1136/jmg.2009.068130

Guckenberger, M., Bachmann, J., Wulf, J., Mueller, G., Krieger, T., Baier, K., . . . Flentje, M. (2010). Stereotactic body radiotherapy for local boost irradiation in unfavourable locally recurrent gynaecological cancer. Radiotherapy and Oncology, 94(1), 53-59. https://doi.org/10.1016/j.radonc.2009.12.004

Guidelines for familial high-risk assessment breast and ovarian cancer. (2014). Fort Washington, PA: National Comprehencive Cancer Network.

Guido, R., Schiffman, M., Solomon, D., Burke, L., & ASCUS LSIL Triage Study (ALTS) Group. (2003). Postcolposcopy management strategies for women referred with low-grade squamous intraepithelial lesions or human papillomavirus DNA-positive atypical squamous cells of undetermined significance: a two-year prospective study. American Journal of Obstetrics and Gynecology, 188(6), 1401-1405.

Gull, B., Karlsson, B., Milsom, I., & Granberg, S. (2003). Can ultrasound replace dilation and curettage? A longitudinal evaluation of postmenopausal bleeding and transvaginal sonographic measurement of the endometrium as predictors of endometrial cancer. American Journal of Obstetrics and Gynecology, 188(2), 401-408. https://doi.org/10.1067/mob.2003.154

Gupta, S., Maheshwari, A., Parab, P., Mahantshetty, U., Hawaldar, R., Sastri Chopra, S., . . . Badwe, R. (2018). Neoadjuvant Chemotherapy Followed by Radical Surgery Versus Concomitant Chemotherapy and Radiotherapy in Patients With Stage IB2, IIA, or IIB Squamous Cervical Cancer: A Randomized Controlled Trial. Journal of Clinical Oncology, 36(16), 1548-1555. https://doi.org/10.1200/jco.2017.75.9985

Guren, M. G., Undseth, C., Rekstad, B. L., Brændengen, M., Dueland, S., Spindler, K. L., . . . Tveit, K. M. (2014). Reirradiation of locally recurrent rectal cancer: a systematic review. Radiotherapy and Oncology, 113(2), 151-157. https://doi.org/10.1016/j.radonc.2014.11.021

Gaarenstroom, K. N., van der Hiel, B., Tollenaar, R. A. E. M., Vink, G. R., Jansen, F. W., van Asperen, C. J., & Kenter, G. G. (2006). Efficacy of screening women at high risk of hereditary ovarian cancer: results of an 11-year cohort study. International Journal of Gynecological Cancer, 16 Suppl 1, 54-59. https://doi.org/10.1111/j.1525-1438.2006.00480.x

Hagen, B., Skjeldestad, F. E., Bratt, H., Tingulstad, S., & Lie, A. K. (1998). CO2 laser conization for cervical intraepithelial neoplasia grade II-III: complications and efficacy. Acta Obstetricia et Gynecologica Scandinavica, 77(5), 558-563.

Hagen, B., Valla, M., Aune, G., Ravlo, M., Abusland, A. B., Araya, E., . . . Tingulstad, S. (2016). Indocyanine green fluorescence imaging of lymph nodes during robotic-assisted laparoscopic operation for endometrial cancer. A prospective validation study using a sentinel lymph node surgical algorithm. Gynecologic Oncology, 143(3), 479-483. https://doi.org/10.1016/j.ygyno.2016.10.029

Haie-Meder, C., Pötter, R., Van Limbergen, E., Briot, E., De Brabandere, M., Dimopoulos, J., . . . Wachter-Gerstner, N. (2005). Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV. Radiotherapy and Oncology, 74(3), 235-245. https://doi.org/10.1016/j.radonc.2004.12.015

Halaska, M., Robova, H., & Rob, L. (2016). Cervical Cancer in Pregnancy. I: A. Ayhan, N. Reed, M. Gultekin, & P. Dursun (red.), Textbook of Gynaecological Oncology (3 utg., s. 1231-1238). Ankara, Istabul, Kartal Şube: Güneş Publishing.

Halaska, M. J., Rob, L., Robova, H., & Cerny, M. (2016). Treatment of gynecological cancers diagnosed during pregnancy. Future Oncology (London, England), 12(19), 2265-2275. https://doi.org/10.2217/fon-2016-0271

Haldorsen, I. S., Lura, N., Blaakær, J., Fischerova, D., & Werner, H. M. J. (2019). What Is the Role of Imaging at Primary Diagnostic Work-Up in Uterine Cervical Cancer? Current Oncology Reports, 21(9), 77. https://doi.org/10.1007/s11912-019-0824-0

Haldorsen, I. S., & Salvesen, H. B. (2016). What Is the Best Preoperative Imaging for Endometrial Cancer? Current Oncology Reports, 18(4), 25. https://doi.org/10.1007/s11912-016-0506-0

Halle, J. S., Rosenman, J. G., Varia, M. A., Fowler, W. C., Walton, L. A., & Currie, J. L. (1986). 1000 cGy single dose palliation for advanced carcinoma of the cervix or endometrium. International Journal of Radiation Oncology, Biology, Physics, 12(11), 1947-1950. https://doi.org/10.1016/0360-3016(86)90130-6

Hampel, H., Panescu, J., Lockman, J., Sotamaa, K., Fix, D., Comeras, I., . . . Vaccarello, L. (2007). Comment on: Screening for Lynch Syndrome (Hereditary Nonpolyposis Colorectal Cancer) among Endometrial Cancer Patients. Cancer Research, 67(19), 9603. https://doi.org/10.1158/0008-5472.Can-07-2308

Hampl, M., Sarajuuri, H., Wentzensen, N., Bender, H. G., & Kueppers, V. (2006). Effect of human papillomavirus vaccines on vulvar, vaginal, and anal intraepithelial lesions and vulvar cancer. Obstetrics and Gynecology, 108(6), 1361-1368. https://doi.org/10.1097/01.aog.0000245786.86267.80

Hancock, B. W., Seckl, M. J., & Berkowitz, R. S. (red.). (2015). Gestational trophoblastic disease (4. utg.). [s.l.]: International Society for the Study of Trophoblastic Diseases. Hentet fra http://isstd.org/gtd-book/front-page/

Hankinson, S. E., Hunter, D. J., Colditz, G. A., Willett, W. C., Stampfer, M. J., Rosner, B., . . . Speizer, F. E. (1993). Tubal ligation, hysterectomy, and risk of ovarian cancer. A prospective study. JAMA, 270(23), 2813-2818.

Hanley, G. E., McAlpine, J. N., Kwon, J. S., & Mitchell, G. (2015). Opportunistic salpingectomy for ovarian cancer prevention. Gynecologic oncology research and practice, 2, 5. https://doi.org/10.1186/s40661-015-0014-1

Harkenrider, M. M., Martin, B., Nieto, K., Small, C., Aref, I., Bergman, D., . . . Small, W., Jr. (2018). Multi-institutional Analysis of Vaginal Brachytherapy Alone for Women With Stage II Endometrial Carcinoma. International Journal of Radiation Oncology, Biology, Physics, 101(5), 1069-1077. https://doi.org/10.1016/j.ijrobp.2018.04.049

Harmsen, M. G., Arts-de Jong, M., Hoogerbrugge, N., Maas, A. H., Prins, J. B., Bulten, J., . . . de Hullu, J. A. (2015). Early salpingectomy (TUbectomy) with delayed oophorectomy to improve quality of life as alternative for risk-reducing salpingo-oophorectomy in BRCA1/2 mutation carriers (TUBA study): a prospective non-randomised multicentre study. BMC Cancer, 15, 593. https://doi.org/10.1186/s12885-015-1597-y

Harris, H. R., & Terry, K. L. (2016). Polycystic ovary syndrome and risk of endometrial, ovarian, and breast cancer: a systematic review. Fertil Res Pract, 2, 14. https://doi.org/10.1186/s40738-016-0029-2

Harrison, M. L., Jameson, C., & Gore, M. E. (2008). Mucinous ovarian cancer. International Journal of Gynecological Cancer, 18(2), 209-214. https://doi.org/10.1111/j.1525-1438.2007.01022.x

Harter, P., du Bois, A., Hahmann, M., Hasenburg, A., Burges, A., Loibl, S., . . . Sehouli, J. (2006). Surgery in recurrent ovarian cancer: the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) DESKTOP OVAR trial. Annals of Surgical Oncology, 13(12), 1702-1710. https://doi.org/10.1245/s10434-006-9058-0

Harter, P., Gershenson, D., Lhomme, C., Lecuru, F., Ledermann, J., Provencher, D. M., . . . du Bois, A. (2014). Gynecologic Cancer InterGroup (GCIG) consensus review for ovarian tumors of low malignant potential (borderline ovarian tumors). International Journal of Gynecological Cancer, 24(9 Suppl 3), S5-8. https://doi.org/10.1097/igc.0000000000000282

Harter, P., Sehouli, J., Lorusso, D., Reuss, A., Vergote, I., Marth, C., . . . Bois, A. D. (2017). LION: Lymphadenectomy in ovarian neoplasms—A prospective randomized AGO study group led gynecologic cancer intergroup trial. Journal of Clinical Oncology, 35(15_suppl), 5500. https://doi.org/10.1200/JCO.2017.35.15_suppl.5500

Hartmann, L. C., & Lindor, N. M. (2016). The Role of Risk-Reducing Surgery in Hereditary Breast and Ovarian Cancer. New England Journal of Medicine, 374(5), 454-468. https://doi.org/10.1056/NEJMra1503523

Hauptmann, S., Friedrich, K., Redline, R., & Avril, S. (2017). Ovarian borderline tumors in the 2014 WHO classification: evolving concepts and diagnostic criteria. Virchows Archiv, 470(2), 125-142. https://doi.org/10.1007/s00428-016-2040-8

Hauspy, J., Beiner, M., Harley, I., Ehrlich, L., Rasty, G., & Covens, A. (2007). Sentinel lymph node in vulvar cancer. Cancer, 110(5), 1015-1023. https://doi.org/10.1002/cncr.22874

Heald, B., Mester, J., Rybicki, L., Orloff, M. S., Burke, C. A., & Eng, C. (2010). Frequent gastrointestinal polyps and colorectal adenocarcinomas in a prospective series of PTEN mutation carriers. Gastroenterology, 139(6), 1927-1933. https://doi.org/10.1053/j.gastro.2010.06.061

Hecht, J. L., Ince, T. A., Baak, J. P., Baker, H. E., Ogden, M. W., & Mutter, G. L. (2005). Prediction of endometrial carcinoma by subjective endometrial intraepithelial neoplasia diagnosis. Modern Pathology, 18(3), 324-330. https://doi.org/10.1038/modpathol.3800328

Heemskerk-Gerritsen, B. A. M., Seynaeve, C., van Asperen, C. J., Ausems, M. G. E. M., Collée, J. M., van Doorn, H. C., . . . Ovarian Cancer Research Group, N. (2015). Breast cancer risk after salpingo-oophorectomy in healthy BRCA1/2 mutation carriers: revisiting the evidence for risk reduction. Journal of the National Cancer Institute, 107(5), djv033. https://doi.org/10.1093/jnci/djv033

Heitz, F., Harter, P., Ataseven, B., Heikaus, S., Schneider, S., Prader, S., . . . du Bois, A. (2018). Stage- and Histologic Subtype-Dependent Frequency of Lymph Node Metastases in Patients with Epithelial Ovarian Cancer Undergoing Systematic Pelvic and Paraaortic Lymphadenectomy. Annals of Surgical Oncology, 25(7), 2053-2059. https://doi.org/10.1245/s10434-018-6412-y

Helse- og omsorgsdepartementet. (2016). Snakk om det! Strategi for seksuell helse (2017–2022). Oslo: Helse- og omsorgsdepartementet. Hentet fra https://www.regjeringen.no/contentassets/284e09615fd04338a817e1160f4b10a7/strategi_seksuell_helse.pdf

Helsedirektoratet. (28. februar 2017). Pakkeforløp for livmorkreft [nettdokument]. Oslo: Helsedirektoratet. Hentet 21. april 2021, fra https://helsedirektoratet.no/retningslinjer/pakkeforlop-for-livmorkreft

Helsedirektoratet. (2019). Nasjonalt handlingsprogram for palliasjon i kreftomsorgen: nasjonal faglig retningslinje (rev utg.). (IS-2800). Oslo: Helsedirektoratet. Hentet fra https://www.helsedirektoratet.no/retningslinjer/palliasjon-i-kreftomsorgen-handlingsprogram/Palliasjon%20i%20kreftomsorgen%20%E2%80%93%20Nasjonalt%20handlingsprogram%20med%20retningslinjer.pdf

Hermsen, B. B. J., Olivier, R. I., Verheijen, R. H. M., van Beurden, M., de Hullu, J. A., Massuger, L. F., . . . Rookus, M. A. (2007). No efficacy of annual gynaecological screening in BRCA1/2 mutation carriers; an observational follow-up study. British Journal of Cancer, 96(9), 1335-1342. https://doi.org/10.1038/sj.bjc.6603725

Hess, V., A'Hern, R., Nasiri, N., King, D. M., Blake, P. R., Barton, D. P. J., . . . Gore, M. E. (2004). Mucinous epithelial ovarian cancer: a separate entity requiring specific treatment. Journal of Clinical Oncology, 22(6), 1040-1044. https://doi.org/10.1200/JCO.2004.08.078

Higham, C. E., & Faithfull, S. (2015). Bone Health and Pelvic Radiotherapy. Clinical Oncology (Royal College of Radiologists), 27(11), 668-678. https://doi.org/10.1016/j.clon.2015.07.006

Hinde, S., Epstein, D., Cook, A., Embleton, A., Perren, T., & Sculpher, M. (2016). The Cost-Effectiveness of Bevacizumab in Advanced Ovarian Cancer Using Evidence from the ICON7 Trial. Value in Health, 19(4), 431-439. https://doi.org/10.1016/j.jval.2016.01.013

Hogen, L., Brar, H., Covens, A., Bassiouny, D., Bernardini, M. Q., Gien, L. T., . . . Vicus, D. (2017). Is adjuvant chemotherapy beneficial for surgical stage I ovarian clear cell carcinoma? Gynecologic Oncology, 147(1), 54-60. https://doi.org/10.1016/j.ygyno.2017.07.128

Hogg, R., & Friedlander, M. (2004). Biology of epithelial ovarian cancer: implications for screening women at high genetic risk. Journal of Clinical Oncology, 22(7), 1315-1327. https://doi.org/10.1200/JCO.2004.07.179

Holschneider, C. H. (7. november 2014). Vulvar intraepithial neoplasia. UpToDate [database]. Waltham, MA: UoToDate, Inc. Hentet 23. juni 2016

Holschneider, C. H., & Berek, J. S. (19. februar 2021). Vaginal intraepithelial neoplasia. UpToDate [database]. Waltman, MA: UpToDate, Inc. Hentet 15. juni 2021

Homesley, H. D., Meltzer, N. P., Nieves, L., Vaccarello, L., Lowendowski, G. S., & Elbendary, A. A. (2008). A phase II trial of weekly 1-hour paclitaxel as second-line therapy for endometrial and cervical cancer. International Journal of Clinical Oncology, 13(1), 62-65. https://doi.org/10.1007/s10147-007-0731-5

Hong, J. H., Tsai, C. S., Lai, C. H., Chang, T. C., Wang, C. C., Chou, H. H., . . . Hsueh, S. (2004). Recurrent squamous cell carcinoma of cervix after definitive radiotherapy. International Journal of Radiation Oncology, Biology, Physics, 60(1), 249-257. https://doi.org/10.1016/j.ijrobp.2004.02.044

Howe, H. L., Wingo, P. A., Thun, M. J., Ries, L. A., Rosenberg, H. M., Feigal, E. G., & Edwards, B. K. (2001). Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends. Journal of the National Cancer Institute, 93(11), 824-842.

Huang, E. Y., Wang, C. J., Chen, H. C., Fang, F. M., Huang, Y. J., Wang, C. Y., & Hsu, H. C. (2008). Multivariate analysis of para-aortic lymph node recurrence after definitive radiotherapy for stage IB-IVA squamous cell carcinoma of uterine cervix. International Journal of Radiation Oncology, Biology, Physics, 72(3), 834-842. https://doi.org/10.1016/j.ijrobp.2008.01.035

Huang, G., Basaria, S., Travison, T. G., Ho, M. H., Davda, M., Mazer, N. A., . . . Bhasin, S. (2014). Testosterone dose-response relationships in hysterectomized women with or without oophorectomy: effects on sexual function, body composition, muscle performance and physical function in a randomized trial. Menopause, 21(6), 612-623. https://doi.org/10.1097/gme.0000000000000093

Huang, Z., Mayr, N. A., Gao, M., Lo, S. S., Wang, J. Z., Jia, G., & Yuh, W. T. (2012). Onset time of tumor repopulation for cervical cancer: first evidence from clinical data. International Journal of Radiation Oncology, Biology, Physics, 84(2), 478-484. https://doi.org/10.1016/j.ijrobp.2011.12.037

Huh, W. K., Joura, E. A., Giuliano, A. R., Iversen, O. E., de Andrade, R. P., Ault, K. A., . . . Luxembourg, A. (2017). Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16-26 years: a randomised, double-blind trial. Lancet, 390(10108), 2143-2159. https://doi.org/10.1016/s0140-6736(17)31821-4

Hui, B., Zhang, Y., Shi, F., Wang, J., Wang, T., Wang, J., . . . Liu, Z. (2014). Association between bone marrow dosimetric parameters and acute hematologic toxicity in cervical cancer patients undergoing concurrent chemoradiotherapy: comparison of three-dimensional conformal radiotherapy and intensity-modulated radiation therapy. International Journal of Gynecological Cancer, 24(9), 1648-1652. https://doi.org/10.1097/igc.0000000000000292

Hunn, J., & Rodriguez, G. C. (2012). Ovarian cancer: etiology, risk factors, and epidemiology. Clinical Obstetrics and Gynecology, 55(1), 3-23. https://doi.org/10.1097/GRF.0b013e31824b4611

Hunter, M. I., Monk, B. J., & Tewari, K. S. (2008). Cervical neoplasia in pregnancy. Part 1: screening and management of preinvasive disease. American Journal of Obstetrics and Gynecology, 199(1), 3-9. https://doi.org/10.1016/j.ajog.2008.04.010

Hunter, M. I., Tewari, K., & Monk, B. J. (2008). Cervical neoplasia in pregnancy. Part 2: current treatment of invasive disease. American Journal of Obstetrics and Gynecology, 199(1), 10-18. https://doi.org/10.1016/j.ajog.2007.12.011

Hørding, U., Junge, J., Poulsen, H., & Lundvall, F. (1995). Vulvar intraepithelial neoplasia III: a viral disease of undetermined progressive potential. Gynecologic Oncology, 56(2), 276-279. https://doi.org/10.1006/gyno.1995.1046

IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. (2012). Human Papillomaviruses. I: Biological agents: a review of human carcinogens (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans Vol. 100 B. s. 255-313). Lyon: IARC. Hentet fra https://monographs.iarc.fr/wp-content/uploads/2018/06/mono100B-11.pdf

Induction Chemotherapy Plus Chemoradiation as First Line Treatment for Locally Advanced Cervical Cancer (INTERLACE) [pågående studie]. (2012-2026). (NCT01566240). Hentet fra https://clinicaltrials.gov/ct2/show/NCT01566240

International Collaboration of Epidemiological Studies of Cervical Cancer, Appleby, P., Beral, V., Berrington de Gonzalez, A., Colin, D., Franceschi, S., . . . Sweetland, S. (2006). Carcinoma of the cervix and tobacco smoking: collaborative reanalysis of individual data on 13,541 women with carcinoma of the cervix and 23,017 women without carcinoma of the cervix from 23 epidemiological studies. International Journal of Cancer, 118(6), 1481-1495. https://doi.org/10.1002/ijc.21493

International Validation Study of Sentinel Node Biopsy in Early Cervical Cancer (SENTICOLIII) [pågående studie]. (2018-2026). (NCT03386734). Hentet fra https://clinicaltrials.gov/ct2/show/NCT03386734

Iodice, S., Barile, M., Rotmensz, N., Feroce, I., Bonanni, B., Radice, P., . . . Gandini, S. (2010). Oral contraceptive use and breast or ovarian cancer risk in BRCA1/2 carriers: a meta-analysis. European Journal of Cancer, 46(12), 2275-2284. https://doi.org/10.1016/j.ejca.2010.04.018

Itamochi, H., Kigawa, J., & Terakawa, N. (2008). Mechanisms of chemoresistance and poor prognosis in ovarian clear cell carcinoma. Cancer Science, 99(4), 653-658. https://doi.org/10.1111/j.1349-7006.2008.00747.x

Iversen, O.-E., L.E., E., Baasland, I., & Kirschner, R. (2014). Premaligne og maligne forandringer i cervix i graviditet I: P. Øian, A. F. Jacobsen, & J. Kessler (red.), Veileder i fødselshjelp 2014. Oslo: Norsk gynekologisk forening. Hentet fra http://legeforeningen.no/Fagmed/Norsk-gynekologisk-forening/Veiledere/Veileder-i-fodselshjelp-2014/Premaligne-og-maligne-forandringer-i-cervix-i-graviditet/

Iversen, T., Abeler, V., & Aalders, J. (1981). Individualized treatment of stage I carcinoma of the vulva. Obstetrics and Gynecology, 57(1), 85-89.

Iversen, T., & Tretli, S. (1998). Intraepithelial and invasive squamous cell neoplasia of the vulva: trends in incidence, recurrence, and survival rate in Norway. Obstetrics and Gynecology, 91(6), 969-972.

Jackson, K. S., Fankam, E. F., Das, N., Naik, R., Lopes, A. D., Godfrey, K. A., . . . Taylor, W. T. (2006). Unilateral groin and pelvic irradiation for unilaterally node-positive women with vulval carcinoma. International Journal of Gynecological Cancer, 16(1), 283-287. https://doi.org/10.1111/j.1525-1438.2006.00370.x

Jacobs, I., Gentry-Maharaj, A., Burnell, M., Manchanda, R., Singh, N., Sharma, A., . . . Menon, U. (2011). Sensitivity of transvaginal ultrasound screening for endometrial cancer in postmenopausal women: a case-control study within the UKCTOCS cohort. Lancet Oncology, 12(1), 38-48. https://doi.org/10.1016/s1470-2045(10)70268-0

Jacquet, P., & Sugarbaker, P. H. (1996). Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Cancer Treatment and Research, 82, 359-374. https://doi.org/10.1007/978-1-4613-1247-5_23

Janda, M., Gebski, V., Davies, L. C., Forder, P., Brand, A., Hogg, R., . . . Obermair, A. (2017). Effect of Total Laparoscopic Hysterectomy vs Total Abdominal Hysterectomy on Disease-Free Survival Among Women With Stage I Endometrial Cancer: A Randomized Clinical Trial. JAMA, 317(12), 1224-1233. https://doi.org/10.1001/jama.2017.2068

Jensen, N. B. K., Pötter, R., Kirchheiner, K., Fokdal, L., Lindegaard, J. C., Kirisits, C., . . . Tanderup, K. (2018). Bowel morbidity following radiochemotherapy and image-guided adaptive brachytherapy for cervical cancer: Physician- and patient reported outcome from the EMBRACE study. Radiotherapy and Oncology, 127(3), 431-439. https://doi.org/10.1016/j.radonc.2018.05.016

Jensen, P. T., Groenvold, M., Klee, M. C., Thranov, I., Petersen, M. A., & Machin, D. (2003). Longitudinal study of sexual function and vaginal changes after radiotherapy for cervical cancer. International Journal of Radiation Oncology, Biology, Physics, 56(4), 937-949. https://doi.org/10.1016/s0360-3016(03)00362-6

Jerzak, K. J., Duska, L., & MacKay, H. J. (2019). Endocrine therapy in endometrial cancer: An old dog with new tricks. Gynecologic Oncology, 153(1), 175-183. https://doi.org/10.1016/j.ygyno.2018.12.018

Johnson, N., Bryant, A., Miles, T., Hogberg, T., & Cornes, P. (2011). Adjuvant chemotherapy for endometrial cancer after hysterectomy. Cochrane Database of Systematic Reviews, (10), CD003175. https://doi.org/10.1002/14651858.CD003175.pub2

Joiner, M. C., & van der Kogel, A. J. (red.). (2019). Basic clinical radiobiology (5. utg.). Boca Raton: CRC Press, Taylor & Francis Group.

Jones, R. W. (2001). Vulval intraepithelial neoplasia: current perspectives. European Journal of Gynaecological Oncology, 22(6), 393-402.

Jones, R. W., & Rowan, D. M. (1994). Vulvar intraepithelial neoplasia III: a clinical study of the outcome in 113 cases with relation to the later development of invasive vulvar carcinoma. Obstetrics and Gynecology, 84(5), 741-745.

Jones, R. W., Rowan, D. M., & Stewart, A. W. (2005). Vulvar intraepithelial neoplasia: aspects of the natural history and outcome in 405 women. Obstetrics and Gynecology, 106(6), 1319-1326. https://doi.org/10.1097/01.AOG.0000187301.76283.7f

Jordan, J., Martin-Hirsch, P., Arbyn, M., Schenck, U., Baldauf, J. J., Da Silva, D., . . . Prendiville, W. (2009). European guidelines for clinical management of abnormal cervical cytology, part 2. Cytopathology, 20(1), 5-16. https://doi.org/10.1111/j.1365-2303.2008.00636.x

Joura, E. A., Garland, S. M., Paavonen, J., Ferris, D. G., Perez, G., Ault, K. A., . . . Haupt, R. M. (2012). Effect of the human papillomavirus (HPV) quadrivalent vaccine in a subgroup of women with cervical and vulvar disease: retrospective pooled analysis of trial data. BMJ, 344, e1401. https://doi.org/10.1136/bmj.e1401

Joura, E. A., Kyrgiou, M., Bosch, F. X., Kesic, V., Niemenen, P., Redman, C. W., & Gultekin, M. (2019). Human papillomavirus vaccination: The ESGO-EFC position paper of the European society of Gynaecologic Oncology and the European Federation for colposcopy. European Journal of Cancer, 116, 21-26. https://doi.org/10.1016/j.ejca.2019.04.032

Kaern, J., Trope, C. G., & Abeler, V. M. (1993). A retrospective study of 370 borderline tumors of the ovary treated at the Norwegian Radium Hospital from 1970 to 1982. A review of clinicopathologic features and treatment modalities. Cancer, 71(5), 1810-1820. https://doi.org/10.1002/1097-0142(19930301)71:5<1810::aid-cncr2820710516>3.0.co;2-v

Kang, W. D., Choi, H. S., & Kim, S. M. (2013). Is vaccination with quadrivalent HPV vaccine after loop electrosurgical excision procedure effective in preventing recurrence in patients with high-grade cervical intraepithelial neoplasia (CIN2-3)? Gynecologic Oncology, 130(2), 264-268. https://doi.org/10.1016/j.ygyno.2013.04.050

Katanyoo, K., Tangjitgamol, S., Chongthanakorn, M., Tantivatana, T., Manusirivithaya, S., Rongsriyam, K., & Cholpaisal, A. (2011). Treatment outcomes of concurrent weekly carboplatin with radiation therapy in locally advanced cervical cancer patients. Gynecologic Oncology, 123(3), 571-576. https://doi.org/10.1016/j.ygyno.2011.09.001

Kauff, N. D., Domchek, S. M., Friebel, T. M., Robson, M. E., Lee, J., Garber, J. E., . . . Rebbeck, T. R. (2008). Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective study. Journal of Clinical Oncology, 26(8), 1331-1337. https://doi.org/10.1200/jco.2007.13.9626

Kavanagh, B. D., Pan, C. C., Dawson, L. A., Das, S. K., Li, X. A., Ten Haken, R. K., & Miften, M. (2010). Radiation dose-volume effects in the stomach and small bowel. International Journal of Radiation Oncology, Biology, Physics, 76(3 Suppl), S101-107. https://doi.org/10.1016/j.ijrobp.2009.05.071

Kavanagh, K., Pollock, K. G., Cuschieri, K., Palmer, T., Cameron, R. L., Watt, C., . . . Robertson, C. (2017). Changes in the prevalence of human papillomavirus following a national bivalent human papillomavirus vaccination programme in Scotland: a 7-year cross-sectional study. Lancet Infectious Diseases, 17(12), 1293-1302. https://doi.org/10.1016/s1473-3099(17)30468-1

Keenan, L. G., Rock, K., Azmi, A., Salib, O., Gillham, C., & McArdle, O. (2018). An atlas to aid delineation of para-aortic lymph node region in cervical cancer: Design and validation of contouring guidelines. Radiotherapy and Oncology, 127(3), 417-422. https://doi.org/10.1016/j.radonc.2018.02.013

Kehoe, S., Hook, J., Nankivell, M., Jayson, G. C., Kitchener, H., Lopes, T., . . . Swart, A.-M. (2015). Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial. Lancet, 386(9990), 249-257. https://doi.org/10.1016/S0140-6736(14)62223-6

Kehoe, S. M., & Kauff, N. D. (2007). Screening and prevention of hereditary gynecologic cancers. Seminars in Oncology, 34(5), 406-410. https://doi.org/10.1053/j.seminoncol.2007.07.004

Kendall, B. S., Ronnett, B. M., Isacson, C., Cho, K. R., Hedrick, L., Diener-West, M., & Kurman, R. J. (1998). Reproducibility of the diagnosis of endometrial hyperplasia, atypical hyperplasia, and well-differentiated carcinoma. American Journal of Surgical Pathology, 22(8), 1012-1019. https://doi.org/10.1097/00000478-199808000-00012

Kenter, G., Greggi, S., Vergote, I., Katsaros, D., Kobierski, J., Massuger, L., . . . Casado, A. (2019). Results from neoadjuvant chemotherapy followed by surgery compared to chemoradiation for stage Ib2-IIb cervical cancer, EORTC 55994. Journal of Clinical Oncology, 37(15_suppl), 5503. https://doi.org/10.1200/JCO.2019.37.15_suppl.5503

Kenter, G. G., Welters, M. J., Valentijn, A. R., Lowik, M. J., Berends-van der Meer, D. M., Vloon, A. P., . . . Melief, C. J. (2009). Vaccination against HPV-16 oncoproteins for vulvar intraepithelial neoplasia. New England Journal of Medicine, 361(19), 1838-1847. https://doi.org/10.1056/NEJMoa0810097

Kessous, R., Laskov, I., Abitbol, J., Bitharas, J., Yasmeen, A., Salvador, S., . . . Gotlieb, W. H. (2017). Clinical outcome of neoadjuvant chemotherapy for advanced ovarian cancer. Gynecologic Oncology, 144(3), 474-479. https://doi.org/10.1016/j.ygyno.2016.12.017

Keys, H. M., Bundy, B. N., Stehman, F. B., Muderspach, L. I., Chafe, W. E., Suggs, C. L., 3rd, . . . Gersell, D. (1999). Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. New England Journal of Medicine, 340(15), 1154-1161. https://doi.org/10.1056/nejm199904153401503

Khanna, N., Rauh, L. A., Lachiewicz, M. P., & Horowitz, I. R. (2016). Margins for cervical and vulvar cancer. Journal of Surgical Oncology, 113(3), 304-309. https://doi.org/10.1002/jso.24108

Kim, D. H., Lee, J. H., Ki, Y. K., Nam, J. H., Kim, W. T., Jeon, H. S., . . . Kim, D. W. (2013). Short-course palliative radiotherapy for uterine cervical cancer. Radiat Oncol J, 31(4), 216-221. https://doi.org/10.3857/roj.2013.31.4.216

Kirchheiner, K., Nout, R. A., Lindegaard, J. C., Haie-Meder, C., Mahantshetty, U., Segedin, B., . . . Tanderup, K. (2016). Dose-effect relationship and risk factors for vaginal stenosis after definitive radio(chemo)therapy with image-guided brachytherapy for locally advanced cervical cancer in the EMBRACE study. Radiotherapy and Oncology, 118(1), 160-166. https://doi.org/10.1016/j.radonc.2015.12.025

Kitagawa, R., Katsumata, N., Shibata, T., Kamura, T., Kasamatsu, T., Nakanishi, T., . . . Yoshikawa, H. (2015). Paclitaxel Plus Carboplatin Versus Paclitaxel Plus Cisplatin in Metastatic or Recurrent Cervical Cancer: The Open-Label Randomized Phase III Trial JCOG0505. Journal of Clinical Oncology, 33(19), 2129-2135. https://doi.org/10.1200/jco.2014.58.4391

Kjellberg, L., Hallmans, G., Ahren, A. M., Johansson, R., Bergman, F., Wadell, G., . . . Dillner, J. (2000). Smoking, diet, pregnancy and oral contraceptive use as risk factors for cervical intra-epithelial neoplasia in relation to human papillomavirus infection. British Journal of Cancer, 82(7), 1332-1338. https://doi.org/10.1054/bjoc.1999.1100

Klopp, A. H., Yeung, A. R., Deshmukh, S., Gil, K. M., Wenzel, L., Westin, S. N., . . . Bruner, D. W. (2018). Patient-Reported Toxicity During Pelvic Intensity-Modulated Radiation Therapy: NRG Oncology-RTOG 1203. Journal of Clinical Oncology, 36(24), 2538-2544. https://doi.org/10.1200/jco.2017.77.4273

Knab, D. R. (1977). Estrogen and endometrial carcinoma. Obstetrical and Gynecological Survey, 32(5), 267-281. https://doi.org/10.1097/00006254-197705000-00001

Knopp, S. (2006). Prognostic studies in vulvar squamous cell carcinoma: with emphasis on cell cycle components, human papillomavirus and occult metastases (doktorgrad). (Series of dissertations submitted to the Faculty of Medicine, University of Oslo No. 492). Oslo: University of Oslo.

Kocken, M., Helmerhorst, T. J., Berkhof, J., Louwers, J. A., Nobbenhuis, M. A., Bais, A. G., . . . Meijer, C. J. (2011). Risk of recurrent high-grade cervical intraepithelial neoplasia after successful treatment: a long-term multi-cohort study. Lancet Oncology, 12(5), 441-450. https://doi.org/10.1016/s1470-2045(11)70078-x

Kohorn, E. I. (1993). Evaluation of the criteria used to make the diagnosis of nonmetastatic gestational trophoblastic neoplasia. Gynecologic Oncology, 48(2), 139-147. https://doi.org/10.1006/gyno.1993.1025

Kohorn, E. I. (1995). The trophoblastic Tower of Babel: classification systems for metastatic gestational trophoblastic neoplasia. Gynecologic Oncology, 56(2), 280-288. https://doi.org/10.1006/gyno.1995.1047

Kokka, F., Singh, N., Faruqi, A., Gibbon, K., & Rosenthal, A. N. (2011). Is differentiated vulval intraepithelial neoplasia the precursor lesion of human papillomavirus-negative vulval squamous cell carcinoma? International Journal of Gynecological Cancer, 21(7), 1297-1305. https://doi.org/10.1097/IGC.0b013e31822dbe26

Kong, A., Johnson, N., Kitchener, H. C., & Lawrie, T. A. (2012). Adjuvant radiotherapy for stage I endometrial cancer. Cochrane Database of Systematic Reviews, (4), CD003916. https://doi.org/10.1002/14651858.CD003916.pub4

Koornstra, J. J., Mourits, M. J., Sijmons, R. H., Leliveld, A. M., Hollema, H., & Kleibeuker, J. H. (2009). Management of extracolonic tumours in patients with Lynch syndrome. Lancet Oncology, 10(4), 400-408. https://doi.org/10.1016/s1470-2045(09)70041-5

Kotsopoulos, J., & Narod, S. A. (2020). Prophylactic salpingectomy for the prevention of ovarian cancer: Who should we target? International Journal of Cancer, 147(5), 1245-1251. https://doi.org/10.1002/ijc.32916

KREMT - Kreftregisterets Elektroniske Meldetjeneste [webbasert portal]. ([s.a.]). Oslo: Kreftregisteret. Hentet fra https://portal.kreftregistrering.no/

Kristensen, G. B. (1999). Studies on prognostic factors in cervical cancer with special attention to early disease (doktorgrad). Oslo: University of Oslo.

Kuchenbaecker, K. B., Hopper, J. L., Barnes, D. R., Phillips, K.-A., Mooij, T. M., Roos-Blom, M.-J., . . . Olsson, H. (2017). Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers. JAMA, 317(23), 2402-2416. https://doi.org/10.1001/jama.2017.7112

Kuhn, E., Kurman, R. J., Vang, R., Sehdev, A. S., Han, G., Soslow, R., . . . Shih Ie, M. (2012). TP53 mutations in serous tubal intraepithelial carcinoma and concurrent pelvic high-grade serous carcinoma--evidence supporting the clonal relationship of the two lesions. Journal of Pathology, 226(3), 421-426. https://doi.org/10.1002/path.3023

Kumar, S., Shah, J. P., & Malone, J. M., Jr. (2009). Vulvar cancer in women less than fifty in United States, 1980-2005. Gynecologic Oncology, 112(1), 283-284; author reply 234. https://doi.org/10.1016/j.ygyno.2008.07.003

Kupets, R., Thomas, G. M., & Covens, A. (2002). Is there a role for pelvic lymph node debulking in advanced cervical cancer? Gynecologic Oncology, 87(2), 163-170. https://doi.org/10.1006/gyno.2002.6815

Kurman, R. J., Carcangiu, M. L., Herrington, C. S., & Young, R. H. (2014). WHO classification of Tumours of Female Reproductive Organs (4. utg.). Lyon: IARC.

Kurman, R. J., Kaminski, P. F., & Norris, H. J. (1985). The behavior of endometrial hyperplasia. A long-term study of "untreated" hyperplasia in 170 patients. Cancer, 56(2), 403-412. https://doi.org/10.1002/1097-0142(19850715)56:2<403::aid-cncr2820560233>3.0.co;2-x

Kurman, R. J., Seidman, J. D., & Shih, I. M. (2005). Serous borderline tumours of the ovary. Histopathology, 47(3), 310-315. https://doi.org/10.1111/j.1365-2559.2005.02186.x

Kurman, R. J., & Shih Ie, M. (2010). The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory. American Journal of Surgical Pathology, 34(3), 433-443. https://doi.org/10.1097/PAS.0b013e3181cf3d79

Kurman, R. J., & Shih Ie, M. (2011). Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer--shifting the paradigm. Human Pathology, 42(7), 918-931. https://doi.org/10.1016/j.humpath.2011.03.003

Kyrgiou, M., Athanasiou, A., Paraskevaidi, M., Mitra, A., Kalliala, I., Martin-Hirsch, P., . . . Paraskevaidis, E. (2016). Adverse obstetric outcomes after local treatment for cervical preinvasive and early invasive disease according to cone depth: systematic review and meta-analysis. BMJ, 354, i3633. https://doi.org/10.1136/bmj.i3633

Kyrgiou, M., Koliopoulos, G., Martin-Hirsch, P., Arbyn, M., Prendiville, W., & Paraskevaidis, E. (2006). Obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: systematic review and meta-analysis. Lancet, 367(9509), 489-498. https://doi.org/10.1016/s0140-6736(06)68181-6

Kärrberg, C., Brannstrom, M., Strander, B., Ladfors, L., & Rådberg, T. (2013). Colposcopically directed cervical biopsy during pregnancy; minor surgical and obstetrical complications and high rates of persistence and regression. Acta Obstetricia et Gynecologica Scandinavica, 92(6), 692-699. https://doi.org/10.1111/aogs.12138

Kaaks, R., Lukanova, A., & Kurzer, M. S. (2002). Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review. Cancer Epidemiology, Biomarkers and Prevention, 11(12), 1531-1543.

Lago, V., Minig, L., & Fotopoulou, C. (2016). Incidence of Lymph Node Metastases in Apparent Early-Stage Low-Grade Epithelial Ovarian Cancer: A Comprehensive Review. International Journal of Gynecological Cancer, 26(8), 1407-1414. https://doi.org/10.1097/IGC.0000000000000787

Lai, K. W., & Mercurio, M. G. (2010). Medical and surgical approaches to vulvar intraepithelial neoplasia. Dermatologic Therapy, 23(5), 477-484. https://doi.org/10.1111/j.1529-8019.2010.01351.x

Lakhani, S. R., Manek, S., Penault-Llorca, F., Flanagan, A., Arnout, L., Merrett, S., . . . Easton, D. F. (2004). Pathology of ovarian cancers in BRCA1 and BRCA2 carriers. Clinical Cancer Research, 10(7), 2473-2481.

Lalwani, N., Shanbhogue, A. K. P., Vikram, R., Nagar, A., Jagirdar, J., & Prasad, S. R. (2010). Current update on borderline ovarian neoplasms. AJR: American Journal of Roentgenology, 194(2), 330-336. https://doi.org/10.2214/AJR.09.3936

Lanceley, A., Fiander, A., McCormack, M., & Bryant, A. (2013). Follow-up protocols for women with cervical cancer after primary treatment. Cochrane Database of Systematic Reviews, (11), CD008767. https://doi.org/10.1002/14651858.CD008767.pub2

Landoni, F., Maneo, A., Colombo, A., Placa, F., Milani, R., Perego, P., . . . Mangioni, C. (1997). Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer. Lancet, 350(9077), 535-540. https://doi.org/10.1016/s0140-6736(97)02250-2

Langmar, Z., Nemeth, M., Vlesko, G., Kiraly, M., Hornyak, L., & Bosze, P. (2011). HE4--a novel promising serum marker in the diagnosis of ovarian carcinoma. European Journal of Gynaecological Oncology, 32(6), 605-610.

Larsen, I. K. (red.). (2011). Cancer in Norway 2009: cancer incidence, mortality, survival and prevalence in Norway. Oslo: Cancer Registry of Norway. Hentet fra https://www.kreftregisteret.no/globalassets/publikasjoner-og-rapporter/cancer-in-norway/cancer_in_norway_2009_and_special_issue.pdf

Larsen, I. K. (red.). (2014). Cancer in Norway 2012: cancer incidence, mortality, survival and prevalence in Norway. Oslo: Cancer Registry of Norway. Hentet fra https://www.kreftregisteret.no/globalassets/cancer-in-norway/2012/cin_2012-web.pdf

Larsen, I. K. (red.). (2015). Cancer in Norway 2013: cancer incidence, mortality, survival and prevalence in Norway. Oslo: Cancer Registry of Norway. Hentet fra https://www.kreftregisteret.no/globalassets/cancer-in-norway/2013/cin_2013.pdf

Larsen, I. K. (red.). (2018). Cancer in Norway 2017: cancer incidence, mortality, survival and prevalence in Norway. Oslo: Cancer Registry of Norway. Hentet fra https://www.kreftregisteret.no/globalassets/cancer-in-norway/2017/cin-2017.pdf

Larsen, I. K. (red.). (2019). Cancer in Norway 2018: cancer incidence, mortality, survival and prevalence in Norway. Oslo: Cancer Registry of Norway. Hentet fra https://www.kreftregisteret.no/Generelt/Rapporter/Cancer-in-Norway/cancer-in-norway-2018/

Laursen, L. V., Elstrøm, U. V., Vestergaard, A., Muren, L. P., Petersen, J. B., Lindegaard, J. C., . . . Tanderup, K. (2012). Residual rotational set-up errors after daily cone-beam CT image guided radiotherapy of locally advanced cervical cancer. Radiotherapy and Oncology, 105(2), 220-225. https://doi.org/10.1016/j.radonc.2012.08.012

Law, E., Kelvin, J. F., Thom, B., Riedel, E., Tom, A., Carter, J., . . . Goodman, K. A. (2015). Prospective study of vaginal dilator use adherence and efficacy following radiotherapy. Radiotherapy and Oncology, 116(1), 149-155. https://doi.org/10.1016/j.radonc.2015.06.018

Lawrie, T. A., Patel, A., Martin-Hirsch, P. P., Bryant, A., Ratnavelu, N. D., Naik, R., & Ralte, A. (2014). Sentinel node assessment for diagnosis of groin lymph node involvement in vulval cancer. Cochrane Database of Systematic Reviews, (6), CD010409. https://doi.org/10.1002/14651858.CD010409.pub2

Ledermann, J., Harter, P., Gourley, C., Friedlander, M., Vergote, I., Rustin, G., . . . Matulonis, U. (2012). Olaparib maintenance therapy in platinum-sensitive relapsed ovarian cancer. New England Journal of Medicine, 366(15), 1382-1392. https://doi.org/10.1056/NEJMoa1105535

Ledermann, J., Harter, P., Gourley, C., Friedlander, M., Vergote, I., Rustin, G., . . . Matulonis, U. (2014). Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: a preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trial. Lancet Oncology, 15(8), 852-861. https://doi.org/10.1016/s1470-2045(14)70228-1

Lee, S. H., Lee, S. H., Lee, K. C., Lee, K. B., Shin, J. W., Park, C. Y., . . . Lee, J. H. (2012). Radiation therapy with chemotherapy for patients with cervical cancer and supraclavicular lymph node involvement. Journal of Gynecologic Oncology, 23(3), 159-167. https://doi.org/10.3802/jgo.2012.23.3.159

Lee, S. I., & Atri, M. (2019). 2018 FIGO Staging System for Uterine Cervical Cancer: Enter Cross-sectional Imaging. Radiology, 292(1), 15-24. https://doi.org/10.1148/radiol.2019190088

Lehtinen, M., Paavonen, J., Wheeler, C. M., Jaisamrarn, U., Garland, S. M., Castellsagué, X., . . . Dubin, G. (2012). Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial. Lancet Oncology, 13(1), 89-99. https://doi.org/10.1016/s1470-2045(11)70286-8

Leitao, M. M., Jr., Kehoe, S., Barakat, R. R., Alektiar, K., Gattoc, L. P., Rabbitt, C., . . . Abu-Rustum, N. R. (2009). Comparison of D&C and office endometrial biopsy accuracy in patients with FIGO grade 1 endometrial adenocarcinoma. Gynecologic Oncology, 113(1), 105-108. https://doi.org/10.1016/j.ygyno.2008.12.017

Lenhard, M. S., Mitterer, S., Kümper, C., Stieber, P., Mayr, D., Ditsch, N., . . . Burges, A. (2009). Long-term follow-up after ovarian borderline tumor: relapse and survival in a large patient cohort. European Journal of Obstetrics, Gynecology, and Reproductive Biology, 145(2), 189-194. https://doi.org/10.1016/j.ejogrb.2009.04.031

Leo, P. J., Madeleine, M. M., Wang, S., Schwartz, S. M., Newell, F., Pettersson-Kymmer, U., . . . Brown, M. A. (2017). Defining the genetic susceptibility to cervical neoplasia-A genome-wide association study. PLoS Genet, 13(8), e1006866. https://doi.org/10.1371/journal.pgen.1006866

Levenback, C., Coleman, R. L., Burke, T. W., Bodurka-Bevers, D., Wolf, J. K., & Gershenson, D. M. (2001). Intraoperative lymphatic mapping and sentinel node identification with blue dye in patients with vulvar cancer. Gynecologic Oncology, 83(2), 276-281. https://doi.org/10.1006/gyno.2001.6374

Levenback, C., van der Zee, A. G. J., & Coleman, R. (red.). (2004). Clinical lymphatic mapping in gynecologic cancers. London and New York: Taylor & Francis.

Levenback, C. F., Ali, S., Coleman, R. L., Gold, M. A., Fowler, J. M., Judson, P. L., . . . Trimble, C. L. (2012). Lymphatic mapping and sentinel lymph node biopsy in women with squamous cell carcinoma of the vulva: a gynecologic oncology group study. Journal of Clinical Oncology, 30(31), 3786-3791. https://doi.org/10.1200/JCO.2011.41.2528

Levernes, S. (2012). Volum og doser i ekstern stråleterapi: definisjoner og anbefalinger (StrålevernRapport 2012:9). Østerås: Statens strålevern. Hentet fra https://dsa.no/publikasjoner/stralevernrapport-9-2012-volum-og-doser-i-ekstern-straleterapi/StralevernRapport_09-2012.pdf

Levernes, S. (2019). Nomenklatur for volumer i stråleterapi (Teknisk dokument 14). Østerås: Direktoratet for strålevern og atomsikkerhet. Hentet fra https://dsa.no/medisinsk-stralebruk/kvist/_/attachment/download/2f7317b7-e2f3-423e-b388-7d1d8d07b271:e947e054b123c9af0fa0fae10c867ce43e3d149e/TekniskDokument14.pdf

Li, Z., & Zhao, C. (2013). Long-term follow-up results from women with cervical adenocarcinoma in situ treated by conization: an experience from a large academic women's hospital. Journal of Lower Genital Tract Disease, 17(4), 452-458. https://doi.org/10.1097/LGT.0b013e318283e2c6

Liavaag, A. H., Dørum, A., Fosså, S. D., Trope, C., & Dahl, A. A. (2007). Controlled study of fatigue, quality of life, and somatic and mental morbidity in epithelial ovarian cancer survivors: how lucky are the lucky ones? Journal of Clinical Oncology, 25(15), 2049-2056. https://doi.org/10.1200/jco.2006.09.1769

Liem, X., Saad, F., & Delouya, G. (2015). A Practical Approach to the Management of Radiation-Induced Hemorrhagic Cystitis. Drugs, 75(13), 1471-1482. https://doi.org/10.1007/s40265-015-0443-5

Lieng, M., Qvigstad, E., Sandvik, L., Jørgensen, H., Langebrekke, A., & Istre, O. (2007). Hysteroscopic resection of symptomatic and asymptomatic endometrial polyps. Journal of Minimally Invasive Gynecology, 14(2), 189-194. https://doi.org/10.1016/j.jmig.2006.09.018

The Lifestyle and Empowerment Techniques in Survivorship of Gynecologic Oncology Study (LETSGO). (2019-2030). [pågående studie]. (NCT04122235). Hentet fra https://clinicaltrials.gov/ct2/show/NCT04122235

Lim, K., Small, W., Jr., Portelance, L., Creutzberg, C., Jürgenliemk-Schulz, I. M., Mundt, A., . . . Fyles, A. (2011). Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy for the definitive treatment of cervix cancer. International Journal of Radiation Oncology, Biology, Physics, 79(2), 348-355. https://doi.org/10.1016/j.ijrobp.2009.10.075

Lim, M. C., Lee, H. S., Seo, S. S., Kim, M. S., Kim, J. Y., Zo, J. I., & Park, S. Y. (2010). Pathologic diagnosis and resection of suspicious thoracic metastases in patients with cervical cancer through thoracotomy or video-assisted thoracic surgery. Gynecologic Oncology, 116(3), 478-482. https://doi.org/10.1016/j.ygyno.2009.10.039

Lindegaard, J. C., Fokdal, L. U., Nielsen, S. K., Juul-Christensen, J., & Tanderup, K. (2013). MRI-guided adaptive radiotherapy in locally advanced cervical cancer from a Nordic perspective. Acta Oncologica, 52(7), 1510-1519. https://doi.org/10.3109/0284186x.2013.818253

Lindemann, K., Gibbs, E., Åvall-Lundqvist, E., dePont Christensen, R., Woie, K., Kalling, M., . . . Kristensen, G. (2017). Chemotherapy vs tamoxifen in platinum-resistant ovarian cancer: a phase III, randomised, multicentre trial (Ovaresist). British Journal of Cancer, 116(4), 455-463. https://doi.org/10.1038/bjc.2016.435

Linkov, F., Edwards, R., Balk, J., Yurkovetsky, Z., Stadterman, B., Lokshin, A., & Taioli, E. (2008). Endometrial hyperplasia, endometrial cancer and prevention: gaps in existing research of modifiable risk factors. European Journal of Cancer, 44(12), 1632-1644. https://doi.org/10.1016/j.ejca.2008.05.001

Lobo, R. A. (2007). Surgical menopause and cardiovascular risks. Menopause, 14(3 Pt 2), 562-566. https://doi.org/10.1097/gme.0b013e318038d333

Longacre, T. A., McKenney, J. K., Tazelaar, H. D., Kempson, R. L., & Hendrickson, M. R. (2005). Ovarian serous tumors of low malignant potential (borderline tumors): outcome-based study of 276 patients with long-term (> or =5-year) follow-up. American Journal of Surgical Pathology, 29(6), 707-723.

Lov om kommunale helse- og omsorgstjenester m.m. (helse- og omsorgstjenesteloven). LOV-2011-06-24-30.

Luo, J., Beresford, S., Chen, C., Chlebowski, R., Garcia, L., Kuller, L., . . . Margolis, K. L. (2014). Association between diabetes, diabetes treatment and risk of developing endometrial cancer. British Journal of Cancer, 111(7), 1432-1439. https://doi.org/10.1038/bjc.2014.407

Lurain, J. R., Singh, D. K., & Schink, J. C. (2006). Role of surgery in the management of high-risk gestational trophoblastic neoplasia. Journal of Reproductive Medicine, 51(10), 773-776.

Madalinska, J. B., van Beurden, M., Bleiker, E. M., Valdimarsdottir, H. B., Hollenstein, J., Massuger, L. F., . . . Aaronson, N. K. (2006). The impact of hormone replacement therapy on menopausal symptoms in younger high-risk women after prophylactic salpingo-oophorectomy. Journal of Clinical Oncology, 24(22), 3576-3582. https://doi.org/10.1200/jco.2005.05.1896

Maeda, Y., Høyer, M., Lundby, L., Buntzen, S., & Laurberg, S. (2010). Temporary sacral nerve stimulation for faecal incontinence following pelvic radiotherapy. Radiotherapy and Oncology, 97(1), 108-112. https://doi.org/10.1016/j.radonc.2010.04.023

Mahner, S., Eulenburg, C., Staehle, A., Wegscheider, K., Reuss, A., Pujade-Lauraine, E., . . . du Bois, A. (2013). Prognostic impact of the time interval between surgery and chemotherapy in advanced ovarian cancer: analysis of prospective randomised phase III trials. European Journal of Cancer, 49(1), 142-149. https://doi.org/10.1016/j.ejca.2012.07.023

Mahner, S., Jueckstock, J. K., Hilpert, F., Lubbe, D., Harter, P., De Gregorio, N., . . . Woelber, L. L. (2012). Impact of adjuvant therapy in lymph-node positive vulvar cancer: The AGO CARE 1 study. Journal of Clinical Oncology, 30(15 SUPPL. 1), abstract 5007.

Makar, A. P., Kristensen, G. B., Børmer, O. P., & Trope, C. G. (1993). Serum CA 125 level allows early identification of nonresponders during induction chemotherapy. Gynecologic Oncology, 49(1), 73-79. https://doi.org/10.1006/gyno.1993.1089

Makker, V., Rasco, D., Vogelzang, N. J., Brose, M. S., Cohn, A. L., Mier, J., . . . Taylor, M. (2019). Lenvatinib plus pembrolizumab in patients with advanced endometrial cancer: an interim analysis of a multicentre, open-label, single-arm, phase 2 trial. Lancet Oncology, 20(5), 711-718. https://doi.org/10.1016/s1470-2045(19)30020-8

Marabelle, A., Fakih, M., Lopez, J., Shah, M., Shapira-Frommer, R., Nakagawa, K., . . . Bang, Y. J. (2020). Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospective biomarker analysis of the multicohort, open-label, phase 2 KEYNOTE-158 study. Lancet Oncology, 21(10), 1353-1365. https://doi.org/10.1016/s1470-2045(20)30445-9

Marabelle, A., Le, D. T., Ascierto, P. A., Di Giacomo, A. M., De Jesus-Acosta, A., Delord, J. P., . . . Diaz, L. A., Jr. (2020). Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability/Mismatch Repair-Deficient Cancer: Results From the Phase II KEYNOTE-158 Study. Journal of Clinical Oncology, 38(1), 1-10. https://doi.org/10.1200/jco.19.02105

Marchetti, C., Kristeleit, R., McCormack, M., Mould, T., Olaitan, A., Widschwendter, M., . . . Ledermann, J. A. (2017). Outcome of patients with advanced ovarian cancer who do not undergo debulking surgery: A single institution retrospective review. Gynecologic Oncology, 144(1), 57-60. https://doi.org/10.1016/j.ygyno.2016.11.001

Marnitz, S., Wlodarczyk, W., Neumann, O., Koehler, C., Weihrauch, M., Budach, V., & Cozzi, L. (2015). Which technique for radiation is most beneficial for patients with locally advanced cervical cancer? Intensity modulated proton therapy versus intensity modulated photon treatment, helical tomotherapy and volumetric arc therapy for primary radiation - an intraindividual comparison. Radiation Oncology (London, England), 10, 91. https://doi.org/10.1186/s13014-015-0402-z

Martin-Hirsch, P. P., Bryant, A., Keep, S. L., Kitchener, H. C., & Lilford, R. (2011). Adjuvant progestagens for endometrial cancer. Cochrane Database of Systematic Reviews, (6), CD001040. https://doi.org/10.1002/14651858.CD001040.pub2

Masseundersøkelsen mot livmorhalskreft: årsrapport 2012. (2014). Oslo: Kreftregisteret. Hentet fra https://www.kreftregisteret.no/globalassets/publikasjoner-og-rapporter/livmorhalskreft/aarsrapport_livmorhals_2012.pdf

Matsuoka, H., Nakamura, K., Matsubara, Y., Ida, N., Saijo, M., Ogawa, C., & Masuyama, H. (2018). The Influence of Chemotherapy-Induced Peripheral Neuropathy on Quality of Life of Gynecologic Cancer Survivors. International Journal of Gynecological Cancer, 28(7), 1394-1402. https://doi.org/10.1097/igc.0000000000001320

May, K., Bryant, A., Dickinson, H. O., Kehoe, S., & Morrison, J. (2010). Lymphadenectomy for the management of endometrial cancer. Cochrane Database of Systematic Reviews, (1), CD007585. https://doi.org/10.1002/14651858.CD007585.pub2

May, T., Goldstein, D. P., & Berkowitz, R. S. (2011). Current chemotherapeutic management of patients with gestational trophoblastic neoplasia. Chemother Res Pract, 2011, 806256. https://doi.org/10.1155/2011/806256

Mayrand, M. H., Duarte-Franco, E., Rodrigues, I., Walter, S. D., Hanley, J., Ferenczy, A., . . . Franco, E. L. (2007). Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer. New England Journal of Medicine, 357(16), 1579-1588. https://doi.org/10.1056/NEJMoa071430

Mazeron, R., Castelnau-Marchand, P., Dumas, I., del Campo, E. R., Kom, L. K., Martinetti, F., . . . Haie-Meder, C. (2015). Impact of treatment time and dose escalation on local control in locally advanced cervical cancer treated by chemoradiation and image-guided pulsed-dose rate adaptive brachytherapy. Radiotherapy and Oncology, 114(2), 257-263. https://doi.org/10.1016/j.radonc.2014.11.045

McCann, G. A., Taege, S. K., Boutsicaris, C. E., Phillips, G. S., Eisenhauer, E. L., Fowler, J. M., . . . Salani, R. (2013). The impact of close surgical margins after radical hysterectomy for early-stage cervical cancer. Gynecologic Oncology, 128(1), 44-48. https://doi.org/10.1016/j.ygyno.2012.10.028

McCredie, M. R., Sharples, K. J., Paul, C., Baranyai, J., Medley, G., Jones, R. W., & Skegg, D. C. (2008). Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study. Lancet Oncology, 9(5), 425-434. https://doi.org/10.1016/s1470-2045(08)70103-7

McKenney, J. K., Balzer, B. L., & Longacre, T. A. (2006). Lymph node involvement in ovarian serous tumors of low malignant potential (borderline tumors): pathology, prognosis, and proposed classification. American Journal of Surgical Pathology, 30(5), 614-624. https://doi.org/10.1097/01.pas.0000194743.33540.e6

Mehmood, Q., Beardwood, M., Swindell, R., Greenhalgh, S., Wareham, T., Barraclough, L., . . . Davidson, S. E. (2014). Insufficiency fractures in patients treated with pelvic radiotherapy and chemotherapy for uterine and cervical cancer. European Journal of Cancer Care (English Language Edition), 23(1), 43-50. https://doi.org/10.1111/ecc.12105

Meltzer-Gunnes, C. J., Smastuen, M. C., Kristensen, G. B., Trope, C. G., Lie, A. K., & Vistad, I. (2017). Vulvar carcinoma in Norway: A 50-year perspective on trends in incidence, treatment and survival. Gynecologic Oncology, 145(3), 543-548. https://doi.org/10.1016/j.ygyno.2017.03.008

Micheletti, L., Bogliatto, F., & Levi, A. C. (2005). La linfoadenectomia inguino-femorale: fondamenti embriologici, anatomotopografici, anatomochirurgici sulla preservazione della fascia femorale. Roma: CIC Edizioni Internazionali.

Micheletti, L., & Preti, M. (2014). Surgery of the vulva in vulvar cancer. Best Practice & Research: Clinical Obstetrics & Gynaecology, 28(7), 1074-1087. https://doi.org/10.1016/j.bpobgyn.2014.07.011

Miles, T., & Johnson, N. (2014). Vaginal dilator therapy for women receiving pelvic radiotherapy. Cochrane Database of Systematic Reviews, 2014(9), CD007291. https://doi.org/10.1002/14651858.CD007291.pub3

Miller, D. S., Filiaci, V. L., Mannel, R. S., Cohn, D. E., Matsumoto, T., Tewari, K. S., . . . Fleming, G. F. (2020). Carboplatin and Paclitaxel for Advanced Endometrial Cancer: Final Overall Survival and Adverse Event Analysis of a Phase III Trial (NRG Oncology/GOG0209). Journal of Clinical Oncology, 38(33), 3841-3850. https://doi.org/10.1200/jco.20.01076

Mills, A. M., Liou, S., Ford, J. M., Berek, J. S., Pai, R. K., & Longacre, T. A. (2014). Lynch syndrome screening should be considered for all patients with newly diagnosed endometrial cancer. American Journal of Surgical Pathology, 38(11), 1501-1509. https://doi.org/10.1097/pas.0000000000000321

Minig, L., Franchi, D., Boveri, S., Casadio, C., Bocciolone, L., & Sideri, M. (2011). Progestin intrauterine device and GnRH analogue for uterus-sparing treatment of endometrial precancers and well-differentiated early endometrial carcinoma in young women. Annals of Oncology, 22(3), 643-649. https://doi.org/10.1093/annonc/mdq463

Minig, L., Heitz, F., Cibula, D., Bakkum-Gamez, J. N., Germanova, A., Dowdy, S. C., . . . Fotopoulou, C. (2017). Patterns of Lymph Node Metastases in Apparent Stage I Low-Grade Epithelial Ovarian Cancer: A Multicenter Study. Annals of Surgical Oncology, 24(9), 2720-2726. https://doi.org/10.1245/s10434-017-5919-y

Mirza, M. R., Monk, B. J., Herrstedt, J., Oza, A. M., Mahner, S., Redondo, A., . . . Investigators, E.-O. N. (2016). Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer. New England Journal of Medicine, 375(22), 2154-2164. https://doi.org/10.1056/NEJMoa1611310

Modan, B., Hartge, P., Hirsh-Yechezkel, G., Chetrit, A., Lubin, F., Beller, U., . . . Wacholder, S. (2001). Parity, oral contraceptives, and the risk of ovarian cancer among carriers and noncarriers of a BRCA1 or BRCA2 mutation. New England Journal of Medicine, 345(4), 235-240. https://doi.org/10.1056/nejm200107263450401

Moehler, M., Shitara, K., Garrido, M., Salman, P., Shen, L., Wyrwicz, L., . . . Janjigian, Y. Y. (2020). LBA6_PR - Nivolumab (nivo) plus chemotherapy (chemo) versus chemo as first-line (1L) treatment for advanced gastric cancer/gastroesophageal junction cancer (GC/GEJC)/esophageal adenocarcinoma (EAC): First results of the CheckMate 649 study. Annals of Oncology, 31(suppl_4), S1142-S1215.

Mohamed, S., Lindegaard, J. C., de Leeuw, A. A., Jürgenliemk-Schulz, I., Kirchheiner, K., Kirisits, C., . . . Tanderup, K. (2016). Vaginal dose de-escalation in image guided adaptive brachytherapy for locally advanced cervical cancer. Radiotherapy and Oncology, 120(3), 480-485. https://doi.org/10.1016/j.radonc.2016.05.020

Mohamed, S. M., Aagaard, T., Fokdal, L. U., Pedersen, E. M., Lindegaard, J. C., & Tanderup, K. (2015). Assessment of radiation doses to the para-aortic, pelvic, and inguinal lymph nodes delivered by image-guided adaptive brachytherapy in locally advanced cervical cancer. Brachytherapy, 14(1), 56-61. https://doi.org/10.1016/j.brachy.2014.07.005

Monk, B. J., Herzog, T. J., & Tewari, K. S. (2016). Evolution of Chemosensitivity and Resistance Assays as Predictors of Clinical Outcomes in Epithelial Ovarian Cancer Patients. Current Pharmaceutical Design, 22(30), 4717-4728. https://doi.org/10.2174/1381612822666160505114326

Moore, D. H., Ali, S., Koh, W. J., Michael, H., Barnes, M. N., McCourt, C. K., . . . Walker, J. L. (2012). A phase II trial of radiation therapy and weekly cisplatin chemotherapy for the treatment of locally-advanced squamous cell carcinoma of the vulva: a gynecologic oncology group study. Gynecologic Oncology, 124(3), 529-533. https://doi.org/10.1016/j.ygyno.2011.11.003

Moore, T. D., Phillips, P. H., Nerenstone, S. R., & Cheson, B. D. (1991). Systemic treatment of advanced and recurrent endometrial carcinoma: current status and future directions. Journal of Clinical Oncology, 9(6), 1071-1088.

Moorman, P. G., Havrilesky, L. J., Gierisch, J. M., Coeytaux, R. R., Lowery, W. J., Peragallo Urrutia, R., . . . Myers, E. R. (2013). Oral contraceptives and risk of ovarian cancer and breast cancer among high-risk women: a systematic review and meta-analysis. Journal of Clinical Oncology, 31(33), 4188-4198. https://doi.org/10.1200/JCO.2013.48.9021

Morice, P. (2006). Borderline tumours of the ovary and fertility. European Journal of Cancer, 42(2), 149-158. https://doi.org/10.1016/j.ejca.2005.07.029

Morice, P., Camatte, S., Wicart-Poque, F., Atallah, D., Rouzier, R., Pautier, P., . . . Castaigne, D. (2003). Results of conservative management of epithelial malignant and borderline ovarian tumours. Human Reproduction Update, 9(2), 185-192.

Morice, P., Castaigne, D., Haie-Meder, C., Pautier, P., El Hassan, J., Duvillard, P., . . . Michel, G. (1998). Laparoscopic ovarian transposition for pelvic malignancies: indications and functional outcomes. Fertility and Sterility, 70(5), 956-960. https://doi.org/10.1016/s0015-0282(98)00284-2

Mork, M. E., Rodriguez, A., Taggart, M. W., Rodriguez-Bigas, M. A., Lynch, P. M., Bannon, S. A., . . . Vilar, E. (2017). Identification of MSH2 inversion of exons 1-7 in clinical evaluation of families with suspected Lynch syndrome. Familial Cancer, 16(3), 357-361. https://doi.org/10.1007/s10689-016-9960-y

Morrison, C., Catania, F., Wakely, P., Jr., & Nuovo, G. J. (2001). Highly differentiated keratinizing squamous cell cancer of the cervix: a rare, locally aggressive tumor not associated with human papillomavirus or squamous intraepithelial lesions. American Journal of Surgical Pathology, 25(10), 1310-1315. https://doi.org/10.1097/00000478-200110000-00013

Muallem, M. Z., Gasimli, K., Richter, R., Almuheimid, J., Nasser, S., Braicu, E. I., & Sehouli, J. (2015). AGO Score As a Predictor of Surgical Outcome at Secondary Cytoreduction in Patients with Ovarian Cancer. Anticancer Research, 35(6), 3423-3429.

Muehlbauer, P. M., Thorpe, D., Davis, A., Drabot, R., Rawlings, B. L., & Kiker, E. (2009). Putting evidence into practice: evidence-based interventions to prevent, manage, and treat chemotherapy- and radiotherapy-induced diarrhea. Clinical Journal of Oncology Nursing, 13(3), 336-341. https://doi.org/10.1188/09.Cjon.336-341

Muñoz, N., Bosch, F. X., de Sanjosé, S., Herrero, R., Castellsagué, X., Shah, K. V., . . . International Agency for Research on Cancer Multicenter Cervical Cancer Study Group. (2003). Epidemiologic classification of human papillomavirus types associated with cervical cancer. New England Journal of Medicine, 348(6), 518-527. https://doi.org/10.1056/NEJMoa021641

Muñoz, N., Castellsagué, X., de González, A. B., & Gissmann, L. (2006). Chapter 1: HPV in the etiology of human cancer. Vaccine, 24 Suppl 3, S3/1-10. https://doi.org/10.1016/j.vaccine.2006.05.115

Muñoz, N., Kjaer, S. K., Sigurdsson, K., Iversen, O. E., Hernandez-Avila, M., Wheeler, C. M., . . . Haupt, R. M. (2010). Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women. Journal of the National Cancer Institute, 102(5), 325-339. https://doi.org/10.1093/jnci/djp534

Mutter, G. L. (2002). Diagnosis of premalignant endometrial disease. Journal of Clinical Pathology, 55(5), 326-331. https://doi.org/10.1136/jcp.55.5.326

Mutter, G. L., Baak, J. P., Crum, C. P., Richart, R. M., Ferenczy, A., & Faquin, W. C. (2000). Endometrial precancer diagnosis by histopathology, clonal analysis, and computerized morphometry. Journal of Pathology, 190(4), 462-469. https://doi.org/10.1002/(sici)1096-9896(200003)190:4<462::Aid-path590>3.0.Co;2-d

Mutter, G. L., Baak, J. P., Fitzgerald, J. T., Gray, R., Neuberg, D., Kust, G. A., . . . Wilcox, M. (2001). Global expression changes of constitutive and hormonally regulated genes during endometrial neoplastic transformation. Gynecologic Oncology, 83(2), 177-185. https://doi.org/10.1006/gyno.2001.6352

Mutter, G. L., Zaino, R. J., Baak, J. P., Bentley, R. C., & Robboy, S. J. (2007). Benign endometrial hyperplasia sequence and endometrial intraepithelial neoplasia. International Journal of Gynecological Pathology, 26(2), 103-114. https://doi.org/10.1097/PGP.0b013e31802e4696

Muyldermans, K., Moerman, P., Amant, F., Leunen, K., Neven, P., & Vergote, I. (2013). Primary invasive mucinous ovarian carcinoma of the intestinal type: importance of the expansile versus infiltrative type in predicting recurrence and lymph node metastases. European Journal of Cancer, 49(7), 1600-1608. https://doi.org/10.1016/j.ejca.2012.12.004

Møller, P., Seppälä, T. T., Bernstein, I., Holinski-Feder, E., Sala, P., Gareth Evans, D., . . . Capella, G. (2018). Cancer risk and survival in path_MMR carriers by gene and gender up to 75 years of age: a report from the Prospective Lynch Syndrome Database. Gut, 67(7), 1306-1316. https://doi.org/10.1136/gutjnl-2017-314057

Najjari Jamal, D., Pötter, R., Haie-Meder, C., Lindegaard, J. C., Juergenliemk-Schulz, I. M., Mahantshetty, U., . . . Kirchheiner, K. (2018). Physician assessed and patient reported lower limb edema after definitive radio(chemo)therapy and image-guided adaptive brachytherapy for locally advanced cervical cancer: A report from the EMBRACE study. Radiotherapy and Oncology, 127(3), 449-455. https://doi.org/10.1016/j.radonc.2018.03.026

Nakamura, K., Banno, K., Yanokura, M., Iida, M., Adachi, M., Masuda, K., . . . Aoki, D. (2014). Features of ovarian cancer in Lynch syndrome (Review). Molecular and clinical oncology, 2(6), 909-916. https://doi.org/10.3892/mco.2014.397

Nam, E. J., Lee, M., Yim, G. W., Kim, J. H., Kim, S., Kim, S. W., . . . Kim, Y. T. (2013). Comparison of carboplatin- and cisplatin-based concurrent chemoradiotherapy in locally advanced cervical cancer patients with morbidity risks. Oncologist, 18(7), 843-849. https://doi.org/10.1634/theoncologist.2012-0455

Nasjonal helseplan (2007–2010). (2006). (Særtrykk av St.prp. nr. 1 (2006–2007) kapittel 6). Oslo: Helse- og omsorgsdepartementet. Hentet fra https://www.regjeringen.no/globalassets/upload/HOD/Sykehus/Nasjonal_helseplan_Sartrykk.pdf

Nasjonal oppfølging av vaksinasjons-programmet for HPV. (02. jan 2020). [nettdokument]. Oslo: Folkehelseinstituttet. Hentet 21. jan 2020, fra https://www.fhi.no/studier/hpv-oppfolging/

Nasjonalt handlingsprogram med retningslinjer for diagnostikk, behandling og oppfølging av pasienter med brystkreft. (2019). (IS-2831). Oslo: Helsedirektoratet. Hentet fra https://www.helsedirektoratet.no/retningslinjer/brystkreft-handlingsprogram

Naucler, P., Ryd, W., Törnberg, S., Strand, A., Wadell, G., Elfgren, K., . . . Dillner, J. (2009). Efficacy of HPV DNA testing with cytology triage and/or repeat HPV DNA testing in primary cervical cancer screening. Journal of the National Cancer Institute, 101(2), 88-99. https://doi.org/10.1093/jnci/djn444

Nebgen, D. R., Hurteau, J., Holman, L. L., Bradford, A., Munsell, M. F., Soletsky, B. R., . . . Lu, K. H. (2018). Bilateral salpingectomy with delayed oophorectomy for ovarian cancer risk reduction: A pilot study in women with BRCA1/2 mutations. Gynecologic Oncology, 150(1), 79-84. https://doi.org/10.1016/j.ygyno.2018.04.564

Neri, F., & Maggino, T. (2009). Surveillance of endometrial pathologies, especially for endometrial cancer, of breast cancer patients under tamoxifen treatment. European Journal of Gynaecological Oncology, 30(4), 357-360.

Niibe, Y., Kazumoto, T., Toita, T., Yamazaki, H., Higuchi, K., Ii, N., . . . Hayakawa, K. (2006). Frequency and characteristics of isolated para-aortic lymph node recurrence in patients with uterine cervical carcinoma in Japan: a multi-institutional study. Gynecologic Oncology, 103(2), 435-438. https://doi.org/10.1016/j.ygyno.2006.03.034

Niibe, Y., Kenjo, M., Kazumoto, T., Michimoto, K., Takayama, M., Yamauchi, C., . . . Hayakawa, K. (2006). Multi-institutional study of radiation therapy for isolated para-aortic lymph node recurrence in uterine cervical carcinoma: 84 subjects of a population of more than 5,000. International Journal of Radiation Oncology, Biology, Physics, 66(5), 1366-1369. https://doi.org/10.1016/j.ijrobp.2006.07.1384

Nilsson, C. G., Haukkamaa, M., Vierola, H., & Luukkainen, T. (1982). Tissue concentrations of levonorgestrel in women using a levonorgestrel-releasing IUD. Clinical Endocrinology, 17(6), 529-536. https://doi.org/10.1111/j.1365-2265.1982.tb01625.x

Nomden, C. N., Pötter, R., de Leeuw, A. A. C., Tanderup, K., Lindegaard, J. C., Schmid, M. P., . . . Jürgenliemk-Schulz, I. M. (2019). Nodal failure after chemo-radiation and MRI guided brachytherapy in cervical cancer: Patterns of failure in the EMBRACE study cohort. Radiotherapy and Oncology, 134, 185-190. https://doi.org/10.1016/j.radonc.2019.02.007

Nygård, M., Daltveit, A. K., Thoresen, S. O., & Nygard, J. F. (2007). Effect of an antepartum Pap smear on the coverage of a cervical cancer screening programme: a population-based prospective study. BMC Health Services Research, 7, 10. https://doi.org/10.1186/1472-6963-7-10

Nøhr, B., Tabor, A., Frederiksen, K., & Kjær, S. K. (2007). Loop electrosurgical excision of the cervix and the subsequent risk of preterm delivery. Acta Obstetricia et Gynecologica Scandinavica, 86(5), 596-603. https://doi.org/10.1080/00016340701279145

Oaknin, A., Tinker, A. V., Gilbert, L., Samouëlian, V., Mathews, C., Brown, J., . . . Sabatier, R. (2020). Clinical Activity and Safety of the Anti-Programmed Death 1 Monoclonal Antibody Dostarlimab for Patients With Recurrent or Advanced Mismatch Repair-Deficient Endometrial Cancer: A Nonrandomized Phase 1 Clinical Trial. JAMA Oncol, 6(11), 1766-1772. https://doi.org/10.1001/jamaoncol.2020.4515

Oguri, T., Shimokata, T., Ito, I., Yasuda, Y., Sassa, N., Nishiyama, M., . . . Ando, Y. (2015). Extension of the Calvert formula to patients with severe renal insufficiency. Cancer Chemotherapy and Pharmacology, 76(1), 53-59. https://doi.org/10.1007/s00280-015-2769-9

Oksefjell, H., Sandstad, B., & Trope, C. (2009). The role of secondary cytoreduction in the management of the first relapse in epithelial ovarian cancer. Annals of Oncology, 20(2), 286-293. https://doi.org/10.1093/annonc/mdn591

Oncolex, Onkologisk oppslagsverk. (2016). [database]. Oslo: Oslo universitetssykehus HF. Hentet 23. juni 2016, fra http://oncolex.no/

Onsrud, M., Hagen, B., & Strickert, T. (2001). 10-Gy single-fraction pelvic irradiation for palliation and life prolongation in patients with cancer of the cervix and corpus uteri. Gynecologic Oncology, 82(1), 167-171. https://doi.org/10.1006/gyno.2001.6233

Oonk, M. H., van Hemel, B. M., Hollema, H., de Hullu, J. A., Ansink, A. C., Vergote, I., . . . van der Zee, A. G. (2010). Size of sentinel-node metastasis and chances of non-sentinel-node involvement and survival in early stage vulvar cancer: results from GROINSS-V, a multicentre observational study. Lancet Oncology, 11(7), 646-652. https://doi.org/10.1016/s1470-2045(10)70104-2

Oonk, M. H. M., Planchamp, F., Baldwin, P., Bidzinski, M., Brannstrom, M., Landoni, F., . . . van der Zee, A. G. J. (2017). European Society of Gynaecological Oncology Guidelines for the Management of Patients With Vulvar Cancer. International Journal of Gynecological Cancer, 27(4), 832-837. https://doi.org/10.1097/igc.0000000000000975

Ortiz, B. H., Ailawadi, M., Colitti, C., Muto, M. G., Deavers, M., Silva, E. G., . . . Gershenson, D. M. (2001). Second primary or recurrence? Comparative patterns of p53 and K-ras mutations suggest that serous borderline ovarian tumors and subsequent serous carcinomas are unrelated tumors. Cancer Research, 61(19), 7264-7267.

Osborne, R. J., Filiaci, V., Schink, J. C., Mannel, R. S., Alvarez Secord, A., Kelley, J. L., . . . Lage, J. M. (2011). Phase III trial of weekly methotrexate or pulsed dactinomycin for low-risk gestational trophoblastic neoplasia: a gynecologic oncology group study. Journal of Clinical Oncology, 29(7), 825-831. https://doi.org/10.1200/jco.2010.30.4386

Oscarsson, N., Müller, B., Rosén, A., Lodding, P., Mölne, J., Giglio, D., . . . Seeman-Lodding, H. (2019). Radiation-induced cystitis treated with hyperbaric oxygen therapy (RICH-ART): a randomised, controlled, phase 2-3 trial. Lancet Oncology, 20(11), 1602-1614. https://doi.org/10.1016/s1470-2045(19)30494-2

OUS Prosedyre: ultrastaging SN for gynekologiske preparater. ([s.a.]). Oslo: OUS, Klinikk for laboratoriemedisin (KLM)/ Avd. patologi/Histologi.

Ovarian cancer. Version 3.2014. (2014). Fort Washington, PA: National Comprehencive Cancer Network.

Overvåking av HPV i Meldingssystemet for smittsomme sykdommer (MSIS). (30. okto 2018). [nettdokument]. Oslo: Folkehelseinstituttet. Hentet 21. jan 2020, fra https://www.fhi.no/hn/helseregistre-og-registre/msis/msis-biobank/hpv-i-msis/

Owings, R. A., & Quick, C. M. (2014). Endometrial intraepithelial neoplasia. Archives of Pathology and Laboratory Medicine, 138(4), 484-491. https://doi.org/10.5858/arpa.2012-0709-RA

Oza, A. M., Cibula, D., Benzaquen, A. O., Poole, C., Mathijssen, R. H. J., Sonke, G. S., . . . Friedlander, M. (2015). Olaparib combined with chemotherapy for recurrent platinum-sensitive ovarian cancer: a randomised phase 2 trial. Lancet Oncology, 16(1), 87-97. https://doi.org/10.1016/S1470-2045(14)71135-0

Ozols, R. F., Bundy, B. N., Greer, B. E., Fowler, J. M., Clarke-Pearson, D., Burger, R. A., . . . Gynecologic Oncology, G. (2003). Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study. Journal of Clinical Oncology, 21(17), 3194-3200. https://doi.org/10.1200/JCO.2003.02.153

Pakkeforløp for eggstokkreft. (2016). (rev. utg.). (IS-2352). Oslo: Helsedirektoratet. Hentet fra https://helsedirektoratet.no/retningslinjer/pakkeforlop-for-eggstokkreft

Pakkeforløp for livmorhalskreft (2016). (rev. utg.). (IS-2354). Oslo: Helsedirektoratet. Hentet fra https://helsedirektoratet.no/retningslinjer/pakkeforlop-for-livmorhalskreft

Palmer, J. E., Macdonald, M., Wells, M., Hancock, B. W., & Tidy, J. A. (2008). Epithelioid trophoblastic tumor: a review of the literature. Journal of Reproductive Medicine, 53(7), 465-475.

Panay, N., & Kalu, E. (2009). Management of premature ovarian failure. Best Practice & Research: Clinical Obstetrics & Gynaecology, 23(1), 129-140. https://doi.org/10.1016/j.bpobgyn.2008.10.008

Panici, P. B., Maggioni, A., Hacker, N., Landoni, F., Ackermann, S., Campagnutta, E., . . . Mangioni, C. (2005). Systematic aortic and pelvic lymphadenectomy versus resection of bulky nodes only in optimally debulked advanced ovarian cancer: a randomized clinical trial. Journal of the National Cancer Institute, 97(8), 560-566. https://doi.org/10.1093/jnci/dji102

Paraskevaidis, E., Jandial, L., Mann, E. M., Fisher, P. M., & Kitchener, H. C. (1991). Pattern of treatment failure following laser for cervical intraepithelial neoplasia: implications for follow-up protocol. Obstetrics and Gynecology, 78(1), 80-83.

Park, J. M., & Kim, M. K. (2014). Hereditary risk evaluation for borderline ovarian tumors based on immunohistochemistry. Journal of menopausal medicine, 20(1), 14-20. https://doi.org/10.6118/jmm.2014.20.1.14

Park, J. Y., Kim, D. Y., Kim, J. H., Kim, Y. M., Kim, K. R., Kim, Y. T., . . . Nam, J. H. (2013). Long-term oncologic outcomes after fertility-sparing management using oral progestin for young women with endometrial cancer (KGOG 2002). European Journal of Cancer, 49(4), 868-874. https://doi.org/10.1016/j.ejca.2012.09.017

Park, K. J. (2020). Cervical adenocarcinoma: integration of HPV status, pattern of invasion, morphology and molecular markers into classification. Histopathology, 76(1), 112-127. https://doi.org/10.1111/his.13995

Parmar, M. K. B., Ledermann, J. A., Colombo, N., du Bois, A., Delaloye, J. F., Kristensen, G. B., . . . Collaborators, A. G. O. (2003). Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial. Lancet, 361(9375), 2099-2106. https://doi.org/10.1016/s0140-6736(03)13718-x

Pasanisi, P., Hédelin, G., Berrino, J., Chang-Claude, J., Hermann, S., Steel, M., . . . Berrino, F. (2009). Oral contraceptive use and BRCA penetrance: a case-only study. Cancer Epidemiology, Biomarkers and Prevention, 18(7), 2107-2113. https://doi.org/10.1158/1055-9965.EPI-09-0024

Patel, S., Liyanage, S. H., Sahdev, A., Rockall, A. G., & Reznek, R. H. (2010). Imaging of endometrial and cervical cancer. Insights Imaging, 1(5-6), 309-328. https://doi.org/10.1007/s13244-010-0042-7

Paulsen, T. (2007). Epithelial ovarian cancer: a clinical epidemiological approach on diagnosis and treatment (doktorgrad). (Series of dissertations submitted to the Faculty of Medicine, University of Oslo No.549). Oslo: University of Oslo. Hentet fra https://www.duo.uio.no/handle/10852/28083

Paulsen, T., Kjaerheim, K., Kaern, J., Tretli, S., & Trope, C. (2006). Improved short-term survival for advanced ovarian, tubal, and peritoneal cancer patients operated at teaching hospitals. International Journal of Gynecological Cancer, 16 Suppl 1, 11-17. https://doi.org/10.1111/j.1525-1438.2006.00319.x

Paulsen, T., Kærn, J., Kjærheim, K., Tropé, C., & Tretli, S. (2005). Symptoms and referral of women with epithelial ovarian tumors. International Journal of Gynaecology and Obstetrics, 88(1), 31-37. https://doi.org/10.1016/j.ijgo.2004.09.008

Paulsen, T., Kærn, J., & Tropé, C. (2011). Improved 5-year disease-free survival for FIGO stage I epithelial ovarian cancer patients without tumor rupture during surgery. Gynecologic Oncology, 122(1), 83-88. https://doi.org/10.1016/j.ygyno.2011.02.038

Peccatori, F., Bonazzi, C., Chiari, S., Landoni, F., Colombo, N., & Mangioni, C. (1995). Surgical management of malignant ovarian germ-cell tumors: 10 years' experience of 129 patients. Obstetrics and Gynecology, 86(3), 367-372. https://doi.org/10.1016/0029-7844(95)00192-t

Pecorelli, S. (2009). Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. International Journal of Gynaecology and Obstetrics, 105(2), 103-104.

Pepas, L., Kaushik, S., Nordin, A., Bryant, A., & Lawrie, T. A. (2015). Medical interventions for high-grade vulval intraepithelial neoplasia. Cochrane Database of Systematic Reviews, (8), CD007924. https://doi.org/10.1002/14651858.CD007924.pub3

Perez, C. A., Grigsby, P. W., Castro-Vita, H., & Lockett, M. A. (1995). Carcinoma of the uterine cervix. I. Impact of prolongation of overall treatment time and timing of brachytherapy on outcome of radiation therapy. International Journal of Radiation Oncology, Biology, Physics, 32(5), 1275-1288. https://doi.org/10.1016/0360-3016(95)00220-s

Perino, A., Quartararo, P., Catinella, E., Genova, G., & Cittadini, E. (1987). Treatment of endometrial hyperplasia with levonorgestrel releasing intrauterine devices. Acta Europaea Fertilitatis, 18(2), 137-140.

Perren, T. J. (2016). Mucinous epithelial ovarian carcinoma. Annals of Oncology, 27(suppl_1), i53-i57. https://doi.org/10.1093/annonc/mdw087 %J Annals of Oncology

Perren, T. J., Swart, A. M., Pfisterer, J., Ledermann, J. A., Pujade-Lauraine, E., Kristensen, G., . . . Oza, A. M. (2011). A phase 3 trial of bevacizumab in ovarian cancer. New England Journal of Medicine, 365(26), 2484-2496. https://doi.org/10.1056/NEJMoa1103799

Persson, I., Weiderpass, E., Bergkvist, L., Bergström, R., & Schairer, C. (1999). Risks of breast and endometrial cancer after estrogen and estrogen-progestin replacement. Cancer Causes and Control, 10(4), 253-260. https://doi.org/10.1023/a:1008909128110

Phillips, A., Sundar, S., Singh, K., Nevin, J., Elattar, A., Kehoe, S., & Balega, J. (2018). Complete cytoreduction after five or more cycles of neo-adjuvant chemotherapy confers a survival benefit in advanced ovarian cancer. European Journal of Surgical Oncology, 44(6), 760-765. https://doi.org/10.1016/j.ejso.2018.01.097

Pieterse, Q. D., Kenter, G. G., Maas, C. P., de Kroon, C. D., Creutzberg, C. L., Trimbos, J. B., & Ter Kuile, M. M. (2013). Self-reported sexual, bowel and bladder function in cervical cancer patients following different treatment modalities: longitudinal prospective cohort study. International Journal of Gynecological Cancer, 23(9), 1717-1725. https://doi.org/10.1097/IGC.0b013e3182a80a65

Pignata, S., Scambia, G., Ferrandina, G., Savarese, A., Sorio, R., Breda, E., . . . Perrone, F. (2011). Carboplatin plus paclitaxel versus carboplatin plus pegylated liposomal doxorubicin as first-line treatment for patients with ovarian cancer: the MITO-2 randomized phase III trial. Journal of Clinical Oncology, 29(27), 3628-3635. https://doi.org/10.1200/JCO.2010.33.8566

Pike, M. C., Peters, R. K., Cozen, W., Probst-Hensch, N. M., Felix, J. C., Wan, P. C., & Mack, T. M. (1997). Estrogen-progestin replacement therapy and endometrial cancer. Journal of the National Cancer Institute, 89(15), 1110-1116.

Pilarski, R., Stephens, J. A., Noss, R., Fisher, J. L., & Prior, T. W. (2011). Predicting PTEN mutations: an evaluation of Cowden syndrome and Bannayan-Riley-Ruvalcaba syndrome clinical features. Journal of Medical Genetics, 48(8), 505-512. https://doi.org/10.1136/jmg.2011.088807

Piver, M. S. (2002). Hereditary ovarian cancer. Lessons from the first twenty years of the Gilda Radner Familial Ovarian Cancer Registry. Gynecologic Oncology, 85(1), 9-17. https://doi.org/10.1006/gyno.2001.6465

Plante, M. (2013). Evolution in fertility-preserving options for early-stage cervical cancer: radical trachelectomy, simple trachelectomy, neoadjuvant chemotherapy. International Journal of Gynecological Cancer, 23(6), 982-989. https://doi.org/10.1097/IGC.0b013e318295906b

Plante, M., Stanleigh, J., Renaud, M. C., Sebastianelli, A., Grondin, K., & Grégoire, J. (2017). Isolated tumor cells identified by sentinel lymph node mapping in endometrial cancer: Does adjuvant treatment matter? Gynecologic Oncology, 146(2), 240-246. https://doi.org/10.1016/j.ygyno.2017.05.024

Plaxe, S. C. (2008). Epidemiology of low-grade serous ovarian cancer. American Journal of Obstetrics and Gynecology, 198(4), 459.e451-459.e454.459E419. https://doi.org/10.1016/j.ajog.2008.01.035

Pollock, K. (2017). The impact of the HPV vaccine in Scotland. Foredrag på HPV Conference, Ashling Hotel in Dublin mai 2017. Hentet fra https://www.hse.ie/eng/health/immunisation/hcpinfo/conference/hpv173.pdf

Pouwer, A. W., Hinten, F., van der Velden, J., Smolders, R. G. V., Slangen, B. F. M., Zijlmans, H., . . . de Hullu, J. A. (2017). Volume-controlled versus short drainage after inguinofemoral lymphadenectomy in vulvar cancer patients: A Dutch nationwide prospective study. Gynecologic Oncology, 146(3), 580-587. https://doi.org/10.1016/j.ygyno.2017.06.031

Powell, C. B., Chen, L. M., McLennan, J., Crawford, B., Zaloudek, C., Rabban, J. T., . . . Ziegler, J. (2011). Risk-reducing salpingo-oophorectomy (RRSO) in BRCA mutation carriers: experience with a consecutive series of 111 patients using a standardized surgical-pathological protocol. International Journal of Gynecological Cancer, 21(5), 846-851. https://doi.org/10.1097/IGC.0b013e31821bc7e3

Prat, J., & FIGO Committee on Gynecologic Oncology. (2014). Staging classification for cancer of the ovary, fallopian tube, and peritoneum. International Journal of Gynaecology and Obstetrics, 124(1), 1-5. https://doi.org/10.1016/j.ijgo.2013.10.001

Preti, M., Van Seters, M., Sideri, M., & Van Beurden, M. (2005). Squamous vulvar intraepithelial neoplasia. Clinical Obstetrics and Gynecology, 48(4), 845-861.

Pretorius, R. G., Belinson, J. L., Burchette, R. J., Hu, S., Zhang, X., & Qiao, Y. L. (2011). Regardless of skill, performing more biopsies increases the sensitivity of colposcopy. Journal of Lower Genital Tract Disease, 15(3), 180-188. https://doi.org/10.1097/LGT.0b013e3181fb4547

Pujade-Lauraine, E., Hilpert, F., Weber, B., Reuss, A., Poveda, A., Kristensen, G., . . . Ray-Coquard, I. (2014). Bevacizumab combined with chemotherapy for platinum-resistant recurrent ovarian cancer: The AURELIA open-label randomized phase III trial. Journal of Clinical Oncology, 32(13), 1302-1308. https://doi.org/10.1200/JCO.2013.51.4489

Purdie, D. M., Bain, C. J., Siskind, V., Webb, P. M., & Green, A. C. (2003). Ovulation and risk of epithelial ovarian cancer. International Journal of Cancer, 104(2), 228-232. https://doi.org/10.1002/ijc.10927

Pötter, R., Tanderup, K., Kirisits, C., de Leeuw, A., Kirchheiner, K., Nout, R., . . . Jürgenliemk-Schulz, I. (2018). The EMBRACE II study: The outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies. Clin Transl Radiat Oncol, 9, 48-60. https://doi.org/10.1016/j.ctro.2018.01.001

Querleu, D., & Morrow, C. P. (2008). Classification of radical hysterectomy. Lancet Oncology, 9(3), 297-303. https://doi.org/10.1016/s1470-2045(08)70074-3

Raimond, E., Delorme, C., Ouldamer, L., Carcopino, X., Bendifallah, S., Touboul, C., . . . Graesslin, O. (2019). Surgical treatment of vulvar cancer: Impact of tumor-free margin distance on recurrence and survival. A multicentre cohort analysis from the francogyn study group. European Journal of Surgical Oncology, 45(11), 2109-2114. https://doi.org/10.1016/j.ejso.2019.07.005

Raja, F. A., Counsell, N., Colombo, N., Pfisterer, J., du Bois, A., Parmar, M. K., . . . Ledermann, J. A. (2013). Platinum versus platinum-combination chemotherapy in platinum-sensitive recurrent ovarian cancer: a meta-analysis using individual patient data. Annals of Oncology, 24(12), 3028-3034. https://doi.org/10.1093/annonc/mdt406

Ramirez, P. T., Frumovitz, M., Pareja, R., Lopez, A., Vieira, M., Ribeiro, R., . . . Obermair, A. (2018). Minimally Invasive versus Abdominal Radical Hysterectomy for Cervical Cancer. New England Journal of Medicine, 379(20), 1895-1904. https://doi.org/10.1056/NEJMoa1806395

Ramlov, A., Assenholt, M. S., Jensen, M. F., Grønborg, C., Nout, R., Alber, M., . . . Lindegaard, J. C. (2017). Clinical implementation of coverage probability planning for nodal boosting in locally advanced cervical cancer. Radiotherapy and Oncology, 123(1), 158-163. https://doi.org/10.1016/j.radonc.2017.01.015

Ramlov, A., Pedersen, E. M., Røhl, L., Worm, E., Fokdal, L., Lindegaard, J. C., & Tanderup, K. (2017). Risk Factors for Pelvic Insufficiency Fractures in Locally Advanced Cervical Cancer Following Intensity Modulated Radiation Therapy. International Journal of Radiation Oncology, Biology, Physics, 97(5), 1032-1039. https://doi.org/10.1016/j.ijrobp.2017.01.026

Randall, T. C., & Kurman, R. J. (1997). Progestin treatment of atypical hyperplasia and well-differentiated carcinoma of the endometrium in women under age 40. Obstetrics and Gynecology, 90(3), 434-440. https://doi.org/10.1016/s0029-7844(97)00297-4

Rao, Y. J., Chin, R. I., Hui, C., Mutch, D. G., Powell, M. A., Schwarz, J. K., . . . Markovina, S. (2017). Improved survival with definitive chemoradiation compared to definitive radiation alone in squamous cell carcinoma of the vulva: A review of the National Cancer Database. Gynecologic Oncology, 146(3), 572-579. https://doi.org/10.1016/j.ygyno.2017.06.022

Rebbeck, T. R., Kauff, N. D., & Domchek, S. M. (2009). Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers. Journal of the National Cancer Institute, 101(2), 80-87. https://doi.org/10.1093/jnci/djn442

Rijkmans, E. C., Nout, R. A., Rutten, I. H., Ketelaars, M., Neelis, K. J., Laman, M. S., . . . Creutzberg, C. L. (2014). Improved survival of patients with cervical cancer treated with image-guided brachytherapy compared with conventional brachytherapy. Gynecologic Oncology, 135(2), 231-238. https://doi.org/10.1016/j.ygyno.2014.08.027

Riman, T., Dickman, P. W., Nilsson, S., Correia, N., Nordlinder, H., Magnusson, C. M., & Persson, I. R. (2001). Risk factors for epithelial borderline ovarian tumors: results of a Swedish case-control study. Gynecologic Oncology, 83(3), 575-585. https://doi.org/10.1006/gyno.2001.6451

Robison, K., Roque, D., McCourt, C., Stuckey, A., DiSilvestro, P. A., Sung, C. J., . . . Moore, R. G. (2014). Long-term follow-up of vulvar cancer patients evaluated with sentinel lymph node biopsy alone. Gynecologic Oncology, 133(3), 416-420. https://doi.org/10.1016/j.ygyno.2014.03.010

Rodolakis, A., Biliatis, I., Morice, P., Reed, N., Mangler, M., Kesic, V., & Denschlag, D. (2015). European Society of Gynecological Oncology Task Force for Fertility Preservation: Clinical Recommendations for Fertility-Sparing Management in Young Endometrial Cancer Patients. International Journal of Gynecological Cancer, 25(7), 1258-1265. https://doi.org/10.1097/igc.0000000000000493

Rogers, L., Siu, S. S., Luesley, D., Bryant, A., & Dickinson, H. O. (2012). Radiotherapy and chemoradiation after surgery for early cervical cancer. Cochrane Database of Systematic Reviews, 5(5), CD007583. https://doi.org/10.1002/14651858.CD007583.pub3

Rogers, L. J., & Cuello, M. A. (2018). Cancer of the vulva. International Journal of Gynaecology and Obstetrics, 143 Suppl 2, 4-13. https://doi.org/10.1002/ijgo.12609

Rose, P. G. (1996). Endometrial carcinoma. New England Journal of Medicine, 335(9), 640-649. https://doi.org/10.1056/nejm199608293350907

Rossi, E. C., Kowalski, L. D., Scalici, J., Cantrell, L., Schuler, K., Hanna, R. K., . . . Boggess, J. F. (2017). A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort study. Lancet Oncology, 18(3), 384-392. https://doi.org/10.1016/s1470-2045(17)30068-2

Rotman, M., Sedlis, A., Piedmonte, M. R., Bundy, B., Lentz, S. S., Muderspach, L. I., & Zaino, R. J. (2006). A phase III randomized trial of postoperative pelvic irradiation in Stage IB cervical carcinoma with poor prognostic features: follow-up of a gynecologic oncology group study. International Journal of Radiation Oncology, Biology, Physics, 65(1), 169-176. https://doi.org/10.1016/j.ijrobp.2005.10.019

Rud, A. K., Bjørgo, S., Kristensen, G. B., & Kongsgaard, U. E. (2009). Hyperbaric oxygen therapy for late radiation tissue injury in gynaecological patients. Supportive Care in Cancer, 17(12), 1517-1521. https://doi.org/10.1007/s00520-009-0619-1

Rustin, G. J., Quinn, M., Thigpen, T., du Bois, A., Pujade-Lauraine, E., Jakobsen, A., . . . Vermorken, J. (2004). Re: New guidelines to evaluate the response to treatment in solid tumors (ovarian cancer). Journal of the National Cancer Institute, 96(6), 487-488.

Rustin, G. J., van der Burg, M. E., Griffin, C. L., Guthrie, D., Lamont, A., Jayson, G. C., . . . Swart, A. M. (2010). Early versus delayed treatment of relapsed ovarian cancer (MRC OV05/EORTC 55955): a randomised trial. Lancet, 376(9747), 1155-1163. https://doi.org/10.1016/s0140-6736(10)61268-8

Rydzewska, L., Tierney, J., Vale, C. L., & Symonds, P. R. (2012). Neoadjuvant chemotherapy plus surgery versus surgery for cervical cancer. Cochrane Database of Systematic Reviews, 12(12), CD007406. https://doi.org/10.1002/14651858.CD007406.pub3

Sadler, L., Saftlas, A., Wang, W., Exeter, M., Whittaker, J., & McCowan, L. (2004). Treatment for cervical intraepithelial neoplasia and risk of preterm delivery. JAMA, 291(17), 2100-2106. https://doi.org/10.1001/jama.291.17.2100

Salani, R., Backes, F. J., Fung, M. F., Holschneider, C. H., Parker, L. P., Bristow, R. E., & Goff, B. A. (2011). Posttreatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncologists recommendations. American Journal of Obstetrics and Gynecology, 204(6), 466-478. https://doi.org/10.1016/j.ajog.2011.03.008

Salvesen, H. B., Akslen, L. A., Iversen, T., & Iversen, O. E. (1997). Recurrence of endometrial carcinoma and the value of routine follow up. British Journal of Obstetrics and Gynaecology, 104(11), 1302-1307.

Salvesen, H. B., Haldorsen, I. S., & Trovik, J. (2012). Markers for individualised therapy in endometrial carcinoma. Lancet Oncology, 13(8), e353-361. https://doi.org/10.1016/s1470-2045(12)70213-9

Salvesen, H. B., Iversen, O. E., & Akslen, L. A. (1999). Prognostic significance of angiogenesis and Ki-67, p53, and p21 expression: a population-based endometrial carcinoma study. Journal of Clinical Oncology, 17(5), 1382-1390.

Salvo, G., Gonzalez Martin, A., Gonzales, N. R., & Frumovitz, M. (2019). Updates and management algorithm for neuroendocrine tumors of the uterine cervix. International Journal of Gynecological Cancer, 29(6), 986-995. https://doi.org/10.1136/ijgc-2019-000504

Sammen mot kreft: nasjonal kreftstrategi 2013-2017. (2013). Oslo: Helse- og omsorgsdepartementet. Hentet fra https://www.regjeringen.no/contentassets/07cd14ff763444a3997de1570b85fad1/kreftstrategien_2013.pdf

Sand, F. L., Kjaer, S. K., Frederiksen, K., & Dehlendorff, C. (2019). Risk of cervical intraepithelial neoplasia grade 2 or worse after conization in relation to HPV vaccination status. International Journal of Cancer, Oct 24 [Epub ahead of print]. https://doi.org/10.1002/ijc.32752

Satoh, T., Takei, Y., Treilleux, I., Devouassoux-Shisheboran, M., Ledermann, J., Viswanathan, A. N., . . . Fujiwara, K. (2014). Gynecologic Cancer InterGroup (GCIG) consensus review for small cell carcinoma of the cervix. International Journal of Gynecological Cancer, 24(9 Suppl 3), S102-108. https://doi.org/10.1097/igc.0000000000000262

Scarselli, G., Tantini, C., Colafranceschi, M., Taddei, G. L., Bargelli, G., Venturini, N., & Branconi, F. (1988). Levo-norgestrel-nova-T and precancerous lesions of the endometrium. European Journal of Gynaecological Oncology, 9(4), 284-286.

Scheistrøen, M., Nesland, J. M., & Trope, C. (2002). Have patients with early squamous carcinoma of the vulva been overtreated in the past? The Norwegian experience 1977-1991. European Journal of Gynaecological Oncology, 23(2), 93-103.

Schiffman, M., & Wentzensen, N. (2010). From human papillomavirus to cervical cancer. Obstetrics and Gynecology, 116(1), 177-185. https://doi.org/10.1097/AOG.0b013e3181e4629f

Schmeler, K. M., Lynch, H. T., Chen, L. M., Munsell, M. F., Soliman, P. T., Clark, M. B., . . . Lu, K. H. (2006). Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome. New England Journal of Medicine, 354(3), 261-269. https://doi.org/10.1056/NEJMoa052627

Schmid, M. P., Franckena, M., Kirchheiner, K., Sturdza, A., Georg, P., Dörr, W., & Pötter, R. (2014). Distant metastasis in patients with cervical cancer after primary radiotherapy with or without chemotherapy and image guided adaptive brachytherapy. Gynecologic Oncology, 133(2), 256-262. https://doi.org/10.1016/j.ygyno.2014.02.004

Schuurman, M. S., van den Einden, L. C., Massuger, L. F., Kiemeney, L. A., van der Aa, M. A., & de Hullu, J. A. (2013). Trends in incidence and survival of Dutch women with vulvar squamous cell carcinoma. European Journal of Cancer, 49(18), 3872-3880. https://doi.org/10.1016/j.ejca.2013.08.003

Seckl, M. J., Sebire, N. J., & Berkowitz, R. S. (2010). Gestational trophoblastic disease. Lancet, 376(9742), 717-729. https://doi.org/10.1016/s0140-6736(10)60280-2

Sedlis, A., Bundy, B. N., Rotman, M. Z., Lentz, S. S., Muderspach, L. I., & Zaino, R. J. (1999). A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: A Gynecologic Oncology Group Study. Gynecologic Oncology, 73(2), 177-183. https://doi.org/10.1006/gyno.1999.5387

Sehouli, J., Drescher, F. S., Mustea, A., Elling, D., Friedmann, W., Kuhn, W., . . . Lichtenegger, W. (2004). Granulosa cell tumor of the ovary: 10 years follow-up data of 65 patients. Anticancer Research, 24(2c), 1223-1229.

Seidman, J. D., & Kurman, R. J. (2000). Ovarian serous borderline tumors: a critical review of the literature with emphasis on prognostic indicators. Human Pathology, 31(5), 539-557.

Sentinel Lymph Node Biopsy in Patients With Early Stages Cervical Cancer (SENTIX) [pågående studie]. (2016-2022). (NCT02494063). Hentet fra https://clinicaltrials.gov/ct2/show/NCT02494063

Sharma, A., & Menon, U. (2006). Screening for gynaecological cancers. European Journal of Surgical Oncology, 32(8), 818-824. https://doi.org/10.1016/j.ejso.2006.03.034

Sherman, M. E., Mink, P. J., Curtis, R., Cote, T. R., Brooks, S., Hartge, P., & Devesa, S. (2004). Survival among women with borderline ovarian tumors and ovarian carcinoma: a population-based analysis. Cancer, 100(5), 1045-1052. https://doi.org/10.1002/cncr.20080

Shi, Q., Sobrero, A. F., Shields, A. F., Yoshino, T., Paul, J., Taieb, J., . . . Iveson, T. (2017). Prospective pooled analysis of six phase III trials investigating duration of adjuvant (adjuv) oxaliplatin-based therapy (3 vs 6 months) for patients (pts) with stage III colon cancer (CC): The IDEA (International Duration Evaluation of Adjuvant chemotherapy) collaboration. Journal of Clinical Oncology, 35(18_suppl), LBA1-LBA1. https://doi.org/10.1200/JCO.2017.35.18_suppl.LBA1

Shylasree, T. S., Bryant, A., & Howells, R. E. (2011). Chemoradiation for advanced primary vulval cancer. Cochrane Database of Systematic Reviews, 2011(4), CD003752. https://doi.org/10.1002/14651858.CD003752.pub3

Sieh, W., Salvador, S., McGuire, V., Weber, R. P., Terry, K. L., Rossing, M. A., . . . Whittemore, A. S. (2013). Tubal ligation and risk of ovarian cancer subtypes: a pooled analysis of case-control studies. International Journal of Epidemiology, 42(2), 579-589. https://doi.org/10.1093/ije/dyt042

Silins, I., Ryd, W., Strand, A., Wadell, G., Tornberg, S., Hansson, B. G., . . . Rylander, E. (2005). Chlamydia trachomatis infection and persistence of human papillomavirus. International Journal of Cancer, 116(1), 110-115. https://doi.org/10.1002/ijc.20970

Silva, E. G., Gershenson, D. M., Malpica, A., & Deavers, M. (2006). The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent. American Journal of Surgical Pathology, 30(11), 1367-1371. https://doi.org/10.1097/01.pas.0000213294.81154.95

Singh, A. K., Grigsby, P. W., Rader, J. S., Mutch, D. G., & Powell, M. A. (2005). Cervix carcinoma, concurrent chemoradiotherapy, and salvage of isolated paraaortic lymph node recurrence. International Journal of Radiation Oncology, Biology, Physics, 61(2), 450-455. https://doi.org/10.1016/j.ijrobp.2004.06.207

Siristatidis, C., Sergentanis, T. N., Kanavidis, P., Trivella, M., Sotiraki, M., Mavromatis, I., . . . Petridou, E. T. (2013). Controlled ovarian hyperstimulation for IVF: impact on ovarian, endometrial and cervical cancer--a systematic review and meta-analysis. Human Reproduction Update, 19(2), 105-123. https://doi.org/10.1093/humupd/dms051

Sjøborg, K. D., Vistad, I., Myhr, S. S., Svenningsen, R., Herzog, C., Kloster-Jensen, A., . . . Tanbo, T. (2007). Pregnancy outcome after cervical cone excision: a case-control study. Acta Obstetricia et Gynecologica Scandinavica, 86(4), 423-428. https://doi.org/10.1080/11038120701208158

Sletten, E. T., Arnes, M., Lysa, L. M., Moe, B. T., Straume, B., & Orbo, A. (2017). Prediction of Relapse After Therapy Withdrawal in Women with Endometrial Hyperplasia: A Long-term Follow-up Study. Anticancer Research, 37(5), 2529-2536. https://doi.org/10.21873/anticanres.11595

Small, W., Jr., Mell, L. K., Anderson, P., Creutzberg, C., De Los Santos, J., Gaffney, D., . . . Mundt, A. J. (2008). Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy in postoperative treatment of endometrial and cervical cancer. International Journal of Radiation Oncology, Biology, Physics, 71(2), 428-434. https://doi.org/10.1016/j.ijrobp.2007.09.042

Smet, S., Pötter, R., Haie-Meder, C., Lindegaard, J. C., Schulz-Juergenliemk, I., Mahantshetty, U., . . . Kirchheiner, K. (2018). Fatigue, insomnia and hot flashes after definitive radiochemotherapy and image-guided adaptive brachytherapy for locally advanced cervical cancer: An analysis from the EMBRACE study. Radiotherapy and Oncology, 127(3), 440-448. https://doi.org/10.1016/j.radonc.2018.03.009

Smith, J. S., Backes, D. M., Hoots, B. E., Kurman, R. J., & Pimenta, J. M. (2009). Human papillomavirus type-distribution in vulvar and vaginal cancers and their associated precursors. Obstetrics and Gynecology, 113(4), 917-924. https://doi.org/10.1097/AOG.0b013e31819bd6e0

Smith, J. S., Green, J., Berrington de Gonzalez, A., Appleby, P., Peto, J., Plummer, M., . . . Beral, V. (2003). Cervical cancer and use of hormonal contraceptives: a systematic review. Lancet, 361(9364), 1159-1167.

Smith, J. S., Lindsay, L., Hoots, B., Keys, J., Franceschi, S., Winer, R., & Clifford, G. M. (2007). Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. International Journal of Cancer, 121(3), 621-632. https://doi.org/10.1002/ijc.22527

Solomon, D., Davey, D., Kurman, R., Moriarty, A., O'Connor, D., Prey, M., . . . Young, N. (2002). The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA, 287(16), 2114-2119.

Soper, J. T., Lewis Jr, J. L., & Hammond, C. (2005). Gestational Trophoblastic Disease. I: W. J. Hoskins, C. A. Perez, & R. Toung (red.), Principles and practice of gynecologic oncology (4 utg., s. 1039-1077). Philadelphia: Lippincott Williams & Wilkins.

Soutter, W. P., Haidopoulos, D., Gornall, R. J., McIndoe, G. A., Fox, J., Mason, W. P., . . . Sarhanis, P. (2001). Is conservative treatment for adenocarcinoma in situ of the cervix safe? BJOG: An International Journal of Obstetrics and Gynaecology, 108(11), 1184-1189.

Spanos, W. J., Jr., Wasserman, T., Meoz, R., Sala, J., Kong, J., & Stetz, J. (1987). Palliation of advanced pelvic malignant disease with large fraction pelvic radiation and misonidazole: final report of RTOG phase I/II study. International Journal of Radiation Oncology, Biology, Physics, 13(10), 1479-1482. https://doi.org/10.1016/0360-3016(87)90314-2

Srodon, M., Stoler, M. H., Baber, G. B., & Kurman, R. J. (2006). The distribution of low and high-risk HPV types in vulvar and vaginal intraepithelial neoplasia (VIN and VaIN). American Journal of Surgical Pathology, 30(12), 1513-1518. https://doi.org/10.1097/01.pas.0000213291.96401.48

Stanley, M. (2010). Pathology and epidemiology of HPV infection in females. Gynecologic Oncology, 117(2 Suppl), S5-10. https://doi.org/10.1016/j.ygyno.2010.01.024

Statistikk for HPV-vaksinasjon i barnevaksinasjonsprogrammet. (21. mai 2019). [nettdokument]. Oslo: Folkehelseinstituttet. Hentet 21. jan 2020, fra https://www.fhi.no/hn/helseregistre-og-registre/sysvak/dekkningsstatistikk/

Steen, R., Dahl, A. A., Hess, S. L., & Kiserud, C. E. (2017). A study of chronic fatigue in Norwegian cervical cancer survivors. Gynecologic Oncology, 146(3), 630-635. https://doi.org/10.1016/j.ygyno.2017.05.028

Stefansson, I. M., Salvesen, H. B., Immervoll, H., & Akslen, L. A. (2004). Prognostic impact of histological grade and vascular invasion compared with tumour cell proliferation in endometrial carcinoma of endometrioid type. Histopathology, 44(5), 472-479. https://doi.org/10.1111/j.1365-2559.2004.01882.x

Stehman, F. B., Bundy, B. N., Thomas, G., Varia, M., Okagaki, T., Roberts, J., . . . Heller, P. B. (1992). Groin dissection versus groin radiation in carcinoma of the vulva: a Gynecologic Oncology Group study. International Journal of Radiation Oncology, Biology, Physics, 24(2), 389-396.

Stirling, D., Evans, D. G., Pichert, G., Shenton, A., Kirk, E. N., Rimmer, S., . . . Porteous, M. E. (2005). Screening for familial ovarian cancer: failure of current protocols to detect ovarian cancer at an early stage according to the international Federation of gynecology and obstetrics system. Journal of Clinical Oncology, 23(24), 5588-5596. https://doi.org/10.1200/jco.2005.05.097

Stockler, M. R., Hilpert, F., Friedlander, M., King, M. T., Wenzel, L., Lee, C. K., . . . Pujade-Lauraine, E. (2014). Patient-reported outcome results from the open-label phase III AURELIA trial evaluating bevacizumab-containing therapy for platinum-resistant ovarian cancer. Journal of Clinical Oncology, 32(13), 1309-1316. https://doi.org/10.1200/JCO.2013.51.4240

Sturdza, A., Pötter, R., Fokdal, L. U., Haie-Meder, C., Tan, L. T., Mazeron, R., . . . Lindegaard, J. C. (2016). Image guided brachytherapy in locally advanced cervical cancer: Improved pelvic control and survival in RetroEMBRACE, a multicenter cohort study. Radiotherapy and Oncology, 120(3), 428-433. https://doi.org/10.1016/j.radonc.2016.03.011

Suh-Burgmann, E. (2006). Long-term outcomes following conservative surgery for borderline tumor of the ovary: a large population-based study. Gynecologic Oncology, 103(3), 841-847. https://doi.org/10.1016/j.ygyno.2006.05.014

Szczesny, W., Langseth, H., Myklebust, T. Å., Kaern, J., Tropé, C., & Paulsen, T. (2018). Survival after secondary cytoreductive surgery and chemotherapy compared with chemotherapy alone for first recurrence in patients with platinum-sensitive epithelial ovarian cancer and no residuals after primary treatment. A registry-based study. Acta Obstetricia et Gynecologica Scandinavica, May 22 [Epub ahead of print]. https://doi.org/10.1111/aogs.13361

Sørensen, S. S., & Mosgaard, B. J. (2011). Combination of cancer antigen 125 and carcinoembryonic antigen can improve ovarian cancer diagnosis. Danish Medical Bulletin, 58(11), A4331-A4331.

Tailor, A., Bourne, T. H., Campbell, S., Okokon, E., Dew, T., & Collins, W. P. (2003). Results from an ultrasound-based familial ovarian cancer screening clinic: a 10-year observational study. Ultrasound in Obstetrics and Gynecology, 21(4), 378-385. https://doi.org/10.1002/uog.65

Tainio, K., Athanasiou, A., Tikkinen, K. A. O., Aaltonen, R., Cárdenas, J., Hernándes, . . . Kalliala, I. (2018). Clinical course of untreated cervical intraepithelial neoplasia grade 2 under active surveillance: systematic review and meta-analysis. BMJ, 360, k499. https://doi.org/10.1136/bmj.k499

Talhouk, A., McConechy, M. K., Leung, S., Yang, W., Lum, A., Senz, J., . . . McAlpine, J. N. (2017). Confirmation of ProMisE: A simple, genomics-based clinical classifier for endometrial cancer. Cancer, 123(5), 802-813. https://doi.org/10.1002/cncr.30496

Tan, L. T., Pötter, R., Sturdza, A., Fokdal, L., Haie-Meder, C., Schmid, M., . . . Tanderup, K. (2019). Change in Patterns of Failure After Image-Guided Brachytherapy for Cervical Cancer: Analysis From the RetroEMBRACE Study. International Journal of Radiation Oncology, Biology, Physics, 104(4), 895-902. https://doi.org/10.1016/j.ijrobp.2019.03.038

Tanderup, K., Fokdal, L. U., Sturdza, A., Haie-Meder, C., Mazeron, R., van Limbergen, E., . . . Pötter, R. (2016). Effect of tumor dose, volume and overall treatment time on local control after radiochemotherapy including MRI guided brachytherapy of locally advanced cervical cancer. Radiotherapy and Oncology, 120(3), 441-446. https://doi.org/10.1016/j.radonc.2016.05.014

Tangjitgamol, S., Katanyoo, K., Laopaiboon, M., Lumbiganon, P., Manusirivithaya, S., & Supawattanabodee, B. (2014). Adjuvant chemotherapy after concurrent chemoradiation for locally advanced cervical cancer. Cochrane Database of Systematic Reviews, 2014(12), CD010401. https://doi.org/10.1002/14651858.CD010401.pub2

Tangjitgamol, S., Tharavichitkul, E., Tovanabutra, C., Rongsriyam, K., Asakij, T., Paengchit, K., . . . Lorvidhaya, V. (2019). A randomized controlled trial comparing concurrent chemoradiation versus concurrent chemoradiation followed by adjuvant chemotherapy in locally advanced cervical cancer patients: ACTLACC trial. Journal of Gynecologic Oncology, 30(4), e82. https://doi.org/10.3802/jgo.2019.30.e82

Tao, R., Tsai, C. J., Jensen, G., Eng, C., Kopetz, S., Overman, M. J., . . . Das, P. (2017). Hyperfractionated accelerated reirradiation for rectal cancer: An analysis of outcomes and toxicity. Radiotherapy and Oncology, 122(1), 146-151. https://doi.org/10.1016/j.radonc.2016.12.015

Tatti, S., Bornstein, J., & Prendiville, W. (2013). Colposcopy: a global perspective: introduction of the new IFCPC colposcopy terminology. Obstetrics and Gynecology Clinics of North America, 40(2), 235-250. https://doi.org/10.1016/j.ogc.2013.02.002

Taylor, A., Rockall, A. G., & Powell, M. E. (2007). An atlas of the pelvic lymph node regions to aid radiotherapy target volume definition. Clinical Oncology (Royal College of Radiologists), 19(7), 542-550. https://doi.org/10.1016/j.clon.2007.05.002

Te Grootenhuis, N. C., Pouwer, A. W., de Bock, G. H., Hollema, H., Bulten, J., van der Zee, A. G. J., . . . Oonk, M. H. M. (2018). Prognostic factors for local recurrence of squamous cell carcinoma of the vulva: A systematic review. Gynecologic Oncology, 148(3), 622-631. https://doi.org/10.1016/j.ygyno.2017.11.006

Te Grootenhuis, N. C., Pouwer, A. W., de Bock, G. H., Hollema, H., Bulten, J., van der Zee, A. G. J., . . . Oonk, M. H. M. (2019). Margin status revisited in vulvar squamous cell carcinoma. Gynecologic Oncology, 154(2), 266-275. https://doi.org/10.1016/j.ygyno.2019.05.010

Terlou, A., Blok, L. J., Helmerhorst, T. J., & van Beurden, M. (2010). Premalignant epithelial disorders of the vulva: squamous vulvar intraepithelial neoplasia, vulvar Paget's disease and melanoma in situ. Acta Obstetricia et Gynecologica Scandinavica, 89(6), 741-748. https://doi.org/10.3109/00016341003739575

Tewari, K. S., Sill, M. W., Long, H. J., 3rd, Penson, R. T., Huang, H., Ramondetta, L. M., . . . Monk, B. J. (2014). Improved survival with bevacizumab in advanced cervical cancer. New England Journal of Medicine, 370(8), 734-743. https://doi.org/10.1056/NEJMoa1309748

Tharavichitkul, E., Lorvidhaya, V., Kamnerdsupaphon, P., Sukthomya, V., Chakrabandhu, S., Klunklin, P., . . . Chitapanarux, I. (2016). Combined chemoradiation of cisplatin versus carboplatin in cervical carcinoma: a single institution experience from Thailand. BMC Cancer, 16, 501. https://doi.org/10.1186/s12885-016-2558-9

The International Commission on Radiation Units & Measurements (ICRU), & Groupe Européen de Curiethérapie/European Society for Radiotherapy and Oncology (GEC/ESTRO). (2016). ICRU Report 89: Prescribing, Recording, and Reporting Brachytherapy for Cancer of the Cervix. Journal of the ICRU, 13(1-2).

Thigpen, J. T., Brady, M. F., Homesley, H. D., Malfetano, J., DuBeshter, B., Burger, R. A., & Liao, S. (2004). Phase III trial of doxorubicin with or without cisplatin in advanced endometrial carcinoma: a gynecologic oncology group study. Journal of Clinical Oncology, 22(19), 3902-3908. https://doi.org/10.1200/jco.2004.02.088

Tinelli, R., Tinelli, A., Tinelli, F. G., Cicinelli, E., & Malvasi, A. (2006). Conservative surgery for borderline ovarian tumors: a review. Gynecologic Oncology, 100(1), 185-191. https://doi.org/10.1016/j.ygyno.2005.09.021

Tingthanatikul, Y., Choktanasiri, W., Rochanawutanon, M., & Weerakeit, S. (2006). Prevalence and clinical predictors of endometrial hyperplasiain anovulatory women presenting with amenorrhea. Gynecological Endocrinology, 22(2), 101-105. https://doi.org/10.1080/09513590600585997

Tingulstad, S., Hagen, B., Skjeldestad, F. E., Halvorsen, T., Nustad, K., & Onsrud, M. (1999). The risk-of-malignancy index to evaluate potential ovarian cancers in local hospitals. Obstetrics and Gynecology, 93(3), 448-452.

Tjalma, W. A., Fiander, A., Reich, O., Powell, N., Nowakowski, A. M., Kirschner, B., . . . Holl, K. (2013). Differences in human papillomavirus type distribution in high-grade cervical intraepithelial neoplasia and invasive cervical cancer in Europe. International Journal of Cancer, 132(4), 854-867. https://doi.org/10.1002/ijc.27713

Toita, T., Ohno, T., Kaneyasu, Y., Kato, T., Uno, T., Hatano, K., . . . Hiraoka, M. (2011). A consensus-based guideline defining clinical target volume for primary disease in external beam radiotherapy for intact uterine cervical cancer. Japanese Journal of Clinical Oncology, 41(9), 1119-1126. https://doi.org/10.1093/jjco/hyr096

Toita, T., Ohno, T., Kaneyasu, Y., Uno, T., Yoshimura, R., Kodaira, T., . . . Hiraoka, M. (2010). A consensus-based guideline defining the clinical target volume for pelvic lymph nodes in external beam radiotherapy for uterine cervical cancer. Japanese Journal of Clinical Oncology, 40(5), 456-463. https://doi.org/10.1093/jjco/hyp191

Toss, A., Tomasello, C., Razzaboni, E., Contu, G., Grandi, G., Cagnacci, A., . . . Cortesi, L. (2015). Hereditary ovarian cancer: not only BRCA 1 and 2 genes. BioMed research international, 2015, 341723. https://doi.org/10.1155/2015/341723

Trabert, B., Ness, R. B., Lo-Ciganic, W.-H., Murphy, M. A., Goode, E. L., Poole, E. M., . . . Ovarian Cancer Association, C. (2014). Aspirin, nonaspirin nonsteroidal anti-inflammatory drug, and acetaminophen use and risk of invasive epithelial ovarian cancer: a pooled analysis in the Ovarian Cancer Association Consortium. Journal of the National Cancer Institute, 106(2), djt431-djt431. https://doi.org/10.1093/jnci/djt431

Trillsch, F., Mahner, S., Vettorazzi, E., Woelber, L., Reuss, A., Baumann, K., . . . du Bois, A. (2015). Surgical staging and prognosis in serous borderline ovarian tumours (BOT): a subanalysis of the AGO ROBOT study. British Journal of Cancer, 112(4), 660-666. https://doi.org/10.1038/bjc.2014.648

Trimble, C. L., Kauderer, J., Zaino, R., Silverberg, S., Lim, P. C., Burke, J. J., 2nd, . . . Curtin, J. (2006). Concurrent endometrial carcinoma in women with a biopsy diagnosis of atypical endometrial hyperplasia: a Gynecologic Oncology Group study. Cancer, 106(4), 812-819. https://doi.org/10.1002/cncr.21650

Trimbos, J. B., Parmar, M., Vergote, I., Guthrie, D., Bolis, G., Colombo, N., . . . Treatment of Cancer Collaborators-Adjuvant ChemoTherapy un Ovarian, N. (2003). International Collaborative Ovarian Neoplasm trial 1 and Adjuvant ChemoTherapy In Ovarian Neoplasm trial: two parallel randomized phase III trials of adjuvant chemotherapy in patients with early-stage ovarian carcinoma. Journal of the National Cancer Institute, 95(2), 105-112.

Tropé, C. (2014). En forenklet kolposkopiguide. Gynekologen, 27(2), 35-40.

Tropé, C., Kærn, J., Vergote, I. B., Kristensen, G., & Abeler, V. (1993). Are borderline tumors of the ovary overtreated both surgically and systemically? A review of four prospective randomized trials including 253 patients with borderline tumors. Gynecologic Oncology, 51(2), 236-243. https://doi.org/10.1006/gyno.1993.1279

Tropé, C. G., Davidson, B., Dørum, A., Kærn, J., Kristensen, G. B., Paulsen, T., & Rokkones, E. (2010). Epithelial ovarian cancer. I: G. C. Peltecu & C. G. Tropé (red.), Gynecologic Oncology (s. 357–444). Bucharest: The Publishing House of the Romanian Academy.

Trovik, J., Wik, E., Werner, H. M., Krakstad, C., Helland, H., Vandenput, I., . . . Salvesen, H. B. (2013). Hormone receptor loss in endometrial carcinoma curettage predicts lymph node metastasis and poor outcome in prospective multicentre trial. European Journal of Cancer, 49(16), 3431-3441. https://doi.org/10.1016/j.ejca.2013.06.016

Uterussarkom I. (2009). Veileder i gynekologisk onkologi. Trondheim/Bergen/Oslo: Norsk gynekologisk forening.

Vaccarella, S., Herrero, R., Snijders, P. J., Dai, M., Thomas, J. O., Hieu, N. T., . . . Franceschi, S. (2008). Smoking and human papillomavirus infection: pooled analysis of the International Agency for Research on Cancer HPV Prevalence Surveys. International Journal of Epidemiology, 37(3), 536-546. https://doi.org/10.1093/ije/dyn033

Vakiani, M., Vavilis, D., Agorastos, T., Stamatopoulos, P., Assimaki, A., & Bontis, J. (1996). Histopathological findings of the endometrium in patients with dysfunctional uterine bleeding. Clinical and Experimental Obstetrics and Gynecology, 23(4), 236-239.

Vale, C. L., Tierney, J., Bull, S. J., & Symonds, P. R. (2012). Chemotherapy for advanced, recurrent or metastatic endometrial carcinoma. Cochrane Database of Systematic Reviews, (8), CD003915. https://doi.org/10.1002/14651858.CD003915.pub4

Van de Putte, G., Lie, A. K., Vach, W., Baekelandt, M., & Kristensen, G. B. (2005). Risk grouping in stage IB squamous cell cervical carcinoma. Gynecologic Oncology, 99(1), 106-112. https://doi.org/10.1016/j.ygyno.2005.05.026

van de Sande, M. A., Creutzberg, C. L., van de Water, S., Sharfo, A. W., & Hoogeman, M. S. (2016). Which cervical and endometrial cancer patients will benefit most from intensity-modulated proton therapy? Radiotherapy and Oncology, 120(3), 397-403. https://doi.org/10.1016/j.radonc.2016.06.016

van de Wetering, F. T., Verleye, L., Andreyev, H. J., Maher, J., Vlayen, J., Pieters, B. R., . . . Scholten, R. J. (2016). Non-surgical interventions for late rectal problems (proctopathy) of radiotherapy in people who have received radiotherapy to the pelvis. Cochrane Database of Systematic Reviews, 4(4), CD003455. https://doi.org/10.1002/14651858.CD003455.pub2

van der Velden, J., Fons, G., & Lawrie, T. A. (2011). Primary groin irradiation versus primary groin surgery for early vulvar cancer. Cochrane Database of Systematic Reviews, (5), CD002224. https://doi.org/10.1002/14651858.CD002224.pub2

van Lonkhuijzen, L., & Thomas, G. (2011). Palliative radiotherapy for cervical carcinoma, a systematic review. Radiotherapy and Oncology, 98(3), 287-291. https://doi.org/10.1016/j.radonc.2011.01.009

van Seters, M., van Beurden, M., & de Craen, A. J. (2005). Is the assumed natural history of vulvar intraepithelial neoplasia III based on enough evidence? A systematic review of 3322 published patients. Gynecologic Oncology, 97(2), 645-651. https://doi.org/10.1016/j.ygyno.2005.02.012

Vandenput, I., Amant, F., & Vergote, I. (2005). Peritoneal recurrences might be less common in advanced stage serous borderline ovarian tumors that were treated by laparotomy. Gynecologic Oncology, 98(3), 523; author reply 524-525. https://doi.org/10.1016/j.ygyno.2005.05.037

Vanneste, B. G., Van De Voorde, L., de Ridder, R. J., Van Limbergen, E. J., Lambin, P., & van Lin, E. N. (2015). Chronic radiation proctitis: tricks to prevent and treat. International Journal of Colorectal Disease, 30(10), 1293-1303. https://doi.org/10.1007/s00384-015-2289-4

Varma, R., Soneja, H., Bhatia, K., Ganesan, R., Rollason, T., Clark, T. J., & Gupta, J. K. (2008). The effectiveness of a levonorgestrel-releasing intrauterine system (LNG-IUS) in the treatment of endometrial hyperplasia--a long-term follow-up study. European Journal of Obstetrics, Gynecology, and Reproductive Biology, 139(2), 169-175. https://doi.org/10.1016/j.ejogrb.2008.02.022

Vasey, P. A., Atkinson, R., Coleman, R., Crawford, M., Cruickshank, M., Eggleton, P., . . . Kaye, S. B. (2001). Docetaxel-carboplatin as first line chemotherapy for epithelial ovarian cancer. British Journal of Cancer, 84(2), 170-178. https://doi.org/10.1054/bjoc.2000.1572

Vercellino, G. F., Koehler, C., Erdemoglu, E., Mangler, M., Lanowska, M., Malak, A. H., . . . Chiantera, V. (2014). Laparoscopic pelvic lymphadenectomy in 32 pregnant patients with cervical cancer: rationale, description of the technique, and outcome. International Journal of Gynecological Cancer, 24(2), 364-371. https://doi.org/10.1097/igc.0000000000000064

Vereide, A. B., Arnes, M., Straume, B., Maltau, J. M., & Ørbo, A. (2003). Nuclear morphometric changes and therapy monitoring in patients with endometrial hyperplasia: a study comparing effects of intrauterine levonorgestrel and systemic medroxyprogesterone. Gynecologic Oncology, 91(3), 526-533. https://doi.org/10.1016/j.ygyno.2003.07.002

Vergote, I., De Brabanter, J., Fyles, A., Bertelsen, K., Einhorn, N., Sevelda, P., . . . Trope, C. G. (2001). Prognostic importance of degree of differentiation and cyst rupture in stage I invasive epithelial ovarian carcinoma. Lancet, 357(9251), 176-182. https://doi.org/10.1016/s0140-6736(00)03590-x

Vergote, I., Kjørstad, K., Abeler, V., & Kolstad, P. (1989). A randomized trial of adjuvant progestagen in early endometrial cancer. Cancer, 64(5), 1011-1016.

Vergote, I., Trope, C. G., Amant, F., Kristensen, G. B., Ehlen, T., Johnson, N., . . . Reed, N. S. (2010). Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer. New England Journal of Medicine, 363(10), 943-953. https://doi.org/10.1056/NEJMoa0908806

Verma, V., Simone, C. B., 2nd, Wahl, A. O., Beriwal, S., & Mehta, M. P. (2016). Proton radiotherapy for gynecologic neoplasms. Acta Oncologica, 55(11), 1257-1265. https://doi.org/10.1080/0284186x.2016.1205218

Vernooij, F., Heintz, P., Witteveen, E., & van der Graaf, Y. (2007). The outcomes of ovarian cancer treatment are better when provided by gynecologic oncologists and in specialized hospitals: a systematic review. Gynecologic Oncology, 105(3), 801-812. https://doi.org/10.1016/j.ygyno.2007.02.030

Vistad, I., Bjørge, L., Solheim, O., Fiane, B., Sachse, K., Tjugum, J., . . . Dørum, A. (2017). A national, prospective observational study of first recurrence after primary treatment for gynecological cancer in Norway. Acta Obstetricia et Gynecologica Scandinavica, 96(10), 1162-1169. https://doi.org/10.1111/aogs.13199

Vistad, I., Fosså, S. D., Kristensen, G. B., & Dahl, A. A. (2007). Chronic fatigue and its correlates in long-term survivors of cervical cancer treated with radiotherapy. BJOG: An International Journal of Obstetrics and Gynaecology, 114(9), 1150-1158. https://doi.org/10.1111/j.1471-0528.2007.01445.x

Viswanathan, A. N., Lee, H., Hanson, E., Berkowitz, R. S., & Crum, C. P. (2006). Influence of margin status and radiation on recurrence after radical hysterectomy in Stage IB cervical cancer. International Journal of Radiation Oncology, Biology, Physics, 65(5), 1501-1507. https://doi.org/10.1016/j.ijrobp.2006.03.010

Viswanathan, A. N., Lee, L. J., Eswara, J. R., Horowitz, N. S., Konstantinopoulos, P. A., Mirabeau-Beale, K. L., . . . Wo, J. Y. (2014). Complications of pelvic radiation in patients treated for gynecologic malignancies. Cancer, 120(24), 3870-3883. https://doi.org/10.1002/cncr.28849

Viswanathan, A. N., Pinto, A. P., Schultz, D., Berkowitz, R., & Crum, C. P. (2013). Relationship of margin status and radiation dose to recurrence in post-operative vulvar carcinoma. Gynecologic Oncology, 130(3), 545-549. https://doi.org/10.1016/j.ygyno.2013.05.036

Viswanathan, A. N., & Thomadsen, B. (2012). American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part I: general principles. Brachytherapy, 11(1), 33-46. https://doi.org/10.1016/j.brachy.2011.07.003

Viswanathan, A. N., Yorke, E. D., Marks, L. B., Eifel, P. J., & Shipley, W. U. (2010). Radiation dose-volume effects of the urinary bladder. International Journal of Radiation Oncology, Biology, Physics, 76(3 Suppl), S116-122. https://doi.org/10.1016/j.ijrobp.2009.02.090

von Gruenigen, V. E., Huang, H. Q., Beumer, J. H., Lankes, H. A., Tew, W., Herzog, T., . . . Fleming, G. (2017). Chemotherapy completion in elderly women with ovarian, primary peritoneal or fallopian tube cancer - An NRG oncology/Gynecologic Oncology Group study. Gynecologic Oncology, 144(3), 459-467. https://doi.org/10.1016/j.ygyno.2016.11.033

Walboomers, J. M., Jacobs, M. V., Manos, M. M., Bosch, F. X., Kummer, J. A., Shah, K. V., . . . Munoz, N. (1999). Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. Journal of Pathology, 189(1), 12-19. https://doi.org/10.1002/(sici)1096-9896(199909)189:1<12::Aid-path431>3.0.Co;2-f

Walker, J. L., Piedmonte, M. R., Spirtos, N. M., Eisenkop, S. M., Schlaerth, J. B., Mannel, R. S., . . . Sharma, S. K. (2009). Laparoscopy compared with laparotomy for comprehensive surgical staging of uterine cancer: Gynecologic Oncology Group Study LAP2. Journal of Clinical Oncology, 27(32), 5331-5336. https://doi.org/10.1200/jco.2009.22.3248

Wang, Y., Wang, Y., Li, J., Cragun, J., Hatch, K., Chambers, S. K., & Zheng, W. (2013). Lynch syndrome related endometrial cancer: clinical significance beyond the endometrium. Journal of Hematology & Oncology, 6, 22. https://doi.org/10.1186/1756-8722-6-22

Watson, P., Bützow, R., Lynch, H. T., Mecklin, J. P., Järvinen, H. J., Vasen, H. F., . . . International Collaborative Group on, H. (2001). The clinical features of ovarian cancer in hereditary nonpolyposis colorectal cancer. Gynecologic Oncology, 82(2), 223-228. https://doi.org/10.1006/gyno.2001.6279

Weiderpass, E., Baron, J. A., Adami, H. O., Magnusson, C., Lindgren, A., Bergstrom, R., . . . Persson, I. (1999). Low-potency oestrogen and risk of endometrial cancer: a case-control study. Lancet, 353(9167), 1824-1828. https://doi.org/10.1016/s0140-6736(98)10233-7

Weinberger, V., Bednarikova, M., Cibula, D., & Zikan, M. (2016). Serous tubal intraepithelial carcinoma (STIC) - clinical impact and management. Expert Review of Anticancer Therapy, 16(12), 1311-1321. https://doi.org/10.1080/14737140.2016.1247699

Westin, S. N., Sun, C. C., Tung, C. S., Lacour, R. A., Meyer, L. A., Urbauer, D. L., . . . Bodurka, D. C. (2016). Survivors of gynecologic malignancies: impact of treatment on health and well-being. Journal of Cancer Survivorship, 10(2), 261-270. https://doi.org/10.1007/s11764-015-0472-9

Wethington, S. L., Park, K. J., Soslow, R. A., Kauff, N. D., Brown, C. L., Dao, F., . . . Gardner, G. J. (2013). Clinical outcome of isolated serous tubal intraepithelial carcinomas (STIC). International Journal of Gynecological Cancer, 23(9), 1603-1611. https://doi.org/10.1097/IGC.0b013e3182a80ac8

WHO Classification of Tumours Editorial Board (red.). (2020). Female Genital Tumours (5. utg.). (WHO Classification of Tumours volume 4). Lyon: International Agency for Research on Cancer.

Wijnen, J., de Leeuw, W., Vasen, H., van der Klift, H., Moller, P., Stormorken, A., . . . Fodde, R. (1999). Familial endometrial cancer in female carriers of MSH6 germline mutations. Nature Genetics, 23(2), 142-144. https://doi.org/10.1038/13773

Wildemeersch, D., Janssens, D., Pylyser, K., De Wever, N., Verbeeck, G., Dhont, M., & Tjalma, W. (2007). Management of patients with non-atypical and atypical endometrial hyperplasia with a levonorgestrel-releasing intrauterine system: long-term follow-up. Maturitas, 57(2), 210-213. https://doi.org/10.1016/j.maturitas.2006.12.004

Willett, C. G., Ooi, C. J., Zietman, A. L., Menon, V., Goldberg, S., Sands, B. E., & Podolsky, D. K. (2000). Acute and late toxicity of patients with inflammatory bowel disease undergoing irradiation for abdominal and pelvic neoplasms. International Journal of Radiation Oncology, Biology, Physics, 46(4), 995-998. https://doi.org/10.1016/s0360-3016(99)00374-0

Williams, S. (1998). D. M. Gershenson & W. P. McGuire (red.), Ovarian Cancer: Controversies in Management (s. 403-404). New York: Churchil Livingstone.

Winter, W. E., 3rd, Maxwell, G. L., Tian, C., Carlson, J. W., Ozols, R. F., Rose, P. G., . . . McGuire, W. P. (2007). Prognostic factors for stage III epithelial ovarian cancer: a Gynecologic Oncology Group Study. Journal of Clinical Oncology, 25(24), 3621-3627. https://doi.org/10.1200/jco.2006.10.2517

Wo, J., & Taghian, A. (2007). Radiotherapy in setting of collagen vascular disease. International Journal of Radiation Oncology, Biology, Physics, 69(5), 1347-1353. https://doi.org/10.1016/j.ijrobp.2007.07.2357

Woelber, L., Choschzick, M., Eulenburg, C., Hager, M., Jaenicke, F., Gieseking, F., . . . Mahner, S. (2011). Prognostic value of pathological resection margin distance in squamous cell cancer of the vulva. Annals of Surgical Oncology, 18(13), 3811-3818. https://doi.org/10.1245/s10434-011-1778-0

Woelber, L., Eulenburg, C., Grimm, D., Trillsch, F., Bohlmann, I., Burandt, E., . . . Prieske, K. (2016). The Risk of Contralateral Non-sentinel Metastasis in Patients with Primary Vulvar Cancer and Unilaterally Positive Sentinel Node. Annals of Surgical Oncology, 23(8), 2508-2514. https://doi.org/10.1245/s10434-016-5114-6

Woelber, L., Griebel, L. F., Eulenburg, C., Sehouli, J., Jueckstock, J., Hilpert, F., . . . Mahner, S. (2016). Role of tumour-free margin distance for loco-regional control in vulvar cancer-a subset analysis of the Arbeitsgemeinschaft Gynäkologische Onkologie CaRE-1 multicenter study. European Journal of Cancer, 69, 180-188. https://doi.org/10.1016/j.ejca.2016.09.038

Woelber, L., Kock, L., Gieseking, F., Petersen, C., Trillsch, F., Choschzick, M., . . . Mahner, S. (2011). Clinical management of primary vulvar cancer. European Journal of Cancer, 47(15), 2315-2321. https://doi.org/10.1016/j.ejca.2011.06.007

Yalvac, S., Kayikcioglu, F., Boran, N., Tulunay, G., Kose, M. F., Bilgic, S., & Haberal, A. (2002). Embolization of uterine artery in terminal stage cervical cancers. Cancer Investigation, 20(5-6), 754-758. https://doi.org/10.1081/cnv-120003543

Yamazawa, K., Hirai, M., Fujito, A., Nishi, H., Terauchi, F., Ishikura, H., . . . Isaka, K. (2007). Fertility-preserving treatment with progestin, and pathological criteria to predict responses, in young women with endometrial cancer. Human Reproduction, 22(7), 1953-1958. https://doi.org/10.1093/humrep/dem088

Yap, J. K., Fox, R., Leonard, S., Ganesan, R., Kehoe, S. T., Dawson, C. W., . . . Luesley, D. M. (2016). Adjacent Lichen Sclerosis predicts local recurrence and second field tumour in women with vulvar squamous cell carcinoma. Gynecologic Oncology, 142(3), 420-426. https://doi.org/10.1016/j.ygyno.2016.06.019

Yedema, C. A., Kenemans, P., Wobbes, T., Thomas, C. M., Bon, G. G., Mulder, C., . . . Hilgers, J. (1992). Use of serum tumor markers in the differential diagnosis between ovarian and colorectal adenocarcinomas. Tumour Biology, 13(1-2), 18-26. https://doi.org/10.1159/000217748

Ytre-Hauge, S., Husby, J. A., Magnussen, I. J., Werner, H. M., Salvesen Ø, O., Bjørge, L., . . . Haldorsen, I. S. (2015). Preoperative tumor size at MRI predicts deep myometrial invasion, lymph node metastases, and patient outcome in endometrial carcinomas. International Journal of Gynecological Cancer, 25(3), 459-466. https://doi.org/10.1097/igc.0000000000000367

Zaino, R. J., Kauderer, J., Trimble, C. L., Silverberg, S. G., Curtin, J. P., Lim, P. C., & Gallup, D. G. (2006). Reproducibility of the diagnosis of atypical endometrial hyperplasia: a Gynecologic Oncology Group study. Cancer, 106(4), 804-811. https://doi.org/10.1002/cncr.21649

Zaino, R. J., Ward, S., Delgado, G., Bundy, B., Gore, H., Fetter, G., . . . Frauenhoffer, E. (1992). Histopathologic predictors of the behavior of surgically treated stage IB squamous cell carcinoma of the cervix. A Gynecologic Oncology Group study. Cancer, 69(7), 1750-1758.

Zanagnolo, V., Minig, L. A., Gadducci, A., Maggino, T., Sartori, E., Zola, P., & Landoni, F. (2009). Surveillance procedures for patients for cervical carcinoma: a review of the literature. International Journal of Gynecological Cancer, 19(3), 306-313. https://doi.org/10.1111/IGC.0b013e3181a130f3

Zanagnolo, V., Pasinetti, B., & Sartori, E. (2004). Clinical review of 63 cases of sex cord stromal tumors. European Journal of Gynaecological Oncology, 25(4), 431-438.

Zhang, Y., Liu, H., Yang, S., Zhang, J., Qian, L., & Chen, X. (2014). Overweight, obesity and endometrial cancer risk: results from a systematic review and meta-analysis. International Journal of Biological Markers, 29(1), e21-29. https://doi.org/10.5301/jbm.5000047

Zola, P., Fuso, L., Mazzola, S., Piovano, E., Perotto, S., Gadducci, A., . . . Scambia, G. (2007). Could follow-up different modalities play a role in asymptomatic cervical cancer relapses diagnosis? An Italian multicenter retrospective analysis. Gynecologic Oncology, 107(1 Suppl 1), S150-154. https://doi.org/10.1016/j.ygyno.2007.07.028

Zola, P., Macchi, C., Cibula, D., Colombo, N., Kimmig, R., Maggino, T., . . . Kesic, V. (2015). Follow-up in Gynecological Malignancies: A State of Art. International Journal of Gynecological Cancer, 25(7), 1151-1164. https://doi.org/10.1097/igc.0000000000000498

Ødegaard, E., Staff, A. C., Langebrekke, A., Engh, V., & Onsrud, M. (2007). Surgery of borderline tumors of the ovary: retrospective comparison of short-term outcome after laparoscopy or laparotomy. Acta Obstetricia et Gynecologica Scandinavica, 86(5), 620-626. https://doi.org/10.1080/00016340701286934

Ørbo, A., Arnes, M., Hancke, C., Vereide, A. B., Pettersen, I., & Larsen, K. (2008). Treatment results of endometrial hyperplasia after prospective D-score classification: a follow-up study comparing effect of LNG-IUD and oral progestins versus observation only. Gynecologic Oncology, 111(1), 68-73. https://doi.org/10.1016/j.ygyno.2008.06.014

Ørbo, A., Arnes, M., Vereide, A. B., & Straume, B. (2016). Relapse risk of endometrial hyperplasia after treatment with the levonorgestrel-impregnated intrauterine system or oral progestogens. BJOG: An International Journal of Obstetrics and Gynaecology, 123(9), 1512-1519. https://doi.org/10.1111/1471-0528.13763

Ørbo, A., Baak, J. P., Kleivan, I., Lysne, S., Prytz, P. S., Broeckaert, M. A., . . . Tichelaar, H. J. (2000). Computerised morphometrical analysis in endometrial hyperplasia for the prediction of cancer development. A long-term retrospective study from northern Norway. Journal of Clinical Pathology, 53(9), 697-703. https://doi.org/10.1136/jcp.53.9.697

Ørbo, A., Vereide, A., Arnes, M., Pettersen, I., & Straume, B. (2014). Levonorgestrel-impregnated intrauterine device as treatment for endometrial hyperplasia: a national multicentre randomised trial. BJOG: An International Journal of Obstetrics and Gynaecology, 121(4), 477-486. https://doi.org/10.1111/1471-0528.12499

Aalders, J., Abeler, V., Kolstad, P., & Onsrud, M. (1980). Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma: clinical and histopathologic study of 540 patients. Obstetrics and Gynecology, 56(4), 419-427.

Aaltonen, L., Johns, L., Järvinen, H., Mecklin, J. P., & Houlston, R. (2007). Explaining the familial colorectal cancer risk associated with mismatch repair (MMR)-deficient and MMR-stable tumors. Clinical Cancer Research, 13(1), 356-361. https://doi.org/10.1158/1078-0432.Ccr-06-1256

Sist faglig oppdatert: 28. juni 2021